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ABSTRACT 
 
Hereditary ataxias are a group of rare neurological genetic disorders characterized by debilitating signs 
and symptoms that include progressive lack of coordination of gait and is also often associated with 
poor coordination of hands, speech, and eye movements. The different forms of ataxia are diagnosed 
by family history, physical examination, neuroimaging, and molecular genetic testing. To date, no 
specific treatments exist for hereditary ataxias. Oculomotor apraxia type 2 (AOA2) is part of a 
subgroup of autosomal recessive cerebellar ataxias (ARCA) characterized by defects in genes 
responsible for the recognition and/or repair of DNA damage. AOA2 is caused by mutations in the 
gene SETX (coding for senataxin), and cells from these patients have been characterized by the 
presence of oxidative stress, defects in the repair of oxidative DNA lesions, and abnormal RNA 
processing and termination of transcription.  
 
Recent studies suggest that senataxin is involved in coordinating events between DNA replication and 
ongoing transcription. To further understand the physiological role of senataxin, we generated the first 
Setx
-/-
 mouse model. In this Report, the phenotypic characterization of this mouse model is discussed. 
An essential role for senataxin in spermatogenesis was demonstrated by showing that the absence of 
senataxin led to the persistence of DNA double strand breaks, disruption of homologous recombination 
and an incomplete diffusion of DNA damage response proteins on the broader XY chromatin. 
Senataxin localized to the XY body during the pachytene stage of spermatogenesis and this was 
dependent on Brca1, which functions early in meiotic sex chromosome inactivation (MSCI) to recruit 
other DNA damage response proteins to the XY body. We observed that there was no diffusion of Atr, 
a key regulator of the DNA damage response during MSCI, to the broader XY chromatin in Setx
-/-
 
pachytene-staged spermatocytes, indicating abnormal Atr activity and signalling during MSCI. The 
persistent activity of RNA polymerase II on the XY body, the disrupted localization of 
heterochromatin markers such as ubH2A, as well as the abnormal expression of XY genes 
demonstrated an essential role for senataxin at the interface of replication and transcription, and in 
coordinating MSCI. The end result was sterility in male Setx
-/-
 mice due to defects in MSCI, increased 
apoptosis, and a failure to complete meiosis during spermatogenesis. 
 
Recent reports have also shown a role for senataxin in resolving R-loops, which are DNA/RNA 
hybrids that occur naturally during transcription behind elongating RNA Polymerase II. Here, the in 
vivo accumulation of R-loops in the testes of Setx
-/-
 mice as well as in that of other ARCA mouse 
models (Atm, Aptx and Tdp1) is reported. This represents the first evidence of R-loop accumulation in 
such mouse models and demonstrates that R-loops can contribute significantly towards genome 
iii 
 
instability. This correlates with the perturbed fertility observed in these disorders. Additionally, we 
also provide further evidence that R-loop formation requires both the activity of replication and 
transcription, and that genomic instability is a consequence of disrupted transcription in the presence 
of DNA double strand breaks that arise during DNA replication or recombination. While R-loops have 
been identified as a substrate for senataxin, the absence of R-loops in post-mitotic tissues may reflect a 
regulatory role for senataxin in transcription and/or RNA processing that does not involve the 
resolution of R-loops per se. AOA2 may represent a novel “RNAopathy” in which defects in senataxin 
can affect the fidelity of the transcriptome. Altogether, these findings reveal a complex and 
coordinated network between transcription, RNA processing, and DNA repair pathways, and support 
the emerging importance of RNA processing factors, such as senataxin, in maintaining genome 
stability. 
iv 
 
DECLARATION BY AUTHOR 
 
This thesis is composed of my original work, and contains no material previously published or written 
by another person except where due reference has been made in the text. I have clearly stated the 
contribution by others to jointly-authored works that I have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical assistance, 
survey design, data analysis, significant technical procedures, professional editorial advice, and any 
other original research work used or reported in my thesis. The content of my thesis is the result of 
work I have carried out since the commencement of my research higher degree candidature and does 
not include a substantial part of work that has been submitted to qualify for the award of any other 
degree or diploma in any university or other tertiary institution. I have clearly stated which parts of my 
thesis, if any, have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, 
subject to the General Award Rules of The University of Queensland, immediately made available for 
research and study in accordance with the Copyright Act 1968. 
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright holder(s) 
of that material. Where appropriate I have obtained copyright permission from the copyright holder to 
reproduce material in this thesis. 
 
 
 
 
 
 
 
 
v 
 
PUBLICATIONS DURING CANDIDATURE 
 
R-Loops in Proliferating Cells but Not in the Brain: Implications for AOA2 and Other 
Autosomal Recessive Ataxias. Yeo AJ, Becherel OJ, Luff JE, Cullen JK, Wongsurawat T, 
Jenjaroenpoon P, Kuznetsov VA, McKinnon PJ, Lavin MF. 2014. PLoS One. 9(3): e90219. 
 
Senataxin Protects the Genome: Implications for Neurodegeneration and other Abnormalities. 
Lavin MF, Yeo AJ and Becherel OJ. 2013. Journal of Rare Diseases. Vol I (Addendum): e25230. 
 
Senataxin saves Sperm- World of Reproduction Biology. Feature article written by Charlotte 
Shubert. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera AM, Woods R, Fleming J, 
Carrie D, McKinney K, Xu X, Deng C, Lavin MF. 2013. Biology of Reproduction. 89 (1) 1, 1-2. 
 
Senataxin Plays an Essential Role with DNA Damage Response Proteins in Meiotic 
Recombination and Gene Silencing. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera 
AM, Woods R, Fleming J, Carrie D, McKinney K, Xu X, Deng C, Lavin MF. 2013. PLoS Genetics. 
9(4): e1003435. 
  
PUBLICATIONS INCLUDED IN THIS THESIS 
 
Publication citation – incorporated as Chapter 5.  
 
R-Loops in Proliferating Cells but Not in the Brain: Implications for AOA2 and Other 
Autosomal Recessive Ataxias. Yeo AJ, Becherel OJ, Luff JE, Cullen JK, Wongsurawat T, 
Jenjaroenpun P, Kuznetsov VA, McKinnon PJ, Lavin MF. 2014. PLoS One. 9(3): e90219. 
 
Contribution of Authors: 
 
Contributor Statement of Contribution 
Author (Abrey J Yeo) 
Designed experiments (60%) 
Performed experiments (80%) 
Analysed the data (70%) 
Wrote the paper (60%) 
Author (Olivier J Becherel) Designed experiments (20%) 
vi 
 
Performed experiments (15%) 
Analysed the data (20%) 
Wrote paper (15%) 
Author (John E. Luff) Managed mouse breeding program 
Author (Jason K. Cullen) Performed experiments (5%) 
Author (Thidathip Wongsurawat) 
Provided prediction program 
Contributed to Figure 4  
Author (Piroon Jenjaroenpoon) Provided prediction program 
Author (Vladimir A. Kuznetsov) Wrote the paper (5%) 
Author (Peter J. McKinnon) Provided Tdp1 and Aptx mice 
Author (Martin F. Lavin) 
Designed experiments (20%) 
Analysed the data (20%) 
Wrote paper (20%) 
 
vii 
 
CONTRIBUTIONS BY OTHERS TO THE THESIS  
 
Prof. Martin F. Lavin was the Principal Investigator for the Project and contributed to discussion on 
study design, data interpretation and provided comments on the Thesis and publications. 
 
Dr. Olivier J. Becherel was the co-supervisor and contributed to discussion on study design, data 
interpretation and provided comments on the Thesis and publications. 
 
Dr. Mark Graham performed the liquid chromatography mass spectrometry and assisted in 
interpreting the data. 
 
Mr. John Luff was in charge of the mouse-breeding program. 
 
STATEMENT OF PARTS OF THE THESIS SUBMITTED TO QUALIFY FOR THE AWARD 
OF ANOTHER DEGREE 
 
None. 
 
viii 
 
ACKNOWLEDGEMENTS 
 
I would first like to thank God for everything. He has blessed me with so much throughout my Ph.D.  
 
I would next like to thank my supervisors, Prof. Martin F. Lavin and Dr. Olivier J. Becherel for their 
guidance and support these few years. A big thank you to Martin for taking me in when I was a green 
horn during my Honours, for believing in me that I could complete a Ph.D. and for inspiring me to 
always be steadfast in my research. I would also like to say a special thank you to Olivier, who has 
always been there for me not only as a mentor but also as a dear friend. Thank you for all your 
encouragement and patience, and for making this journey more fun to travel on. I would also like to 
acknowledge the financial support provided to me by the University of Queensland, the QIMR 
Berghofer Medical Research Institute, the BrAshA-T Foundation, the Australian National Health & 
Medical Research Council (NHMRC) and the Australian Research Council (ARC), without which I 
would not have been able to embark on this course.  
 
To my parents, Anthony and Jane, thank you so much for giving me the opportunity and support to 
study in Australia. Thank you for always being there for me all these years and for all your sacrifices 
and prayers from afar. Dad, thank you for all your encouragement, practical advice and for keeping me 
on track. Mum, thank you for always being my sounding board, for your nurturing love and support. I 
love you both so much and no words can express the heartfelt gratitude I have for you both. 
Appreciation also goes out to my one and only sister, Audrey, who has shared in my many moments of 
tears and joy. 
 
I would also like to thank my fiancé, Clement, for always being there for me through thick and thin. 
Thank you for your patience and for understanding my Ph.D.-related mood swings during this time.  
 
Lastly, I would like to thank all my colleagues at UQCCR and QIMR, Dr. Amanda Kijas, Dr. Sergei 
Kozlov, Dr. Magtouf Gatei, Dr. Yi Chieh Lim, Ms. Aine Farrell, Mr. John Luff, Mr. Romal Stewart 
and Ms. Hazel Quek for being part of my journey, and for all the advice, fun and laughter shared with 
me during this time. 
 
 
 
ix 
 
KEYWORDS 
 
senataxin, mouse model, meiosis, R-loops, DNA damage repair, spermatogenesis, transcription. 
 
AUSTRALIAN AND NEW ZEALAND STANDARD RESEARCH CLASSIFICATIONS 
(ANZSRC) 
 
ANZSRC code: 060103 Cell Development, Proliferation and Death, 40% 
ANZSRC code: 060199, Biochemistry and Cell Biology not elsewhere classified, 40% 
ANZSRC code: 060408 Genomics, 20% 
 
FIELDS OF RESEARCH (FOR) CLASSIFICATION 
 
FoR code: 0601, Biochemistry and Cell Biology, 70% 
FoR code: 0699, Other Biological Sciences, 20% 
FoR code: 0604, Genomics, 10% 
x 
 
LIST OF FIGURES 
 
Chapter 1: 
 
1.1 ATM activation and signalling to downstream substrates in response to DNA DSBs 
1.2 Mechanism of action of Topo I 
1.3 Aprataxin removes 5’-AMP from abortive DNA ligation intermediates 
1.4 Distribution of mutations along SETX 
1.5 Schematic domain organization of SETX and related proteins 
1.6 Role for senataxin in R loop resolution 
1.7 Role of senataxin in relations to neurodegeneration  
1.8 Effects of ROS/RNS on cells 
1.9 Models of DNA repair pathways 
1.10 DNA strand break repair pathways during nervous system development  
1.11 Process of spermatogenesis 
1.12 Schematic time line of the first wave of spermatogenesis 
1.13 Different stages of synaptonemal complex (SC) formation in mouse spermatocytes 
1.14 Schematic diagram of DNA repair proteins in meiotic recombination  
1.15 The initiation of MSCI 
1.16 Alternative splicing mechanism 
1.17 Potential models of transcriptional R-loops mediated DNA damage 
1.18 R-loops prevent methylation of CpG island promoters 
 
Chapter 3: 
 
3.1 Targeted disruption of mouse Setx gene 
3.2 Disruption of the Setx gene in Setx
-/-
 mice 
3.3 Absence of neurological phenotype and ataxia in Setx
-/-
 mice 
3.4 No gross cellular or structural differences in brain or cerebellum of Setx
-/-
 mice 
3.5 Setx
-/-
 mice have normal Purkinje cell arrangement 
3.6 Defect in spermatogenesis in Setx
-/-
 mice 
3.7  Normal ovarian structure in Setx
-/-
 mice 
3.8 Block in meiosis at pachytene stage in Setx
-/-
 spermatocytes 
3.9 Increased apoptosis in germ cells in Setx
-/-
 mice 
3.10  Persistence of DNA DSBs (γH2AX) in Setx-/- spermatocytes 
xi 
 
3.11 Persistence of DNA DSBs (Rad51)  in Setx
-/-
 spermatocytes 
3.12 Absence of crossing-over in Setx
-/-
 spermatocytes 
3.13 Similar expression levels of Rad51 and Mlh1in Setx mice 
3.14 Senataxin localizes to the XY chromosomes during meiosis 
3.15 Aberrant meiotic sex chromosome inactivation (MSCI) in Setx
-/-
 spermatocytes 
 
Chapter 4: 
 
4.1 SUMO is confined to the axial element of the XY chromosomes in Setx
-/-
 spermatocytes 
4.2 Senataxin interacts with SUMO-1 at the XY chromosomes in Setx
+/+
 spermatocytes 
4.3 Excision of bands following SUMO-1 immunoprecipitation from Setx
+/+
 and Setx
-/-
 testes 
4.4 Atrip is SUMOylated in spermatocytes of Setx
+/+
 but not Setx
-/-
 mice 
4.5 Normal recruitment of Brca1 in Setx
+/+
 and Setx
-/-
 spermatocytes 
4.6 Recruitment of senataxin is dependent on Brca1 
4.7 No direct interaction between senataxin and Brca1 
4.8 Decreased levels of TopBP1 on XY chromosomes of Setx
-/-
 spermatocytes 
4.9 Lack of diffusion of Atr over XY chromosomes in Setx
-/-
 spermatocytes 
4.10 Lack of diffusion of p-Atr (S428) over XY chromosomes in Setx
-/-
 spermatocytes 
4.11 Decreased levels of Atrip on XY chromosomes in Setx
-/-
 spermatocytes 
4.12 Lack of diffusion of p-Rpa (S33) over XY chromosomes in Setx
-/-
 spermatocytes 
4.13 Decreased levels of p-Chk1 (S317) on XY chromosomes in Setx
-/-
 spermatocytes 
4.14 DDR protein levels in Setx
+/+
 and Setx
-/-
 testes 
4.15 Mis-localization of Nek1 in Setx
-/-
 spermatocytes 
4.16 Differential localization of ubH2A in Setx
-/-
 spermatocytes 
4.17 Differential formation of heterochromatin of XY chromosomes in Setx
-/-
 spermatocytes 
4.18 Lack of recruitment of Chd4 over XY chromosomes in Setx
-/-
 spermatocytes 
4.19 In-situ interaction of senataxin with Chd4 at the XY chromosomes in Setx
+/+
 spermatocytes 
during MSCI 
4.20 Molecular mechanism of MSCI failure in in Setx
-/-
 mice 
 
Chapter 5: 
 
5.1 Treatment of Atm and Aptx mice with topotecan hydrochloride induces severe weight loss 
5.2 Induction of R-loops in proliferating cells after topotecan hydrochloride treatment 
xii 
 
5.3 Topotecan hydrochloride treatment does not induce R-loop formation in post-mitotic nervous 
tissues in Atm
-/- 
mice 
5.4 Increased R-loop formation in topotecan hydrochloride-treated Atm
-/-
 and Aptx
-/-
 mice 
5.5 Increased R-loop formation at Fra8E1 in testes of Setx
-/-
 mice 
5.6 R-loop formation sites predicted by QuadFinder on the mouse XY genes Ube1y and Tktl1 
5.7 PCR amplification of predicted R-loop formation sites from DRIP assay performed in Setx 
mice 
5.8 Problems that can arise from R-loop accumulation 
 
Chapter 6: 
 
6.1 Senataxin in proliferating and post-mitotic cells 
 
xiii 
 
LIST OF TABLES 
 
Chapter 1: 
 
1.1 Genetic and clinical features of ARCAs associated with defects in DNA repair 
1.2 Neurological disorders associated with RNA processing defects 
 
Chapter 2: 
 
2.1 Description of primers for genotyping of animals 
2.2 Description of primary antibodies for immunofluorescence 
2.3 Description of secondary antibodies for immunofluorescence  
2.4 Description of primary antibodies for PLA 
2.5 Description of primers for RT-PCR 
2.6 Description of primary antibodies for immunoblotting 
2.7  Description of secondary antibodies for immunoblotting 
2.8 Description of primers for DRIP assay 
 
Chapter 3: 
 
3.1 Essential role for senataxin in spermatogenesis and germ cell maturation 
 
xiv 
 
LIST OF COMMONLY USED ABBREVIATIONS 
 
8-oxo-dG 8’-oxo-2’-deoxy guanosine 
γH2AX Phosphorylated histone H2AX 
ALS4  Amyotrophic lateral sclerosis type 4 
AOA1  Ataxia oculomotor apraxia type I 
AOA2  Ataxia oculomotor apraxia type II 
ARCA  Autosomal recessive cerebellar ataxia 
A-T  Ataxia Telangiectasia 
A-TLD Ataxia telangiectasia-like Disorder 
ATM  Ataxia-telangiectasia mutated 
ATR  Ataxia telangiectasia and Rad3 related  
ATRIP  ATR interacting protein 
bp  Base pair 
BRCA1 Breast cancer 1 
C3ABR Control lymphoblastoid cell line 
CHD4  Chromodomain helicase DNA binding protein 4 
CHK1  Checkpoint kinase 1 
DDR  DNA damage repair 
DMC1  DNA Meiotic Recombinase 1 
DRIP  DNA:RNA immunoprecipitation 
DSB  Double strand break 
dsDNA Double-stranded DNA 
H3K4me1 Histone H3 Lysine 4 (mono-methylated) 
H&E  Haematoxylin & Eosin 
HR  Homologous recombination 
IP  Immunoprecipitation 
iPSCs  Induced pluripotent stem cells 
kb  Kilo base 
LCL  Lymphoblastoid cell line 
MDC1  Mediator of DNA-damage checkpoint 1 
MLH1  MutL homolog 1 
MRN  MRE11-RAD50-NBS  
MS  Mass spectrometry 
MSCI  Meiotic sex chromosome inactivation 
xv 
 
MSH4/5 MutS Homolog 4/5 
NuRD  Nucleosome remodeling deacetylase 
ONSCs Olfactory neural stem cells 
PCR  Polymerase chain reaction 
RLFS  R-loop forming site 
RNAPII RNA polymerase II 
RPA  Replication protein A 
RT-PCR Reverse-transcriptase polymerase chain reaction 
SCAN1 Spinocerebellar ataxia with axonal neuropathy type I 
SCP3  Synaptonemal complex protein 3 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SETX  Senataxin 
SSB  Single strand break 
ssDNA Single-stranded DNA 
SUMO  Small ubiquitin-like modifier 
TopBP1 DNA topoisomerase 2-binding protein 1 
TAE  Tris-Acetate-EDTA  
TDP1  Tyrosyl-DNA phosphodiesterase 1 
TUNEL  Terminal deoxynucleotidyl transferase dUTP nick end labelling 
ubH2A Ubiquitinated histone H2A 
WT  Wild type 
 
xvi 
 
 
TABLE OF CONTENTS 
 
ABSTRACT .............................................................................................................................................. ii 
DECLARATION BY AUTHOR ............................................................................................................. iv 
PUBLICATIONS DURING CANDIDATURE ....................................................................................... v 
PUBLICATIONS INCLUDED IN THIS THESIS ................................................................................... v 
CONTRIBUTIONS BY OTHERS TO THE THESIS ............................................................................ vii 
STATEMENT OF PARTS OF THE THESIS SUBMITTED TO QUALIFY FOR THE AWARD OF 
ANOTHER DEGREE ............................................................................................................................. vii 
ACKNOWLEDGEMENTS ................................................................................................................... viii 
KEYWORDS ........................................................................................................................................... ix 
AUSTRALIAN AND NEW ZEALAND STANDARD RESEARCH CLASSIFICATIONS (ANZSRC)ix 
FIELDS OF RESEARCH (FOR) CLASSIFICATION ........................................................................... ix 
LIST OF FIGURES .................................................................................................................................. x 
LIST OF COMMONLY USED ABBREVIATIONS ............................................................................ xiv 
 
CHAPTER 1 Literature Review ............................................................................................................ 1 
1.1Autosomal recessive cerebellar ataxias ................................................................................................ 3 
1.1.1 Ataxia-Telangiectasia (A-T) ................................................................................................... 4 
1.1.2 Ataxia-Telangiectasia-related disorders ................................................................................. 6 
1.1.3 Spinocerebellar ataxia with axonal neuropathy (SCAN1) ...................................................... 8 
1.1.4 Ataxia oculomotor apraxia type I (AOA1) ............................................................................. 9 
1.1.5 Ataxia oculomotor apraxia type II (AOA2) .......................................................................... 10 
1.2 DNA damage and DNA repair .......................................................................................................... 14 
1.2.1 Oxidative stress and DNA damage ....................................................................................... 14 
1.2.2 DNA strand break repair ....................................................................................................... 16 
1.2.2.1  Single strand break (SSB) repair ................................................................................................. 16 
1.2.2.2  Double strand break (DSB) repair ............................................................................................... 16 
xvii 
 
1.3 DNA Repair & Spermatogenesis ...................................................................................................... 19 
1.3.1 Spermatogenesis ................................................................................................................... 19 
1.3.2 Meiotic Sex Chromosome Inactivation (MSCI) ................................................................... 24 
1.4 Transcription regulation & disease ................................................................................................... 25 
1.4.1 Aberrant splicing & neurodegeneration ................................................................................ 25 
1.4.2 Transcription regulation & genomic instability .................................................................... 28 
1.4.2.1  R-loops accumulation can cause genomic instability ............................................................ 28 
1.4.2.2  R-loops & gene expression (CpG methylation) ...................................................................... 31 
1.4.2.3  G-quadruplexes & R-loop formation .......................................................................................... 32 
1.5 Aims of Project ................................................................................................................................. 33 
 
CHAPTER 2: Materials & Methods ................................................................................................... 35 
2.1 Animal husbandry & genotyping ...................................................................................................... 36 
2.2 Cell culture ........................................................................................................................................ 37 
2.3 Senataxin immunoprecipitation ........................................................................................................ 37 
2.4 Histological analyses of Setx mouse tissues ..................................................................................... 38 
2.5 Immunofluorescence ......................................................................................................................... 38 
2.6 TUNEL assay .................................................................................................................................... 40 
2.7 Spermatocyte spreads ........................................................................................................................ 41 
2.8 Proximity ligation assay (PLA)......................................................................................................... 41 
2.9 RT-PCR & gene expression analyses ............................................................................................... 42 
2.10 Immunoprecipitation of SUMOylated proteins from Setx
+/+
 and Setx
-/-
 testes ............................... 43 
2.11 Tryptic digestion of SUMOylated proteins from mice spermatocytes for Mass Spectrometry ...... 44 
2.12 Immunoblotting for DDR proteins from Setx
+/+
 and Setx
-/-
 testes .................................................. 44 
2.13 Transfection of HeLa and U2OS cells with Stealth
TM
 siRNA ........................................................ 46 
2.14 Treatment of HeLa and U2OS cells with Camptothecin and Actinomycin D ................................ 46 
2.15 DNA:RNA immunoprecipitation assay (DRIP) ............................................................................. 47 
2.16 PCR analyses for DRIP assay ......................................................................................................... 48 
xviii 
 
CHAPTER 3 Characterization of the Setx
-/-
 Mouse .......................................................................... 49 
3.1 Introduction ....................................................................................................................................... 50 
3.2 Results ............................................................................................................................................... 52 
3.2.1 Generation of Setx
-/-
 mice ..................................................................................................... 52 
3.2.2 Absence of neurological phenotype in Setx
-/-
 mice............................................................... 53 
3.2.4 Senataxin is essential for male germ cell development and fertility .................................... 56 
3.2.5 Defects in homologous recombination in Setx
-/-
 spermatocytes ........................................... 60 
3.2.6 Defect in meiotic sex chromosome inactivation (MSCI) in Setx
-/-
 spermatocytes ............... 65 
3.3 Discussion ......................................................................................................................................... 69 
 
CHAPTER 4: Senataxin regulates Atr activity and chromatin remodeling during MSCI ........... 72 
4.1 Introduction ....................................................................................................................................... 73 
4.2 Results ............................................................................................................................................... 74 
4.2.1 Defect in SUMOylation in spermatocytes of Setx
-/-
 mice during MSCI .............................. 74 
4.2.2 Senataxin is SUMOylated ..................................................................................................... 76 
4.2.3 Identification of SUMOylated proteins- Candidate selected: Atrip ..................................... 78 
4.2.4 Normal recruitment of Brca1 and TopBP1 observed in spermatocytes of Setx
-/-
 mice during 
MSCI .................................................................................................................................... 81 
4.2.5 Defect in Atr-Atrip signaling in Setx
-/-
 mice ......................................................................... 84 
4.2.6 Defect in XY heterochromatin formation in Setx
-/-
 mice ...................................................... 92 
4.3 Discussion ....................................................................................................................................... 97 
 
CHAPTER 5: Senataxin & R-loop Resolution ................................................................................. 104 
5.1 Introduction ..................................................................................................................................... 105 
5.3 Results (continued) ......................................................................................................................... 106 
5.3.1 DNA damage induces R-loop accumulation in proliferative tissues in Atm
-/-
 and  
 Aptx
-/- 
mice .......................................................................................................................... 106 
5.3.2 R-loops accumulate along the mouse WWOX and XY genes in Setx
-/- 
spermatocytes ..... 110 
xix 
 
5.4 Discussion ....................................................................................................................................... 114 
 
CHAPTER 6: General Discussion & Future Directions ................................................................. 118 
6.1 General discussion .......................................................................................................................... 119 
6.2 Future directions ............................................................................................................................. 126 
 
REFERENCES .................................................................................................................................... 129 
APPENDIX .......................................................................................................................................... 151 
 
APPENDIX I 
 
Senataxin Plays an Essential Role with DNA Damage Response Proteins in Meiotic 
Recombination and Gene Silencing. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera 
AM, Woods R, Fleming J, Carrie D, McKinney K, Xu X, Deng C, Lavin MF. 2013. PLoS Genetics. 
9(4): e1003435. 
 
APPENDIX II 
 
Senataxin saves Sperm- World of Reproduction Biology. Feature article written by Charlotte 
Shubert. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera AM, Woods R, Fleming J, 
Carrie D, McKinney K, Xu X, Deng C, Lavin MF. 2013. Biology of Reproduction. 89 (1) 1, 1-2. 
 
APPENDIX III 
 
Senataxin Protects the Genome: Implications for Neurodegeneration and other Abnormalities. 
Lavin MF, Yeo AJ and Becherel OJ. 2013. Journal of Rare Diseases. Vol I (Addendum): e25230. 
 
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 Literature Review 
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1.1 Autosomal recessive cerebellar ataxias 
 
Autosomal recessive cerebellar ataxias (ARCAs) are a diverse group of rare neurodegenerative 
disorders that result from cerebellar atrophy and spinal tract dysfunction, and can cause various 
neurological, ophthalmological, and in some cases, systemic symptoms
1-3
. Several distinguishable 
groups of ARCAs, based on causal pathological mechanisms include congenital ataxias, 
degenerative ataxias, ataxias associated with metabolic dysfunction and ataxias with DNA damage 
repair defects
4
.  
 
This study focuses on a subset of ARCAs associated with defective DNA damage repair 
mechanisms, and we aim to understand how gene transcription regulation and aberrant RNA 
processing may contribute to neurodegeneration as observed in patients suffering from these 
disorders. This subset of related ARCAs include Ataxia Telangiectasia (A-T), Ataxia 
Telangiectasia-like Disorder (A-TLD), Ataxia Oculomotor Apraxia Types 1 and 2 (AOA1 and 
AOA2), juvenile onset of Amyotrophic Lateral Sclerosis 4 (ALS4), and Spinocerebellar Ataxia with 
Axonal Neuropathy Type 1 (SCAN1) 
5,6
, which will be introduced in the following sections. The 
focus of the present study is AOA2 and its clinical, biochemical and genetic aspects will be 
discussed in greater detail in this report. 
 
Disease Gene/Protein 
Age of 
onset 
(years) 
Clinical features 
Ataxia Telangiectasia 
(A-T) 
ATM 
ATM 
2-6 
Cerebellar ataxia, oculomotor apraxia, 
predisposition to cancer, 
immunodeficiency, radiosensitivity, 
increased α-feto protein levels 
Ataxia Telangiectasia-
like Disorder (A-TLD) 
MRE11A 
MRE11 
2-6 
Cerebellar ataxia, oculomotor apraxia, 
peripheral neuropathy, radiosensitivity 
Nijmegen Breakage 
Syndrome (NBS) 
NBS1 
NBS1 
1-4 
Microcephaly, peripheral neuropathy, 
growth retardation, immunodeficiency, 
predisposition to cancer, radiosensitivity 
Nijmegen Breakage 
Syndrome-Like (NBS-
like) Disorder 
RAD50 
RAD50 
 
Microcephaly, growth retardation, 
chromosomal instability, ataxia 
4 
 
 
Table 1.1: Genetic and clinical features of ARCAs associated with defects in DNA repair. 
Name of disorder, mutated gene, dysfunctional protein, age of onset of disorder and symptoms of 
disorder listed. Table adapted from Palau 2006
4
. 
 
 
1.1.1 Ataxia-Telangiectasia (A-T) 
 
Ataxia Telangiectasia (A-T) is a multi-systemic disorder characterized by ataxia resulting from 
cerebellar degeneration, in particular, from the loss of Purkinje cells
7
. Clinical symptoms of A-T 
include oculocutaneous telangiectasia, apraxia, immunodeficiency, predisposition to cancers (in 
particular lymphoid cancers), hypersensitivity to ionizing radiation (IR) and increased α-feto protein 
levels
8,9
. Other characteristics of A-T include dysarthric speech, choreoathetosis, hypogonadism and 
sterility, growth and mental retardation
10
. The incidence of A-T is estimated to be 1 in every 40,000 
to 100,000 live births in the US and has an early onset of between 2 to 3 years, with children almost 
always requiring wheelchairs by the age of 10
10,11
. A-T patients often succumb to respiratory 
infections such as pneumonia. These infections can occur during ingestion of food due to the 
inability of A-T patients to coordinate breathing and swallowing 
12
. 
 
The causative gene for A-T is Ataxia Telangiectasia Mutated (ATM) 
13
 and most mutations (e.g. 
nonsense, frameshift, point mutations) giving rise to A-T destabilizes ATM protein 
14
. Patients with 
less clinically severe A-T display either reduced levels of functional protein or normal levels of 
ATM with significantly reduced activity
15
. ATM is mapped to chromosome 11q22-23, and encodes 
a ~350 kDa serine-threonine protein kinase that belongs to the phosphoinositide 3-kinase related 
Ataxia Oculomotor 
Apraxia Type 1 
(AOA1) 
APTX 
Aprataxin 
2-6 
Cerebellar ataxia, oculomotor apraxia, 
peripheral neuropathy, 
hypoalbuminaemia, 
hypercholesterolaemia 
Ataxia Oculomotor 
Apraxia Type 2 
(AOA2) 
SETX 
Senataxin 
11-22 
Cerebellar ataxia, oculomotor apraxia, 
elevated α-feto protein levels, peripheral 
neuropathy 
Spinocerebellar Ataxia 
with Axonal 
Neuropathy Type 1 
(SCAN1) 
TDP1 
Tyrosyl-DNA 
phosphodiesterase I 
10-20 
Cerebellar ataxia, axonal neuropathy 
with progressive loss of sensation in the 
hands and legs, decreased serum levels 
of albumin and cholesterol 
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protein kinase (PI3KK) family
2,13
. ATM is predominantly found in the nucleus, although low levels 
of cytoplasmic forms have also been reported
2,16
.  
 
The most well characterized role of ATM is its participation in a signaling cascade that occurs in 
response to DNA double-strand breaks (DSBs) caused by damaging agents, and in cell-cycle 
checkpoints activation
17
. Upon the occurrence of DSBs, inactive dimeric ATM undergoes auto-
phosphorylation and becomes an active monomer which subsequently phosphorylates and activates 
various protein substrates such as p53, breast cancer-associated 1 (BRCA1) and checkpoint kinase 2 
(CHK2), all of which are involved in cell-cycle regulation
16,18
 (Fig 1.1). ATM is also involved in 
physiological DSB events such as that occurring in meiosis, during the maintenance of telomeres, 
and during DNA homologous recombination (HR) in immune system maturation
13
. Cells cultured 
from A-T patients show sensitivity to IR and radio-resistant DNA synthesis with abnormal G1/S and 
G2/M checkpoints
19
. Induction of p53, a key player involved in IR-induced apoptosis, was found to 
be decreased in these cells after irradiation as compared to wildtype cells, further supporting the 
signaling role for ATM in DSB repair
20
.  
 
ATM also interacts directly with the MRN complex, a heterotrimeric group of proteins which 
consists of MRE11, RAD50 and NBS1, which is involved in maintaining genome stability by 
initiating DNA damage signaling during DSB events
13,21
. Deficiency in ATM results in 
chromosomal instability and early senescence as seen in cells cultured from A-T patients
20
. The 
importance of the interaction between ATM and the MRN complex is observed in other A-T-related 
syndromes that result from mutations in NBS1 (causing Nijmegen Breakage Syndrome), RAD50 
(causing Nijmegen Breakage Syndrome-like disorder)
22
 and MRE11 (causing Ataxia-
Telangiectasia-Like Disorder)
13
 which will be discussed in sections 1.1.2.  
 
Several Atm
-/-
 mouse models have been generated previously and some phenotypical similarities 
between these models and A-T patients were observed. Atm
-/-
 mice displayed growth retardation, 
infertility, sensitivity to IR, immunological abnormalities and high incidences of thymic 
lymphomas
7,20,23,24
. However, neither histological evidences of ocular telangiectasia nor 
neurodegeneration were observed despite mild abnormalities in motor function
7,20,25
.  
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Fig 1.1: ATM activation and signaling to downstream substrates in response to DNA DSBs. 
Upon formation of a DNA DSB, ATM is recruited to break sites by the MRN complex, a DNA 
DSB sensor. It then undergoes autophosphorylation and subsequently initiates the DNA damage 
response by phosphorylating downstream substrates such as 53BP1, BRCA1, FANCD2 and MDC1, 
which are proteins involved in DNA damage repair and cell cycle checkpoints. Image taken from 
Lavin 2008 
2
. 
 
 
1.1.2 Ataxia-Telangiectasia-related disorders  
 
MRE11A encodes the MRE11 protein which is the 1
st
 component of the MRN complex that acts 
upstream of ATM to detect DSBs
15
. MRE11 contains a nuclease domain which is one of the most 
highly conserved components of DNA damage repair (DDR) factors, with orthologues observed 
even in organisms such as the bacteriophage T4
26
. A deficiency in MRE11 destabilizes the MRN 
complex and thus compromises genomic integrity
13
. Mutations in the MRE11A gene that lead to a 
loss of protein function results in Ataxia Telangiectasia-Like Disorder (A-TLD). Clinical symptoms 
of A-TLD are similar to but not as severe as that seen in A-T. A-TLD has a later onset and slower 
disease progression as compared to A-T. Patients with A-TLD display neurodegeneration, 
peripheral neuropathy and oculomotor apraxia but neither telangiectasia, cancer predisposition nor 
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immune deficiencies
27
. Null mutants for Mre11 in mice are embryonic lethal, indicating that it is 
required for development
28
. Knock-in mutant mice for Mre11 harboring different point mutations 
display a range of defects that include DNA damage sensitivity, reduced fertility, early cellular 
senescence, a reduction in class-switch recombination and impaired DNA DSB repair in B cells 
28,29
. 
 
NBS1 is the 2
nd
 component of the MRN complex and is also an ATM substrate involved in the S 
phase checkpoint of the cell cycle following DNA damage
30
. Hypomorphic mutations in the NBS1 
gene result in Nijmegen Breakage Syndrome (NBS). Clinical symptoms of NBS are also similar to 
that seen in A-T and include immunodeficiency, chromosomal instability, sensitivity to IR and a 
predisposition to hematopoietic cancers
31
. However, NBS patients display neither neurological 
abnormalities, ocular telangiectasia nor increased α-feto protein levels31. Patients instead display 
microcephaly as a neurological hallmark instead of neurodegeneration
31
. Similar to Mre11, null 
mutants for Nbs1 in mice were also found to be embryonic lethal
28
. Mice expressing mutant NBS1 
with N- or C-terminal truncations display various defects including intra-S and G2/M checkpoint 
defects, DNA damage sensitivity, chromosomal instability, decreased ATM activity, defects in 
immune system development and reduced fertility
32-35
.  
 
RAD50 is the 3
rd
 component of the MRN complex, and mutations in this gene lead to an NBS-like 
disorder. To date, only two patients have been described with this disorder
36
. These patients 
displayed microcephaly and mental retardation without immunodeficiency or predisposition to 
malignancies. Patients’ cells were reported to show chromosomal instability, sensitivity to radiation, 
failure to form DNA damage-induced MRN foci, and decreased activation of ATM and its 
subsequent downstream signaling pathway. These cells also showed impaired G1/S cell-cycle-
checkpoint activation and displayed radio-resistant DNA synthesis and G2-phase accumulation
22
. 
Several Rad50 mutant mouse models have been made and like the null mutants for Mre11 and 
Nbs1, null mutants for Rad50 were embryonic lethal
37
. It was observed that mice with hypomorphic 
mutations in Rad50 had short lifespans of approximately three months, gradual loss of germ cells 
and died with bone marrow failure
38
. These mice also displayed chromosomal instability, sensitivity 
to topoisomerase poisons and cancer predisposition
39
. 
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1.1.3 Spinocerebellar ataxia with axonal neuropathy (SCAN1) 
 
Spinocerebellar ataxia with axonal neuropathy (SCAN1) is a very rare disorder caused by a 
mutation in the tyrosyl-DNA phosphodiesterase (TDP1) gene
40
. Only one family originating from 
Saudi Arabia has been described with this disorder
40
. SCAN1 is characterized by an adolescent 
onset, ataxia, axonal neuropathy with progressive loss of sensation in the hands and legs, and 
decreased serum levels of albumin and cholesterol
41
. No significant extra-neurological symptoms 
have been observed. However, detailed clinical studies have not been possible due to the rarity of 
this disease and the lack of relevant phenotype observed in the animal models
5
.  
 
TDP1 has been mapped to chromosome 14q32 and codes for tyrosyl-DNA phosphodiesterase I 
(TDP1) and is a protein involved in the repair of DNA single strand breaks (SSB) generated by 
abortive topoisomerase I DNA cleavage complexes (Topo 1)
5,42
. Topo I acts to relieve super-helical 
torsion in DNA by introducing a transient, reversible nick in which it is attached covalently to the 
3’-terminus 42. Following the release of torsional stress, the Topo I cleavage complex is removed, 
allowing the repair of the nick and thereby maintaining genomic integrity
43
 (Fig 1.2). However, 
Topo I cleavage complexes can become trapped on DNA if they collide with the replication fork or 
transcription machinery, or if they encounter lesions along the DNA. In normal individuals, TDP1 
removes the bound Topo I cleavage complex and allows repair of DNA SS- or DSBs. In the 
absence of TDP1, bound Topo I cleavage complexes remain trapped on DNA, preventing the 
efficient repair of DNA breaks
42,44
. 
 
 
Fig 1.2: Mechanism of action of Topo I. Topo I binds to supercoiled DNA and forms a 3’-
phosphotyrosyl enzyme intermediate or cleavage complex, a single strand of DNA is then cut, 
allowing relaxation of supercoiled DNA for subsequent genomic replication and/or RNA 
replication.  
 
Several Tdp1
-/-
 mice generated independently failed to elicit any obvious behavioural deficits. 
Additionally, gross histological analyses of brain and cerebellar tissues from these mice did not 
show any significant differences in comparison to their wild type littermates either
45,46
. Katyal et al. 
2007 and Hirano et al. 2007 both showed an in vivo hypersensitivity of Tdp1
-/-
 mice to 
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camptothecin and topotecan (an analogue of camptothecin), two Topo I inhibitors. However, doses 
of these compounds even up to a lethal level, failed to stimulate SCAN1-type symptoms
5,46
. These 
data show that the phenotype of the Tdp1
-/-
 mouse model does not recapitulate that seen in humans. 
It was suggested that rather than a complete loss of TDP1, the unique features of mutant TDP1 in 
humans contribute to the SCAN1 phenotype in response to high levels of Topo I complexes found 
in the Purkinje cells of adolescents instead
45,47
. 
 
1.1.4 Ataxia oculomotor apraxia type I (AOA1) 
 
Ataxia Oculomotor Apraxia Type I (AOA1), also known as early onset ataxia with 
hypoalbuminemia (EAOH), has an onset from between 2 to 6 years of age
48
. Clinical symptoms of 
AOA1 include progressive ataxia resulting from cerebellar atrophy, oculomotor ataxia, peripheral 
neuropathy, loss of reflexes, mild mental retardation, hypoalbuminemia and hypercholesterolemia
4
.         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
The gene mutated in AOA1 is APTX and has been mapped to chromosome 9q13
49
. APTX encodes 
the protein aprataxin, which is a 342 amino acid-long nuclear protein that belongs to the histidine 
triad (HIT) domain superfamily of nucleotide hydrolases/transferases
50
. The N-terminus of 
aprataxin shares homology with that of PNK, a protein involved in SSB repair, and upon closer 
inspection, was found to contain a putative fork-head associated (FHA) domain
50,51
. This domain 
was found to mediate interaction with other proteins involved in DNA repair such as the X-ray 
repair cross-complementing group 1 and 4 proteins (XRCC1 and XRCC4) and mediator of DNA 
damage checkpoint 1 (MDC1), all of which are scaffold proteins involved in SS- and DSB repair 
respectively. An interaction with Poly(ADP-ribose) polymerase I (PARP-1), a nick sensor in DNA 
SSB repair was also found
52,53. Aprataxin possesses 5’ DNA adenylate hydrolase activity that is 
essential for the resolution of abortive DNA ligation intermediates that occur at sites of SSBs
54
 (Fig 
1.3). The presence of unrepaired SSBs with blocked termini may hinder the progression of RNA 
polymerases, thereby inhibiting transcription and leading to cellular collapse 
55
. Becherel et al. 2006 
also found an interaction between aprataxin and nucleolar proteins such as nucleolin, 
nucleophosmin and UBF-1, and suggested a role for aprataxin in DDR in the nucleolus where high 
rates of transcription occur
56
. 
 
Although several roles for aprataxin have been described, conflicting results have been observed in 
attempts to demonstrate a defect in DNA strand break repair in the absence of aprataxin. Some 
studies showed SSB repair defects
6,57
 while others do not
58
. It was suggested that the lack of 
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consistent data was due to low frequencies of breaks with 5’-AMP, or that there are other factors to 
repair these breaks
59
.  
 
 
Fig 1.3: Aprataxin removes 5’-AMP from abortive DNA ligation intermediates. As a 
consequence of abortive ligation at sites of SSB, an AMP moiety remains covalently attached to the 
5’ end of the break. Aprataxin removes the resulting 5’-adenylate group at the SSB to allow 
subsequent repair. Image taken from Ahel et al. 2006
54
. 
  
1.1.5 Ataxia oculomotor apraxia type II (AOA2) 
 
Ataxia oculomotor apraxia type II (AOA2) is characterized by progressive cerebellar atrophy and 
peripheral sensorimotor neuropathy (~93% of patients) with a late onset of between 11 to 22 years 
of age, oculomotor apraxia (~47% of patients), dysarthria, and elevated α-feto-protein (AFP), γ-
globulin and creatine kinase serum levels
60,61
. Neither mental retardation, immunodeficiency nor 
predisposition to cancers have been reported
62
  
 
The gene mutated in AOA2 is SETX which has been mapped to chromosome 9q34
61
. SETX encodes 
for the protein senataxin which is approximately 2,667 amino acid-long. Senataxin contains a 
highly conserved C-terminal seven-motif domain found in the superfamily I of DNA/RNA 
helicases, and an N-terminal domain believed to be important for protein-protein interaction
60,63
. 
Additionally, senataxin is related to other DNA/RNA helicases such as RENT1/Upf1 and 
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IGHMBP2 (Fig 1.4 and 1.5)
63
. Interestingly, RENT1/Upf1 has been implicated in nonsense-
mediated RNA decay and IGHMBP2, dysfunctional in spinal muscular atrophy, is thought to be a 
DNA-binding protein with transcriptional trans-activating activity
64,65
. SETX is highly polymorphic 
and >95% of individuals harbour benign mutations
66
. Pathogenic mutations in AOA2 patients 
include point mutations, frameshift mutations, premature truncation and splicing mutations, leading 
to a deficiency in senataxin
61,67
. Mutations in SETX have also been associated with amyotrophic 
lateral sclerosis type 4 (ALS4), a juvenile-onset form of an autosomal dominant disorder
68
 (Fig 1.4).  
 
 
 
Fig 1.4: Distribution of mutations along SETX. Black arrows represent point mutations 
(missense, in-frame deletions, splice and truncating mutations) occurring in the SETX gene of 
AOA2 patients
69
. Orange arrows represent point mutations leading to ALS4
68
. Image adapted from 
Anheim et al. 2009
69
.  
 
Senataxin shares homology with the yeast Saccharomyces cerevisiae splicing endonuclease 1 
protein (Sen1p) that has RNA helicase activity and is involved in splicing and termination of tRNA, 
small nuclear and nucleolar RNA
61
. Sen1p also interacts with Rpo21p (a subunit of RNA 
polymerase II), Rad2 (required for DNA repair) and Rnt1p (an endoribonuclease required for RNA 
maturation), suggesting that Sen1p is involved RNA processing, transcription and transcription-
coupled DNA repair
70
. Sen1p1 and Sen1p2, which are homologs of Sen1p in Schizosaccharomyces 
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pombe include (Fig 1.5), also show DNA/RNA helicase activity and have been implicated in RNA 
metabolism
61
.  
 
 
 
Fig 1.5: Schematic illustration of senataxin and related proteins. The N-terminal domain 
(orange) is shared between senataxin and Schizosaccharomyces pombe Sen1p1 and 2. Green; 
helicase domain. White; the intermediate domain that is weakly conserved between human 
senataxin and Sen1p1 and 2. Pink; domains specific to RENT1 or to IGHMBP2 proteins. a.a; amino 
acid length. Image adapted from Moreira et. al. 2004
61
.  
 
Similarly, senataxin interacts with proteins involved in RNA transactions that include Sit4 
associated protein (SAP155), polyadenylate-binding protein 1 and 2 (PABP1/2), survival motor 
neuron 1 (SMN1), nucleolin, heterogenous ribonucleoprotein 1 (hnRNPA1) and RNA Polymerase 
II (RNAPII), and has also been found to play a role in transcription regulation by modulating RNA 
Pol II binding to various gene loci 
71
. mRNA splicing efficiency, alternative splicing, splice site 
selection and transcription termination were altered in senataxin-deficient cells
71
. This was in 
agreement with studies with the yeast homolog Sen1p
72
. A recent study has described an additional 
role for senataxin in transcription elongation and termination
73
 (Fig 1.6). An increase in RNA read-
through and Pol II concentration downstream of the poly(A) site was detected in cells deficient in 
senataxin. Furthermore, increased levels of R-loop formation were also reported
73
. R-loops are 
DNA:RNA hybrids that form over transcriptional pause sites by the interaction of nascent mRNA 
with a ssDNA template behind an elongating RNA Polymerase II. These structures can cause 
genomic instability if left unresolved
73-75
. Incidentally, it has also been shown that the yeast 
orthologue of senataxin, Sen1p, protects its highly-transcribed genome from R-loop-mediated DNA 
damage, suggesting that Sen1p function in transcription elongation and termination may be 
associated with R-loop resolution
76
.  
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Fig 1.6: Role for senataxin in R-loop resolution. R-loops are DNA:RNA hybrids that form over 
transcription pause sites (usually GC-rich regions or with specific pause sequences), behind 
elongating RNA Polymerase. Proteins such as senataxin and several other factors (e.g. RNAse H, 
DHX9) resolve these structures, thereby allowing for the efficient termination of transcription. 
Image adapted from Skourti-Stathaki et. al. 2011 
73
. 
 
Although the precise mechanism by which mutant senataxin causes neurodegeneration in 
AOA2/ALS4 patients remains unclear, a deregulation in the various roles of senataxin such as RNA 
processing, DNA repair and transcription regulation, may account for the neurodegenerative 
phenotype observed in AOA2 patients (Fig 1.7).  
 
 
 
Fig 1.7: Roles of senataxin in relation to neurodegeneration. Defects in senataxin lead to an 
accumulation of R-loops, which can affect several cellular functions that include transcription 
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regulation, mRNA splicing, DNA repair and transcription termination, which may then contribute 
to the neurodegenerative phenotype observed in AOA2/ ALS4 patients
71
. Image adapted from 
Suraweera et al. 2009. 
 
 
1.2 DNA damage and DNA repair 
 
1.2.1 Oxidative stress and DNA damage 
 
Reactive oxygen and nitrogen species (ROS/RNS), are free radicals which are byproducts of 
cellular metabolism. These free radicals possess redox activities that have detrimental effects on 
cellular components such as protein, DNA and lipids, if left unresolved
77,78
 (Fig 1.8). This is evident 
in many neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and ALS, 
where post-mortem brain examinations of patients show an increase in oxidative stress in affected 
regions of the brain
79
. Post-mortem brain sections of AOA1 patients have also shown evidence of 
increased oxidative DNA damage (8-oxo-dG staining) 
80
. Studies on several neurodegenerative 
mouse models have also suggested an association of oxidative stress with neuronal cell death
78
. 
Given the high metabolic rates in neuronal cells and high oxygen concentration in nervous tissues 
such as the brain and cerebellum, it is possible that oxidative stress could significantly contribute 
neuronal cell degeneration
81
.  
 
 
 
Fig 1.8: Effects of ROS/RNS on cells. Free radicals (ROS/RNS) resulting from by endo- or 
exogenous insults can react with biomolecules such as lipids, proteins and nucleic acids (DNA) and 
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in turn lead to a variety of physiological dysfunctions and ultimately to cell death. Image adapted 
from Scandalios 2005
82
. 
 
Although the body has several antioxidant defense mechanisms to counter the effects of ROS/RNS, 
a slight perturbation in these homeostatic operations can potentially cause extensive damage 
especially in the brain, which is extremely sensitive to oxidative damage
83
. Abnormal control of 
ROS has been observed in cells of A-T patients, where the cells show sensitivity to oxidative stress 
and have less effective antioxidant systems
81
. Oxidative stress can also lead to DNA damage, as 
observed in cells of SCAN-1 patients
84
. Incidentally, defects in repair of these DNA breaks are also 
thought to contribute to neurodegeneration
83
. Cells from AOA2 patients were found to be sensitive 
to H2O2 and the repair of H2O2-induced DNA DSB was compromised in these cells. These data 
indicate that senataxin also exerts a protective function against oxidative DNA damage
63
. 
 
A-T provided one of the first direct links between DNA damage repair and neurodegeneration. The 
protein defective in A-T, ATM, responds directly to endogenous DNA damage in the nervous 
system, as shown by the requirement of ATM for DNA damage-induced apoptosis arising from Lig 
IV deficiency 
85,86
. It was suggested that loss of ATM function in eliminating neural cells that 
acquire DNA damage can result in cell death and subsequent neurodegeneration 
87
. Other diseases 
associated with neuropathology have further strengthened the connection between DNA damage 
and perturbation of neural homeostasis. As aforementioned, hypomorphic mutations in both 
MRE11 and NBS1 leading to A-TLD and NBS respectively, have overlapping clinical phenotypes 
with A-T and are each a result of defects in different stages of DNA DSB repair. The sensitivity of 
AOA2 cells to oxidizing agents and the repair defect of ROS-induced DNA DSB in AOA2 cells 
further support the contribution of DNA damage and oxidative stress to neurodegeneration
71
. Not 
only has DSB repair defects been implicated in such disorders, defective SSB repair has also been 
implicated in neurodegenerative diseases such as AOA1 and SCAN-1
87
.  
 
DNA is subject to continuous modifications from both endogenous reactive compounds such as free 
radicals and exogenous factors such as industrial genotoxins, ultraviolet (UV) rays and ionizing 
radiation (IR) that can cause base modifications, single- and/or double-strand breaks (SSB/DSB)
88
. 
DNA is also characterized by spontaneous base loss and deamination of uracil occurring at high 
frequencies
89
. While many DNA repair systems exist, defects in proteins involved in these systems 
can lead to less efficient repair and mutagenesis, resulting in genomic instability, apoptosis or 
malignant transformations
3,90
. In the nervous system, defective DNA repair can lead to pronounced 
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neuropathologies as observed in several ARCAs described above. The following sections will 
briefly describe DNA SSB and DSB repair mechanisms.  
  
1.2.2 DNA strand break repair 
 
 1.2.2.1  Single strand break (SSB) repair 
 
SSBs are one of the most common DNA lesions and there has been four repair pathways reported 
for SSB repair (SSBR)- direct SSBR, mismatch repair (MMR), nucleotide excision repair (NER) 
and base excision repair (BER). BER repairs damage to bases caused by hydrolysis oxidation, 
deamination and/or alkylation. Damaged bases are excised by DNA glycosylases and the gaps are 
filled in by DNA polymerases
91
 (Fig 1.9). In BER, the endonuclease APEX-1 initiates base 
excision, poly(ADP-ribose) polymerase (PARP-1), a multi-functional protein associated with DNA 
repair, subsequently recruits other proteins such as DNA ligase 3α and PNKP, and processes the 
damaged termini 
92
. Gap filling by DNA polymerase and ligation then occurs
93
. MMR corrects 
errors that occur during DNA replication and recombination where incorrect nucleotides may be 
inserted and produce mismatched nucleotides. Conversely, the exact mechanism of how nucleotides 
are excised and repaired remains unclear 
94
. NER recognizes DNA structure-distorting lesions, such 
as pyrimidine dimers, and recruits repair factors which excise ~30 nucleotides from the affected 
region, leaving a gap that is consequently filled in by DNA polymerases.  
 
 1.2.2.2  Double strand break (DSB) repair 
 
DNA DSBs are lethal lesions, therefore mammalian cells have evolved two DNA repair pathways 
that include: (1) homologous recombination (HR) and (2) non-homologous end joining (NHEJ) (Fig 
1.9). Briefly, HR is a high fidelity repair pathway that utilizes the undamaged, homologous DNA 
strand as a template and ensures the accurate repair of DSBs. Some proteins involved in HR include 
BRCA1/2, RAD51 and RAD52
95
. HR occurs primarily during early embryogenesis and in 
proliferating cells in late S to G2 phase
87,96
. Upon occurrence of DSBs, RAD52 binds rapidly to the 
ends of DNA and subsequently recruits RAD51-family proteins (e.g. XRCC2/3, RAD51B/C/D). 
The MRN complex is subsequently recruited and resection of the termini by MRE11 occurs. 
RAD51 then promotes strand invasion between the damaged and undamaged homologous DNA 
strands. This results in the formation of Holliday Junctions, where nascent DNA is synthesized by 
DNA Polymerase. Upon completion, the Holliday Junction is resolved and DNA nicks are re-sealed 
by DNA ligases 
97
.  
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In contrast, NHEJ is a low fidelity repair pathway that is the primary method of DSB repair in non-
proliferating, G1 phase cells, repairing DSBs by end-processing and ligation of the ends 
98
. NHEJ is 
initiated by DNA-end binding heterodimer proteins, Ku70 and Ku80. The Ku proteins align broken 
DNA ends and together with scaffold protein, XRCC4, stabilize the interaction of PI3KK DNA-
dependent Protein Kinase catalytic subunit (DNA-PKcs) with the termini. DNA ends are then 
processed by nucleases that include the WRN helicase and Artemis complex (as a result of end 
processing, NHEJ often results in microdeletions of DNA). Finally, Lig IV ligates the DNA ends 
and the DSB is repaired
87,99
. 
 
 
Fig 1.9: Model of DNA repair pathways. DNA DSBs are repaired via homologous recombination 
(HR) or non-homologous end joining (NHEJ). In HR repair, RAD52 bind to DSBs and recruits 
RAD51. RAD51 facilitates crossing over of undamaged homologous chromosomes, forming a 
repair bubble (also known as Holliday junction) where nascent DNA is synthesized by DNA Pols. 
In NHEJ, DSBs are recognized by heterodimeric Ku proteins, which recruit DNA-PKcs and the 
XRCC4/Lig IV complex. Nucleases such as Artemis and WRN process DNA ends to generate blunt 
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termini, which are subsequently ligated by the XRCC4/Lig IV complex. DNA SSBs repaired via 
base excision repair (BER) is shown here. SSBs lead to the accumulation of poly ADP-ribose 
polymerase 1 (PARP1) which recruits other repair factors that modify DNA ends for ligation. 
Image taken from Mckinnon 2009
93
. 
 
In summary, these repair pathways utilize different repair complexes, have different levels of repair 
fidelity and occur preferentially at different stages of the cell cycle
87
 (Fig 1.10). Both oxidative 
stress and defective DNA damage repair may play a role in neurodegeneration. The brain utilizes 
~20% of total consumed oxygen due to high levels of metabolic and transcriptional activities 
occurring in neurons but contains a lower capacity to neutralize free radicals, making neurons 
especially vulnerable to oxidative stress
100
. High oxidative loads in neurons can generate DNA 
breaks, and if left unrepaired, cells can undergo apoptosis once it has acquired too much damage. 
DNA breaks can also interfere with the transcriptional machinery, thereby resulting in cell death
87
. 
 
 
Fig 1.10: DNA strand break repair pathways during nervous system development. 
Development occurs via proliferation, differentiation/migration and maturation. Three major 
pathways repair DNA breaks during development. DSBR occurs via NHEJ or HR, with HR 
primarily occurring in proliferating and replicating cells. SSBR occurs during development through 
to maturity. In some cases, HR can repair SSBs during replication (black arrow). Together, these 
pathways maintain genomic integrity throughout the development and maintenance of the nervous 
system. Various neuropathologies can result if these systems are defective. Image adapted from 
Katyal and Mckinnon 2007
87
. 
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1.3 DNA Repair & Spermatogenesis 
 
DNA damage response proteins such as Brca1, Rad51 and Atr function not only in response to 
inadvertent cellular damage but also in programmed DNA damage, where the repair of DNA DSBs 
is required for the recombination of parental genomes during meiosis in order to generate mature 
germ cells
101,102
. This Report will focus on spermatogenesis, the process by which male germ cells 
(spermatozoa) are produced. 
 
1.3.1 Spermatogenesis 
 
Spermatogenesis is necessary for male fertility and continues
 
during the course of adult life in most 
mammals, ensuring a continuous supply of mature germ cells. This intricate process involves cell 
proliferation and differentiation, and occurs in the
 
seminiferous tubules of the testes containing an 
epithelium populated by a
 
mixture of germ cells and Sertoli cells
103
. Sertoli cells serve a
 
fundamental nourishing role for germ cells and are involved in coordinating important events 
during spermatogenesis
104
. Mammalian spermatogenesis is a continuous process in which 3 major 
phases can be discerned, namely- (1) spermatogonial renewal and proliferation, (2) meiosis and (3) 
spermiogenesis, with the germ cells moving from the peripheral region to the lumen of the 
seminiferous tubules. Spermatogenesis is initiated by the mitotic division of stem cells (type A 
spermatogonia), which give rise to daughter cells that either remain as type A spermatogonia (self-
renewal) or differentiate to form type B spermatogonia also known as primary spermatocytes.  
 
Primary spermatocytes enter meiosis prophase I where sister chromatids assemble and the exchange 
of genetic material via homologous recombination (HR) occur. This process is then followed by 
meiotic prophase II, where sister chromatids separate and give rise to round, haploid spermatids
105
. 
These round spermatids subsequently enter spermiogenesis, forming elongating spermatids that 
eventually develop into mature spermatozoa (Fig 1.11).  
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Fig 1.11: Process of spermatogenesis. The process of germ cell development in the seminiferous 
tubules of mammalian males from the primordial germ cells, through spermatogonia, 
spermatocytes, spermatids to mature spermatozoa. Image taken from Campbell et. al. 1999 (Fig 
46.1, p922 in Biology, 5
th
 Edition). 
 
In mice, this entire process spans approximately 35 days, where the
 
mitotic, meiotic and post-
meiotic phase lasts about 11, 10 and 14 days respectively. Spermatogenesis also
 
begins 
approximately every 8-9 days
106
 (Fig 1.12). This multi-faceted, highly-ordered process is 
orchestrated by many proteins that play essential roles during the specific phases of germ cell 
development. Additionally, the temporal, stage-specific expression of these proteins is regulated by 
both the transcriptional and translation control mechanisms of these cells
107
. In this Report, the 
events that occur during meiosis prophase I will be focused on. 
 
 
Fig 1.12: Schematic time line of the first wave of spermatogenesis. Spermatogenesis can be 
divided into 3 distinct phases- mitotic, meiotic and post-meiotic phase, lasting approximately 11, 10 
and 14 days respectively. Image taken from Yu et al. 2009
108
. 
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Meiotic recombination is a crucial stage in spermatogenesis whereby diploid germ cells divide and 
differentiate into haploid spermatids. This promotes genetic diversity and it also helps promote 
accurate segregation of homologous sister chromosomes for the generation of haploid gametes
109
. 
Meiotic prophase I can be divided into 4 distinct cytological stages- leptotene (chromatin 
condensation and initiation of programmed DNA DSBs), zygotene (initiation of synapsis of 
homologous chromosomes), pachytene (full synapsis, development of crossing over sites on 
homologous chromosomes) and diplotene (de-synapsis)
105,110
. During these stages, homologous 
chromosomes are bound by cohesion complex proteins and the synapsis of these chromosomes is 
achieved by the formation of a large zipper-like arrangement known as the synaptonemal complex 
(SC)
111
. The SC is made up of two parallel lateral elements, the synaptonemal complex protein 3 
(SCP3) and the synaptonemal complex protein 2 (SCP2), that is connected by transverse filaments 
made up of synaptonemal complex protein 1 (SCP1) (Fig 1.13)
112
. Proper formation of the SC 
between homologous chromosomes is vital for meiotic recombination to occur
111,113
. 
 
 
Fig 1.13: Synaptonemal complex (SC) formation in spermatocytes. Immunostaining using an 
antibody against SCP3, a component of the synaptonemal complex, allows the visual differentiation 
between the various stages in meiosis prophase I. Image adapted from Cohen and Pollard 2001. 
 
As illustrated in Fig 1.14, initiation of meiotic recombination occurs when the endonuclease SPO11, 
a DNA topoisomerase II-like protein, induces programmed DNA DSBs during the leptotene 
stage
114
. These breaks then initiate the phosphorylation of histone H2AX at Ser139
115,116
. Histone 
H2AX is a variant of the core histone H2A and is distributed widely throughout the genome
117
. 
Upon DNA damage, histone H2A becomes phosphorylated on Ser139 (γH2AX) and this is 
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commonly used as a marker to observe for DNA DSBs in cells
118
. During the zygotene stage, these 
DSBs initiate the pairing and synapsis of homologous chromosomes
119
. DNA strands containing 
DSBs introduced by SPO11 have their 5’ ends resected to produce 3’ single-stranded tails and these 
ssDNA are bound by replication protein A (RPA), which in turn recruit other DNA repair proteins 
such as RAD51 and meiosis-specific DMC1
109,120
. Given the fundamental role of DNA DSB 
formation and repair that occur normally during meiosis, it is not surprising that these DNA damage 
repair proteins play important roles during meiosis
121
.  
 
Both RAD51 and DMC1 subsequently promote strand invasion between homologous chromosomes 
which is required for HR and repair
109,120
. These DNA DSBs are gradually repaired during the 
zygotene stage and γH2AX phosphorylation intensity decreases. By the pachytene stage, γH2AX 
phosphorylation is no longer detectable on autosomal chromosomes due to the effective repair of 
DNA breaks and γH2AX phosphorylation becomes restricted only to the XY chromosomes. This 
2
nd
 wave of γH2AX phosphorylation occurs only on the XY chromosomes and is important for 
silencing during the pachytene stage
122
. The two major events that occur during the pachytene stage 
are (1) chromosomal crossing over and homologous recombination, and (2) meiotic sex 
chromosome inactivation (MSCI; which will be discussed in more detail in section 1.3.2). 
Stabilization of the Holiday junctions during meiotic recombination is ensured by the mismatch 
repair heterodimer MutS Homologs 4 and % (MSH4/MSH5) which then recruits MutL Homolog 1 
(MLH1) to sites of crossing over
123
. During crossing over, MLH1 localizes to sites of reciprocal 
recombination on meiotic chromosomes and is regularly used as a marker of chiasmata, which is the 
physical connection between homologous chromosomes during strand invasion
124
.  
 
23 
 
 
Fig 1.14: Schematic diagram of DNA repair proteins in meiotic recombination. In the leptotene 
stage, programmed DNA DSBs are induced by SPO11 and these breaks trigger phosphorylation of 
histone H2AX. RPA coats resected ssDNA and recruits ATR. Other DNA repair proteins such as 
RAD51, which promotes strand invasion and HR, are subsequently recruited.  In pachytene stage, 
MLH1 and MSH4/MSH5 work together in promoting and stabilizing sites of crossing over. By 
diplotene stage, DSBs are repaired and cells can progress to the post-meiotic phase to form haploid 
germ cells. 
 
By diplotene, crossing over is complete and the SC begins to degrade, allowing the uncoupling of 
homologous chromosomes
125
. These homologs however, remain tightly bound at the chiasmata, 
appearing as foci when visualized with SCP3 (Fig 1.13). These homologs will remain bound at the 
chiasmata until segregation into haploid cells
125
. These spermatocytes then enter into the second 
phase of meiosis, spermiogenesis, where they further divide into haploid cells, before undergoing 
cytological transformation to form mature spermatozoa
107
.  
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1.3.2 Meiotic Sex Chromosome Inactivation (MSCI) 
 
During meiosis prophase I, an important phenomena known as meiotic sex chromosome 
inactivation (MSCI) occurs in the pachytene stage. Due to the lack of homology, the X and Y 
chromosomes remain largely unpaired with exception to the pseudo-autosomal region (PAR), and 
this leads to the formation of the XY body
111
. MSCI is essentially the transcriptional silencing of 
the X and Y chromosomes following large-scale, epigenetic changes to the chromatin. Failure in 
MSCI has been shown to lead to active sex-linked gene expression and ultimately, spermatocyte 
death via apoptosis
126
. The X and Y chromosomes remain transcriptionally active during the 
leptotene and zygotene stages, however they are rapidly silenced and compartmentalized into a 
peripheral subdomain within the nucleus during the pachytene stage
127
.  MSCI then persists through 
to the diplotene stage
126
. Although the exact function of MSCI is still unknown, it has been 
postulated that MSCI may act to suppress any illegitimate recombination between the non-
homologous X and Y chromosomes
128
, suppress expression of sex-linked genes that may be toxic to 
cells during spermatogenesis and/or act as a driving force for trans-generational epigenetic 
inheritance
129,130
, in order for successful meiotic recombination to occur and for the production of 
mature germ cells
131
. 
 
Silencing is attained through the remodeling of chromatin into a highly condensed structure 
(heterochromatin) and this renders the chromatin inaccessible to the transcription machinery
126,132
. 
Although the exact mechanism of how MSCI occurs remains unclear, several DNA damage repair 
(DDR) factors such as the breast cancer susceptibility 1 (BRCA1) and ataxia-telangiectasia and 
Rad3-related kinase (ATR) proteins have been shown to play critical roles in this phenomenon
133
. 
Prior to MSCI, BRCA1 has been shown to localize and associate with the axial element of the 
unsynapsed XY chromosomes (Fig 1.15). ATR is then recruited in a BRCA1-dependent manner 
and localizes to the axial element as well. ATR subsequently translocates from the axial element 
and into the chromatin loops, creating a diffused staining pattern over the XY chromosomes
126,134
. It 
then phosphorylates histone H2AX on the XY chromosomes and this contributes to the XY 
silencing that is required for MSCI
126
.  
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Fig 1.15: The initiation of MSCI. The initiation of MSCI occurs when BRCA1 is recruited to the 
axial element of the X and Y chromosomes (white arrow). This is followed by a BRCA1-dependent 
recruitment of ATR to the axial element before translocating into the chromatin loops and 
phosphorylating histone H2AX (γH2AX). Silencing occurs as soon as phosphorylation is initiated. 
Image taken from Turner et al. 2004. 
 
The progression of meiotic events and XY body formation are also tightly regulated by various 
post-translational modifications. SUMOylation (covalent modification by small ubiquitin-like 
modifiers; SUMO) has been implicated in a range of cellular pathways, such as protein-protein 
interactions, transcription regulation (repression, in most cases), DNA repair, and formation of 
specific heterochromatic nuclear subdomains
131,135,136
. There are four different members of the 
SUMO family in mammals, namely SUMO-1, -2, -3 and -4. SUMO-1 shares about 45% homology 
with SUMO-2 and -3(which are approximately 96% identical, commonly termed SUMO-2/3) and 
SUMO-4 shares 87% homology to SUMO 2/3
137
. While SUMO-1 and -2/3 are expressed 
ubiquitously, SUMO-4 has been identified as a kidney-specific protein
137
. Interestingly, SUMO-1 
and -2/3 have been shown to localize to the XY chromosomes during the pachytene stage, 
suggesting roles in MSCI
138,131
. However the exact role of each of the different SUMO isoforms 
during MSCI remains unclear.  
 
 
1.4 Transcription regulation & disease 
 
1.4.1 Aberrant splicing & neurodegeneration 
 
In recent years, the contribution of aberrant RNA metabolism to neurodegeneration has become 
increasingly clear
139
. Following its transcription from DNA, RNA undergoes a series of complex 
processing that include capping, splicing, editing and association with various proteins that changes 
its function, stability and subcellular localization. Of particular interest is the process of alternative 
splicing, a mechanism that generates a versatile repertoire of functionally different proteins within 
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individual cells
140
 (Fig 1.16). The importance of alternative splicing is evidently clear in highly 
specialized cells such as neurons
141,142
. For example, all of the main neurotransmitter receptors 
contain subunits, which influence their localization, ligand-binding, signal-transducing and 
electrophysiological properties, and the synthesis of neurotransmitters and their subunits are 
generated through alternative splicing
140
. 
 
 
 
Fig 1.16: Alternative splicing mechanism. Genes are transcribed into pre-mRNAs that contain 
both introns and exons (white spaces and lines). Processing of pre-mRNAs leads to the excision of 
introns. Exons are then joined together to generate mature mRNA which then get translated into 
protein. This process allows different mRNAs/proteins to be produced from a single gene and pre-
mRNA transcript by the regulation of splice site selection and the choice of exons to be included in 
the mature transcript. Image adapted from Dredge et. al. 2001 
140
. 
 
Aberrant splicing of mRNAs encoding proteins that are critical for the proper function of neuronal 
cells has been associated with several neurological diseases
140,142
. An example of such a 
phenomenon is observed in spinal muscular atrophy (SMA), an autosomal recessive disorder 
resulting from the dysfunction of lower motor neurons
143
. The causative gene for SMA is SMN1, 
where mutations lead to a loss of the motor neuron protein, SMN
144
. The loss of SMN is due to a 
mutation in the last exon of the SMN1 gene that affects its splicing, thereby resulting in a 
predominantly truncated, unstable form of SMN. SMA is a disease caused by defects in RNA 
processing as SMN itself is an RNA-binding protein involved in several facets of RNA functions 
such as splicing and mRNA localization to the axon
139,140
. Interestingly, SMN also interacts with 
senataxin, which as mentioned previously, is another protein involved in RNA metabolism that can 
cause AOA2 if mutated
145
. Senataxin also interacts with several key proteins that include RNA Pol 
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II, SAP155, Nucleolin, PABP1/2, and hnRNPA1 which are all involved in RNA processing, 
splicing and transport
71
.  Additionally, alternative splicing in the nervous system coordinates the 
activity of protein networks at the synapse and is important for genes encoding for receptors, signal 
transduction proteins, and splicing regulators
146
. Alternative splicing can also lead to the alteration 
of functional properties of neuronal receptors by modifying their affinity to agonists or by changing 
their localization
139
.  
 
Other neurological disorders associated with aberrant RNA processes such as RNA editing, 
polyadenylation, nuclear mRNA export, mRNA stabilization and localization, as well as aberrant 
regulation by non-coding regulatory RNAs such as small-interfering RNAs (siRNAs) and 
microRNAs (miRNAs)
147-149
, are summarized in the table below (Table 1.2). 
 
Aberrant RNA 
process 
Neurological disorder Details 
RNA editing 
Amyotrophic lateral sclerosis (ALS) 
Alzheimer’s disease (AD) 
Huntington’s disease (HD) 
Reduced editing efficiency off the 
GluR2 AMPA receptor subunit at 
Q/R site 
Epilepsy 
Increased editing efficiency of the 
GluR2 AMPA receptor subunit at the 
R/G site 
Alternative 
splicing 
Spinal muscular atrophy (SMA) Truncated protein via exon skipping 
Spinocerebellar ataxias (SCA) type 2, 
8, 10, 12 
Splicing factors interact with several 
ataxia-causing proteins 
Rett syndrome (RTT) 
Mutations in causative gene, 
MECP2, affects splicing of target 
mRNAs 
Polyadenylation 
Oculopharyngeal muscular dystrophy 
(OPMD) 
Polyalanine expansion and 
aggregation of polyadenylation 
binding protein nuclear 1 (PABPN1) 
Nuclear mRNA 
transport 
Fragile X syndrome (FXS) 
Deletion of fragile X mental 
retardation protein (FMRP) prevents 
its interaction with export factor, 
NXF2 
Lethal congenital contracture Disease-causing mutations in the 
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Table 1.2: Neurological disorders associated with RNA processing defects. Table adapted from 
Anthony and Gallo 2010
139
. 
 
1.4.2 Transcription regulation & genomic instability 
 
1.4.2.1  R-loops accumulation can cause genomic instability 
 
R-loops are naturally occurring DNA:RNA hybrid structures that form behind elongating RNA 
Polymerase (cis) by the interaction between the nascent mRNA and its ssDNA template from which 
it was transcribed from, over transcriptional pause sites
150
. R-loops can also form when an RNA 
transcript hybridizes into an opened bubble that arises from negative DNA supercoils
151,152
. Wahba 
et al. 2013 also showed that R-loops can form in trans where RNA was found to invade DNA 
duplexes at a distant genomic loci in yeast. Interestingly, they also reported that Rad51, a DDR 
protein involved in promoting strand invasion during homologous recombination, promoted R-loop 
formation
153
. Although the exact function of R-loops is unclear, it is believed that these structures 
allow for efficient transcription initiation and termination through RNA Polymerase stalling
73
, 
induce transcription-associated recombination
74
 or mutagenic events such as class-switch 
recombination and somatic hyper-recombination in B lymphocytes
75
. 
 
syndrome type 1 (LCCS1) gene encoding mRNA export 
protein, GLE1 
mRNA 
stabilization and 
localization 
SMA 
Defect in the localization of β-actin 
mRNA to the growth cones of motor 
neurons 
ALS 
TDP43 stabilizes human low 
molecular weight neurofilament 
(hNFL) mRNA by binding directly 
to 3’UTR 
Regulation by 
noncoding RNAs 
SCA1 
miRNAs miR-19, -101 and -130 co-
regulate ataxin 1 (ATXN1) levels in 
Purkinje cells and inhibition of these 
proteins enhances cytotoxicity of 
polyglutamine-expanded ATXN1 
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Wongsurawat et al. 2011 mapped R-loop forming sequences (RLFS, as defined by Roy and Lieber 
2009
154
) on 66,083 sequences defined by the UCSC Genome Bioinformatics database 
(http://genome.ucsc.edu/)  as “known” genes and found that ~59%  of these transcribed sequences 
contain at least 1 RLFS
155
. It was predicted that many oncogenes, tumour suppressor genes (e.g. 
p53, BRCA1 and 2, Kras) and neurodegenerative disease-related genes (e.g. ATM, Park2, Ptprd) are 
also susceptible to significant R-loop formation
155
. The formation of these stable secondary 
structures can potentially pose a threat to genomic integrity
73
 and reports have shown that R-loops 
are often associated with neurodegenerative diseases caused by trinucleotide repeats such as 
spinocerebellar ataxia type 1 (SCA1), myotonic dystrophy (DM1) and fragile X type A 
(FRAXA)
156-158
.  
 
Unresolved R-loops can cause DNA DSBs and chromosomal rearrangements as observed in a study 
by Li and Manley 2005, where cells depleted of the protein-splicing factor ASF/SF2 led to an 
accumulation of R-loops which subsequently resulted in hypermutagenic cells with high molecular 
weight DNA fragmentation
75,159
. Although little is known about the molecular mechanisms by 
which transcriptional R-loops influence genome stability, several hypotheses have been raised. 
First, because ssDNA is known to be more susceptible to mutations than dsDNA, it has been 
proposed that extensive R-loop formation may expose highly transcribed regions of the genome to 
more DNA damage by increasing the incidence of single-stranded DNA (Fig 1.17A). Second, it has 
been proposed that protein factors that specifically recognize R-loops may be involved in the 
generation of mutagenic and/or recombinant DNA lesions (Fig 1.17B). One instance of this is seen 
in G-rich class-switch recombination (CSR) sites in B lymphocytes where R-loop formation 
preferentially occur
160
. An example of a protein involved in CSR is activation-induced (cytidine) 
deaminase (AID)
161
. AID deaminates cytidine to form uracil preferentially on single-stranded non-
template DNA, and the resulting mismatch is subsequently processed by uracil DNA glycolase 
(UNG) and/or apurinic/apyrimidinic endonuclease (APE), components of the base excision repair 
machinery, thereby generating DNA nicks in the region. These nicks are then converted into DSBs 
by mismatch repair proteins to initiate recombination
159
. Hence, an accumulation of R-loops at 
inappropriate gene regions may then cause illegitimate hyper-recombination to occur. Third, G-rich 
ssDNA regions are prone to folding and forming stable parallel four-stranded DNA structures called 
G-quadruplexes (further discussed in section 1.4.2.3)
73,159
. Hence, it was suggested that these higher 
order structures generate susceptible sites for specific nucleases (Fig 1.17C). These nucleases such 
as DNA2 and GQN1 have been found to cleave specifically DNA in single-stranded regions 5’ of 
G-quadruplex structures
162,163
. Lastly, it was hypothesized that R-loops may block or collide with 
oncoming or stalled replication machinery, consequently leading to DNA DSBs, aberrant 
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recombination and cell death
164,165
 (Fig 1.17D). Such a phenomenon has been observed in yeast and 
bacteria, where transcription-dependent replication fork collisions have been shown to induce 
recombination and DSBs
159
. Therefore, an accumulation of R-loops may disturb the gene 
expression or repression balance in cells and further contribute to abnormal transcription regulation 
that could lead to genomic instability
166
. 
 
 
Fig 1.17: Potential models of R-loop-mediated genomic instability. A. R loops make the genome 
more susceptible to DNA-damaging agents by increasing the frequency of single-stranded regions. 
B. AID-mediated DNA cytosine deamination generates abasic sites on the non-template DNA 
strand within R-loop regions. These can cause DNA lesions and lead to illegitimate recombination, 
through the generation of nicks by base excision repair components, UNG and APE. C. G-
quadruplexes form from non-template ssDNA and may both contribute to R-loop formation due to 
the stalling of RNA Polymerase II. D. Collisions between the DNA replication apparatus and 
transcription machinery can lead to the formation of DNA DSBs. Black lines indicate DNA, dotted 
blue line indicate nascent RNA. 
 
The resolution of R-loop structures is dependent on several DNA/RNA helicases, enzymes that act 
to unwind the DNA and/or RNA duplexes in an ATP-dependent manner. The uncoupling of DNA 
or RNA complementary strands is an essential requirement for many metabolic processes in cells. 
The unwinding of these duplexes allows the access of proteins of the transcription, recombination, 
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replication and repair machineries to the DNA template
167
. Generally, helicases possess specific 
polarity, moving in 3’-5’ or 5’-3’ direction depending upon the strand on which they act on167. An 
example of a helicase that can unwind R-loop structures is the human DHX9 helicase, also known 
as the nuclear DNA helicase II or RNA helicase A
168
. DHX9 belongs to the superfamily II of 
DNA/RNA helicase and has been shown to dissociate DNA duplexes, RNA duplexes as well as R-
loops with a 3′–5′ polarity; despite this little is known about its substrate specificity168. Other well-
characterized R-loop-resolving enzymes include RNAse H1/H2, where they act by removing the 
RNA component of  R-loops
169
. It is also possible that senataxin is another protein that resolves R-
loop structures as reported by Skourti-Stathaki et al. 2011, as it contains a predicted DNA/RNA 
helicase domain
61,73
. 
 
1.4.2.2  R-loops & gene expression (CpG methylation) 
 
CpG islands are short interspersed DNA sequences that are GC-rich regions, which function as 
promoter regions for about 60% of human genes and are predominantly maintained in a non-
methylated state
170
. Silencing of these CpG promoters is achieved through methylation and are 
therefore capable of influencing local chromatin structure and modify regulation of gene activity
171
.  
In 2011, Deaton et al. reported that R-loops structures form over these CpG islands and prevent 
their methylation
171
. It was also shown that the formation of R-loops could be a new mechanism in 
the retention of CpG islands in its non-methylated state (Fig 1.18)
170
. Wongsurawat et al. 2011 
reported the presence of RLFS in the Dazl gene, which encodes potential RNA binding proteins that 
are expressed in pre- and postnatal germ cells of males and females. Due to the negative effect of R-
loop formation on the methylation of promoters, it is interesting to note that the incorrect 
methylation of the Dazl gene has been associated with defective human sperm
155
. This is 
reminiscent of the recently observed role of R-loops on the inhibition of CpG island methylation 
(Fig 1.17)
172
. 
 
 
Fig 1.18: R-loops prevent methylation of CpG island promoters. Formation of R-loops at CpG 
island promoters is favored by the GC-sequence skew and these structures can inhibit the actions of 
DNA methyltransferases. Image adapted from Vertino and Wade 2012. 
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1.4.2.3  G-quadruplexes & R-loop formation 
 
Genomic DNA is generally maintained in a duplex formation, but DNA also can form other 
structures and one such sequence motif particularly susceptible to tertiary structure formation is a 
guanine-run
173
. Sequences containing continuous guanine bases readily fold into four-stranded 
structures stabilized by planar arrays of four hydrogen-bonded guanines, and these tertiary 
structures are known as G-quadruplexes
174
.  
 
Although the exact functions of these structures remains unknown, there have been reports 
associating G-quadruplexes to several essential cellular processes that include DNA replication, 
transcription regulation and overall genomic stability
175
. Several chromosomal regions contain G-
rich sequences that form G-quadruplexes in the genome and indeed, these G-quadruplexes which 
have also been linked with R-loop formation, have been shown to affect transcription termination, 
alternative splicing and gene expression
175-177
. G-rich chromosomal domains include four classes of 
repetitive regions—telomeres, rDNA, immunoglobulin heavy chain switch regions, and G-rich 
minisatellites
178
. Telomeric repeats in almost all eukaryotes contain runs of guanines and these 
telomeric sequences form have been reported to form G-quadruplexes in vitro
179
. Mammalian 
rDNA, which encodes ribosomes, also contain large stretches of over 40kb of G-rich repeats, on the 
non-template DNA strand
180
. These structures can form both within the region that is transcribed 
into mature rRNA and within spacers
181
. The immunoglobulin heavy chain class switch regions, 
which are required for class-switch recombination, consists too of numerous G-rich repeats that 
range from 2kb to 10 kb in length and conform to a loose consensus
161
. Overall, the human genome 
contains many repetitive minisatellites, and among those that exhibit the most marked instability are 
G-rich sequences that form G-quadruplexes
182,183
. 
33 
 
1.5 Aims of Project  
 
Mutations in several proteins involved in DNA damage repair (DDR) such as ataxia-telangiectasia 
(ATM), senataxin (SETX), aprataxin (APTX) and tyrosyl-DNA phosphodiesterase 1 (TDP1), lead 
to autosomal recessive cerebellar ataxias (ARCA). Mutant senataxin was identified to cause the 
human ARCA, ataxia oculomotor apraxia type 2 (AOA2). Senataxin is a putative DNA/RNA 
helicase that, in addition to its role in DDR, has been reported to be involved in several RNA 
metabolic processes such as splice site selection, transcription initiation and termination, and R-loop 
resolution
71,73
. Additionally, senataxin-deficient cells display sensitivity to several DNA damaging 
agents such as hydrogen peroxide and camptothecin, exhibit constitutive oxidative DNA damage 
and chromosomal instability
63
.  
 
To better understand the role of senataxin in vivo, the first Setx
-/-
 mouse model was generated and 
this Project represents the characterization of this mouse model. The specific aims of this Project 
are as follows: 
 
1. To characterize the Setx
-/-
 mouse model.  
 
This involves the overall phenotypic characterization and behavioral analyses of these mice, 
followed by the morphological analyses of nervous tissue as well as the structural analyses of 
Purkinje cells in the cerebellum, which is the affected cell type in ARCAs. 
 
2. To investigate the role of senataxin in DDR during meiotic sex chromosome inactivation 
(MSCI) 
 
Several ARCA mouse models do not show neurological defects but display fertility issues as a 
common feature. Here, the role of senataxin in DDR in spermatogenesis, more specifically, during 
meiotic sex chromosome inactivation in male Setx
-/-
 mouse will be investigated.  
 
3. To investigate the role of R-loop as a form of transcription deregulation in ARCA mouse 
models.  
 
This involves the investigation of how senataxin influences R-loop formation and resolution, and 
how this impacts gene expression in Setx
-/- 
mice. Furthermore, given the association of these DDR 
proteins (ATM, APTX and TDP1 in addition to SETX) in transcription regulation, the prevalence of 
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R-loop structures in these respective ARCA mouse models will also be examined to investigate the 
impact of R-loop accumulation and its effect on transcription deregulation in other systems, 
including the nervous system. Because these models do not recapitulate the neurodegenerative 
phenotype observed in human patients, attempts to induce such a phenotype via DNA damage 
exposure will be performed to determine whether a correlation between DNA damage and R-loop 
accumulation exists. 
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CHAPTER 2: Materials & Methods 
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2.1 Animal husbandry & genotyping 
 
All animal experiments were approved by the QIMR Berghofer Medical Research Institute (aka 
QIMR) Animal Ethics Committee. The mice were weaned at 21 days post-partum and ear clipped 
for identification. Genotyping was carried out via PCR on genomic DNA isolated from tail tips. See 
Table 2.1 for description of primers for genotyping the animals. 
 
To genotype Setx mice, primers used were In3F, In3R and LoxPR. PCR cycling conditions were as 
follows: 35 cycles, denaturation at 95ºC for 30 sec, annealing at 49 ºC for 30 sec, extension at 72ºC 
for 1 min, with a final cycle and extension of 7 min at 72ºC. Two PCR products were generated, a 
wild type PCR product of 600 bp, and the targeted PCR product of 339 bp. 
 
To genotype Atm mice, primers used were KO1F, KO1R and KO2R. PCR cycling conditions were 
as follows: 35 cycles, denaturation at 94ºC for 45 sec, annealing at 62 ºC for 45 sec, extension at 
72ºC for 1 min, with a final cycle and extension of 5 min at 72ºC. Two PCR products were 
generated, a wild type PCR product of 344 bp, and the targeted PCR product of 402 bp.  
 
To genotype Tdp1 mice, primers used were TDP1F, TDP1R and GEOR. PCR cycling conditions 
were as follows: 35 cycles, denaturation at 94ºC for 30 sec, annealing at 60 ºC for 45 sec, extension 
at 72ºC for 45 sec, with a final cycle and extension of 6 min at 72ºC. Two PCR products were 
generated, a wild type PCR product of 300 bp, and the targeted PCR product of 550 bp.  
 
To genotype Aptx mice, primers used were APTX1F, APTX1R and APTX2R. PCR cycling 
conditions were as follows: 35 cycles, denaturation at 94ºC for 30 sec, annealing at 60 ºC for 45 sec, 
extension at 72ºC for 45 sec, with a final cycle and extension of 6 min at 72ºC. Two PCR products 
were generated, a wild type PCR product of 224 bp, and the targeted PCR product of 300 bp. 
 
PCR products were electrophoresed at 100V for 30 min on 2% TAE Agarose (Boehringer 
Mannheim, Amresco, Lewes, UK) stained with Ethidium bromide and visualised with UV 
transillumination using a GelDoc
TM
XR (Biorad Laboratories Inc, California, USA).  
 
Mouse model Primer name Primer sequence 
Atm 
KO1F 5’-TGGTCAGTGTAACAGTCATTGTGC-3’ 
KO1R 5’-AAGGTTGTAGATAGGTCAGCATTG-3’ 
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KO2R 5’AACGAGATCAGCAGCCTCTGTTCC-3’ 
Setx 
In3F 5’-TTTAAGGAACAGTGCTGC-3’ 
In3R 5’-ATGAAGCAGGTAGGATT-3’ 
LoxPR 5’-CGAAGTTATATTAAGGGT-3’ 
Tdp1 
TDP1F 5’-TCTTCCAGTTCTTAGCCTCCTCTGC-3’ 
TDP1R 5’-TGGCCTGGATCTCACTCTGGAGGC-3’ 
GEOR3 5’-GAGTTCCCAGGAGGAGCCAAGGC-3’ 
Aptx 
APTX1F 5’-TTCTCTCCATGACTGGTCATGGC-3’ 
APTX1R 5’-TATACTCAGAGCCGGCCT-3’ 
APTX2R 5’-TCCTCGTCGTTTACGGTATC-3’ 
 
Table 2.1: Primers for genotyping animals 
 
2.2 Cell culture 
 
Lymphoblastoid cell lines (LCLs) from control (C3ABR) and AOA2 patients (SETX2RM) were 
cultured in RPMI 1640 medium (Gibco BRL, Life Technologies, California, USA) containing 6% 
fetal calf serum (JRH Biosciences, Kansas, USA), 2mM L-glutamine (Life Technologies, 
California, USA), 100U/ml penicillin (Gibco BRL, Life Technologies, California, USA) and 
100U/ml streptomycin (Gibco BRL, Life Technologies, California, USA). Cells were maintained in 
a humidified incubator at 37°C/5% CO2.  
 
HeLa and U2OS cell lines were cultured under identical conditions with DME medium (Gibco BRL, 
Life Technologies, California, USA) containing 10% foetal calf serum, 100U/ml penicillin (Gibco 
BRL, Life Technologies, California, USA) and 100U/ml streptomycin (Gibco BRL, Life 
Technologies, California, USA). Cells were maintained in a humidified incubator at 37°C/5% CO2. 
 
2.3 Senataxin immunoprecipitation 
 
LCLs and testes from 35 day-old mice (ground with a pestle to disrupt their structure) were lysed 
for 1 h at 4ºC on a rotating wheel with 1 ml of lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
2 mM EGTA, 2mM EDTA, 25 mM β-glycerophosphate, 0.1 mM sodium orthovanadate (Na3VO4), 
0.1 mM PMSF, 25 mM sodium fluoride (NaF), 0.2% Triton X-100, 0.3% NP-40 and 1X EDTA-
free Complete Protease inhibitor (Roche, Basel Switzerland)). Cellular debris were pelleted by 
38 
 
centrifugation at 16,100 x g at 4ºC for 10 min, and protein concentration was determined using the 
Lowry Assay (Biorad Laboratories Inc, California, USA). 2 mg of total protein extract were pre-
cleared with 10 μl of Protein G beads (50:50 slurry) (Merck Millipore, Massachusetts, USA) for 3 h 
at 4ºC on a rotating wheel. Extracts were centrifuged for 5 min at 2000 x g, beads were removed, 
and 10 μg of anti-human senataxin antibody (Ab-1 #OB 1) was added to the extract. Extracts and 
antibody were incubated overnight at 4ºC on a rotating wheel to allow binding of the antibody to 
senataxin. The next day, 20 μl of Protein G beads (50:50 slurry) (Merck Millipore, Massachusetts, 
USA) were added to the protein extract and incubated for 2 h at 4ºC on a rotating wheel. Protein 
extracts were centrifuged for 5 min at 2000 x g and the beads were removed. The 
immunoprecipitate was subsequently washed 3 times with lysis buffer and the beads were 
resuspended in SDS loading buffer containing 2X DTT and separated via 5% SDS-PAGE at 
constant current (20 mA) per gel for 1.5 h. Once separated, proteins were transferred onto an 
Amersham Hybond-C nitrocellulose membrane (GE Healthcare, Queensland, Australia) for 1 h at 
4ºC with constant voltage (100 Volts). Immunoblotting with anti-senataxin (Ab-1) antibody was 
performed as described in section 2.12. 
 
2.4 Histological analyses of Setx mouse tissues 
 
Testes, ovaries, brains and cerebellums from 35-day-old and 20-month-old mice were collected and 
fixed in PBS containing 10% formalin, embedded in paraffin blocks and sectioned at 4 µm by the 
Histology Department at the QIMR Berghofer Medical Research Institute (aka QIMR). Sections 
were stained with Hematoxylin and Eosin (H&E). Slides were examined under light microscope 
and then scanned using Scanscope CS system (Aperio Technologies, Vista, USA). Images 
corresponding to ×10 and ×20 magnifications were captured and assembled in Adobe Photoshop 
CS5 (Adobe Systems Inc, USA). 
 
2.5 Immunofluorescence 
 
Tissue sections embedded in paraffin and mounted onto glass slides were dewaxed and rehydrated 
with Shandon Varistain® Gemini ES (Thermo Scientific, Massachusetts, USA). Briefly, slides were 
first immersed twice for 2 min each in xylene, dipped into absolute ethanol, 90% ethanol, then 70% 
ethanol for 2 min and rinsed with distilled water. Enzymatic antigen retrieval was performed by 
incubating the sections with 1:10 trypsin dilution in PBS for 20 min at 37ºC.  Slides were washed 3 
times for 5 min with PBS on an orbital shaker at room temperature for 5 min each. Spermatocyte 
spreads that were fixed onto glass slides by PFA did not require dewaxing. Slides were blocked in 
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20% FCS, 2% BSA, 0.2% Triton X-100 in 1 X PBS for 1 h at room temperature. Slides were 
incubated with primary antibody (Table 2.2) overnight at 4ºC in a humidified chamber. The next 
day, slides were washed 5 times with 1 X PBS containing 0.5% Triton X-100 for 5 min each at 
room temperature on an orbital shaker. Alexa-Dye-conjugated secondary antibody (Life 
Technologies, California, USA) (Table 2.3) was added and slides were incubated for 1 h at 37ºC in 
a humidified chamber. Subsequently, slides were washed 3 times as before and Hoechst 33342 
(1:10,000) (Life Technologies, California, USA) was added for 10 min to stain nuclei. Slides were 
finally washed twice and glass coverslips were mounted for imaging. Images were captured using a 
digital camera (AxioCam Mrm, Carl Zeiss Microimaging Inc., Jena, Germany) attached to a 
fluorescent microscope (Axioskop 2 mot plus, Carl Zeiss Microimaging Inc., Jena, Germany) 
equipped with the appropriate filters, and the AxioVision 4.8 software (Carl Zeiss Microimaging 
Inc., Jena, Germany). The objective employed was an EC Plan-Neofluar 10x/0.3 (Carl Zeiss 
Microimaging Inc, Jena, Germany). 
 
Primary antibody Species Dilution Catalogue number Manufacturer 
Scp3 Rabbit 1:100 NB300-230 Novus Biologicals 
Scp3 Mouse 1:100 AB97672 Abcam  
Atr Goat 1:100 SC-1887 Santa Cruz Biotechnology 
Nek1 Rabbit 1:100 BS-7814R Bioss Inc. 
Atrip Rabbit 1:100 A300-670 Bethyl Laboratories Inc. 
Chk1 Mouse 1:100 2360 Cell Signaling Technology 
Chd4 Rabbit 1:100 AB72418 Abcam 
Rad51 Rabbit 1:100 SC-6862 Santa Cruz Biotechnology 
Mlh1 Mouse 1:10 SC-56161 Santa Cruz Biotechnology 
Setx Sheep 1:300 - In-house  
Brca1 Rabbit 1:300 
- With courtesy, David 
Livingstone (Dana Farber 
Cancer Institute, MA, 
USA) 
TopBp1 Rabbit 1:100 AB2402 Abcam 
SUMO-1 Rabbit 1:100 AB32058 Abcam 
SUMO-2/3 Rabbit 1:100 A3742 Abcam 
Phospho-Atr 
(S428) 
Rabbit 1:100 
2853 
Cell Signaling Technology 
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Phospho-RNAPII 
(S2) 
Rabbit 1:100 
AB24758 
Abcam 
Phospho-Rpa (S33) Rabbit 1:100 A300-246A Bethyl Laboratories Inc. 
Phospho-Chk1 
(S317) 
Rabbit 1:100 
2344 
Cell Signaling Technology 
γH2AX Mouse 1:100 Y-91016 Merck Millipore 
H3K4me1 Rabbit 1:100 AB8895 Abcam 
Gapdh Rabbit 1:500 GTX100118 Genetex 
α-tubulin Rabbit 1:500 GTX112141 Genetex 
S9.6 (R-loop) Mouse 1:100 
- With courtesy, Stephen 
Leppla (National Institute 
of Health, MD, USA) 
 
Table 2.2: Description of primary antibodies used for immunofluorescence. 
 
Secondary antibodies Dilution Catalogue 
number 
Manufacturer 
Alexa 488-labeled chicken anti-mouse 1:250 A-21200 Life Technologies 
Alexa 594-labeled donkey anti-rabbit 1:250 A-11032 Life Technologies 
Alexa 594-labled donkey anti-goat 1:250 A-11058 Life Technologies 
Alexa 350-labeled anti-mouse 1:100 A-11045 Life Technologies 
 
Table 2.3: Description of secondary antibodies used for immunofluorescence. 
 
2.6 TUNEL assay  
 
Slides with tissue sections were de-waxed as previously described. TUNEL assay was performed 
using the Fluorescence in situ Cell Death Detection Kit (Roche, Basel, Switzerland) following the 
manufacturer’s instructions. Slides were visualised under a fluorescent microscope and images were 
captured as previously described. The objective employed was an EC Plan-Neofluar 10x/0.3 (Carl 
Zeiss, Jena, Germany). For double staining, TUNEL was carried out before immunostaining as 
described in section 2.5. 
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2.7 Spermatocyte spreads 
 
 All spreads were made from testes collected from adult 35-day-old mice. Briefly, testes were 
decapsulated, finely chopped and rinsed in 1 ml of GIBCO serum-free DME medium (Life 
Technologies, California, USA) containing 1X Complete Protease inhibitor (Roche, Basel, 
Switzerland). 6 ml of GIBCO serum-free DME medium (Life Technologies, California, USA) was 
then added and tubes were allowed to stand on ice for 5 min to allow large clumps and cellular 
debris to settle. 6 ml of the remaining supernatant from each sample was subsequently aliquoted 
into Eppendorf tubes, with each tube containing 1 ml of suspension. Tubes were then centrifuged 
for 5 min at 5000 xg to pellet the cell suspension. The pellet was then resuspended in 0.1 M sucrose 
and applied onto glass slides pre-wetted with 1% paraformaldehyde and 0.1% Triton X-100 in PBS. 
Cells were fixed on the glass slides and allowed to air-dry for 3 h at room temperature. The slides 
were subsequently washed with 1:250 Kodak Photo-Flo 200 (Kodak Professional, New York, USA) 
in 1X PBS and air-dried for 1 h. Once dried, spreads were stored at −80°C. 
 
2.8 Proximity ligation assay (PLA) 
 
Proximity Ligation Assay (PLA) (Duolink, Olink Bioscience, Uppsala, Sweden) was performed 
according to the manufacturer's protocol using the relevant primary antibodies (Table 2.4) and their 
corresponding PLA PLUS and MINUS probes. Identification of pachytene stage spermatocytes was 
determined by counterstaining with SCP3 antibody. Slide mounting and imaging was performed as 
described in section 2.5. 
 
Primary antibodies Species Dilution 
Catalogue 
number 
Manufacturer 
Brca1 Rabbit 1:300 - 
With courtesy, David 
Livingstone (Dana Farber 
Cancer Institute, MA, USA) 
Atr Goat 1:100 SC-1887 Santa Cruz Biotechnology 
Senataxin Sheep 1:100 - In-house 
Chd4 Rabbit 1:100 AB72418 Abcam 
SUMO-1 Rabbit 1:100 AB32058 Abcam 
 
Table 2.4: Description of primary antibodies used for PLA. 
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2.9 RT-PCR & gene expression analyses 
 
Total RNA was isolated from 35-day-old Setx
+/+
 and Setx
-/-
 mice testes using the RNeasy mini kit 
(Qiagen, Limburg, Netherlands) according to the manufacturer's protocol. RNA concentrations 
were determined by UV spectrophotometry using a NanoDrop ND-1000 (Thermo Scientific, 
Massachusetts, USA). cDNA was made from 5 µg of purified RNA. Briefly, RNA was mixed with 
1 µl of random hexamer primers (Bio-Rad Laboratories Inc. USA), 1 µl of 10 mM dNTP mix and 
DEPC-treated water (Life Technologies, California, USA) up to a 14 µl volume. The mixture was 
heat-denatured at 65°C for 5 min. 4 µl of First Strand buffer (Life Technologies, California, USA), 
1 µl of 1 mM DTT, 1 µl of RNAaseIN (Promega, Wisconsin, USA), and 1 µl of SuperScriptIII 
Reverse Transcriptase enzyme (Life Technologies, California, USA) was added to the mixture, and 
incubated for 10 min at 25°C, then 60 min at 50°C, 15 min at 70°C, and chilled on ice. 1 µl of 
RNAse H was subsequently added to each tube and incubated for 20 min at 37°C, followed by heat 
inactivation for 20 min at 65°C. The resulting cDNA were stored at −20°C prior to use.  
 
Gene expression analysis was performed by PCR in a 2720 Thermal Cycler (Life Technologies, 
California, USA). 25 µl reactions contained 14.5 µl of sterile water, 50 ng of cDNA template, 1X 
PCR Buffer II (Roche, Basel, Switzerland), 2.5 mM MgCl2 (Roche, Basel, Switzerland), 20 µM 
dNTPs, 1 µM of each primer, and 5 µl of AmpliTaq Gold DNA Polymerase (Roche, Basel, 
Switzerland) (Table 2.5). Amplification was for 30 cycles and cycling conditions were as follows: 
denaturation for 5 min at 95°C for 30 sec, annealing at 55°C for 30 sec, elongation for 1 min at 
72°C followed by a final extension step of 7 min at 72°C.  
 
PCR products were electrophoresed at 100V for 30 min on 2% TAE Agarose (Boehringer 
Mannheim, Lewes, UK) stained with ethidium bromide (Sigma Aldrich, Missouri, USA) and 
visualised with UV transillumination using a GelDoc
TM 
XR (Biorad Laboratories Inc, California, 
USA).  
 
Regions Primer name Primer sequence 
Ube1y 
Ube1yF 5’-ATTGACTTTGAGAAGGATGAC-3’ 
Ube1yR 5’-CAGACACSCSSGGCCAACTAT-3’ 
Ube1x 
Ube1xF 5’-GTGCATTCCCCTAAGCCCCA-3’ 
Ube1xR 5’-GGGTAATTATCCTTTTATTGGGAT-3’ 
Rbmy RbmyF 5’-AACCGAAGTAACATATACTCA-3’ 
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RbmyR 5’-ATCTGCTTTCTCCACGACCTC-3’ 
Fthl17 
Fth17F 5’-TACTTTGACCGTGATGACGTG-3’ 
Fthl17R 5’-AGTTTTGCTCCAGGAAATGGC-3’ 
Usp26 
Usp26F 5’-AATGTAACGAAGGGAGAAGTG-3’ 
Usp26R 5’-AGGCTTTGCCTTCTTATCGAG-3’ 
Tktl1 
Tktl1F 5’-TCAAAGGGACTACCATTTGTT-3’ 
Tktl1R 5’-AACAGGGGGCGAAGTCATACA-3’ 
Dazl 
DazlF 5’-TTCAGGCATATCCTCCTTATC-3’ 
DazlR 5’-ATGCTTCGGTCCACAGACTTC-3’ 
Setx 
SetxF 5’-CCGGGATTCATTATTAAGACCAGTGACCC-3’ 
SetxR 5’-GATGGCCTCGAGCTATAGAAATTGTCTCCTC-3’ 
β-actin 
ActbF 5’-GCGGACTGTTACTGAGCTGCGT-3’ 
ActbR 5’-GAAGCAATGCTGTCACCTTCCC-3’ 
 
Table 2.5: Description of primers used for RT-PCR 
 
2.10 Immunoprecipitation of SUMOylated proteins from Setx
+/+
 and Setx
-/-
 testes 
 
Testes of 35 day-old mice (ground with a pestle to disrupt their structure) were lysed for 1 h at 4ºC 
on a rotating wheel with 1 ml of lysis buffer [50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM 
EGTA, 2mM EDTA, 25 mM β-glycerophosphate, 0.1 mM Sodium Orthovanadate, 0.1 mM PMSF, 
25 mM Sodium Fluoride, 0.2% Triton X-100, 0.3% NP-40 and 1 X EDTA-free Complete Protease 
inhibitor (Roche, Basel, Switzerland) 25 µM NEM (Sigma Aldrich, Missouri, USA)]. Cellular 
debris were pelleted by centrifugation at 16,100 x g at 4ºC for 10 min, and protein concentration 
was determined using Lowry Assay (Bio-Rad Laboratories, Inc, California, USA). 3 mg of total cell 
extract were pre-cleared with 20 μl of Protein A beads (50:50 slurry) (Merck Millipore, 
Massachusetts, USA) for 3 h at 4ºC on a rotating wheel. Extracts were centrifuged for 5 min at 2000 
x g, beads were removed, and 10 μg of anti-SUMO antibody (Abcam, Cambridge, UK) was added 
to the extract. Extracts and antibody were incubated overnight at 4ºC on a rotating wheel to allow 
binding of the antibody to SUMOylated protein. The next day, 40 μl of Protein A beads (50:50 
slurry) (Merck Millipore, Massachusetts, USA) was added to the extract and incubated for 2 h at 
4ºC on a rotating wheel. Extracts were centrifuged for 5 min at 2000 x g and the beads were 
removed. The immunoprecipitate was subsequently washed 3 times with lysis buffer and the beads 
were resuspended in SDS loading buffer containing 2X DTT and separated via 4-12% SDS-PAGE 
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using Novex Tris-Glycine gels (Life Technologies, California, USA) at 110V for 1.5 h. Once 
separated, gel was stained with G-250 Colloidal Coomassie (Life Technologies, California, USA) 
overnight. Gel was subsequently de-stained using Milli-Q water. 
 
2.11 Tryptic digestion of SUMOylated proteins from mice spermatocytes for Mass 
Spectrometry 
 
Bands were excised from gel using a sterile scalpel and were left to de-stain (50% acetonitrile, 50% 
ammonium bicarbonate) for 4 hours. Trypsin (Promega, Wisconsin, USA) was added 1:20 by 
weight in 50 mM ammonium bicarbonate until gel pieces were covered and left to digest overnight. 
Subsequently, 100% acetonitrile was added and tube was vortexed for 10 min. Liquid in the tube 
was then transferred into a fresh Eppendorf tube. 50% acetonitrile was added to the gel pieces and 
vortexed again for 10 min. Liquid was combined with the liquid collected in the previous step. 
Tubes were spun in a Speedy-Vac for 30 min to dry liquid to approximately 5 µl. This volume was 
reconstituted to 20 µl 0.1% TFA and applied to a C18 STAGE tip (Thermo Scientific, 
Massachusetts, USA) by pipetting up and down for approximately 10 times. Tips were then washed 
with 10 µl of 0.1% TFA and peptides were eluted with 50% acetonitrile intro a fresh Eppendorf 
tube. Eluant was frozen at -20°C and shipped to Dr. Mark Graham (Children’s Medical Research 
Institute, University of Sydney, Australia) for Liquid Chromatography Mass Spectrometry analyses. 
 
2.12 Immunoblotting for DDR proteins from Setx
+/+
 and Setx
-/-
 testes 
 
Testes of 35 day-old mice (ground with a pestle to disrupt their structure) were lysed for 1 h at 4ºC 
on a rotating wheel with 1 ml of lysis buffer [50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM 
EGTA, 2mM EDTA, 25 mM β-glycerophosphate, 0.1 mM Sodium Orthovanadate, 0.1 mM PMSF, 
25 mM Sodium Fluoride, 0.2% Triton X-100, 0.3% NP-40 and 1 X EDTA-free Complete Protease 
inhibitor (Roche, Basel, Switzerland)]. Cellular debris was pelleted by centrifugation at 16,100 x g 
at 4ºC for 10 min, and protein concentration was determined using Lowry Assay (Bio-Rad 
Laboratories, Inc, California, USA). 30 µg of total cell extract were resuspended in SDS loading 
buffer containing 2X DTT and separated via 4-12% SDS-PAGE using Novex Tris-Glycine gels 
(Life Technologies, California, USA) at 110V for 1.5 h. The proteins were then transferred onto a 
Hybond-C nitrocellulose membrane (Pall Life Sciences, NY, USA) using a high molecular weight 
transfer buffer (100mM Tris, 40mM Glycine, 0.05% SDS, 20% Methanol) at 100V for 1 h at 4ºC in 
a mini-protean gel rig (Biorad, CA, USA). The membrane was the blocked in 5% skim milk in 
TBS/Tween 20 or 5% BSA/TBS/Tween 20 and immunoblotting was performed with various 
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antibodies (Table 2.6). Membranes were incubated with primary antibody in 5% skim 
milk/TBS/Tween 20 or 5% BSA/TBS/Tween 20 overnight at 4ºC and washed thrice the following 
day with TBS/Tween 20 for 5 min each. Secondary antibody conjugated with horseradish 
peroxidase (HRP) (Table 2.7) in 5% skim milk/TBS/Tween 20 or 5% BSA/TBS/Tween 20 was then 
applied to the membrane for 1 h at room temperature. Membranes were then analysed using the 
Western Lightning Plus Enhanced Chemiluminescence (ECL) reagent (Perkin Elmer,MA, USA). 
 
Primary antibody Species Dilution Catalogue number Manufacturer 
Atr Goat 1:1000 SC-1887 Santa Cruz Biotechnology 
Nek1 Rabbit 1:1000 BS-7814R Bioss Inc. 
Atrip Rabbit 1:1000 A300-670 Bethyl Laboratories Inc. 
Chk1 Mouse 1:1000 2360 Cell Signaling Technology 
Chd4 Rabbit 1:1000 AB72418 Abcam 
Rad51 Rabbit 1:1000 SC-6862 Santa Cruz Biotechnology 
Mlh1 Mouse 1:500 SC-56161 Santa Cruz Biotechnology 
Setx Sheep 1:500 - In-house  
TopBp1 Rabbit 1:1000 AB2402 Abcam 
SUMO-1 Rabbit 1:1000 AB32058 Abcam 
Phospho-Atr 
(S428) 
Rabbit 1:1000 
2853 
Cell Signaling Technology 
Phospho-Chk1 
(S317) 
Rabbit 1:1000 
2344 
Cell Signaling Technology 
Gapdh Rabbit 1:2000 GTX100118 Genetex 
α-tubulin Rabbit 1:2000 GTX112141 Genetex 
 
Table 2.6: Description of primary antibodies used for immunoblotting 
 
Secondary antibodies Dilution Catalogue 
number 
Manufacturer 
HRP-conjugated donkey anti-sheep 1:5000 AP184P Merk Millipore 
HRP-conjugated donkey anti-mouse 1:5000 AP192P Merk Millipore 
HRP-conjugated donkey anti-rabbit 1:5000 AP182P Merk Millipore 
 
Table 2.7: Description of secondary antibodies used for immunoblotting. 
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2.13 Transfection of HeLa and U2OS cells with Stealth
TM
 siRNA 
 
HeLa and U2OS cells were transfected with Stealth
TM
 siRNA negative control LO GC (#12935200) 
(Life Technologies, California, USA) and Stealth
TM
 siRNA specific for the knockdown of SETX 
(CCAUCUAACUCUGUACAACUUGCUU, Life Technologies, California, USA). 
Lipofectamine
TM
 2000 (Life Technologies, California, USA) was used for the transfections. Briefly, 
2.5-10x105 cells were seeded in a 6-well plate and upon transfection, cells were washed with 2X 
OPTIMEM® I Reduced Serum Medium (Life Technologies, California, USA). For transfection 
with Stealth
TM
  siRNA negative control, 5 μl of a 20 μM stock of oligoribonucleotide was diluted in 
250 μl of OPTIMEM® I Reduced Serum Medium and for the transfection StealthTM siRNA SETX, 
5 μl of a 20 μM stock of oligoribonucleotide was diluted in 250 μl of OPTIMEM® I Reduced 
Serum Medium. For each transfection, 10 μl of LipofectamineTM 2000 was diluted in 250 μl of 
OPTIMEM® I Reduced Serum Medium and the mixture was incubated at room temperature for 5 
min. Subsequently, the diluted oligoribonucleotides (either control or SETX RNAi) were combined 
with the diluted Lipofectamine
TM
 2000 (total volume 500 μl) and incubated at room temperature for 
20 min. The oligoribonucleotide- Lipofectamine
TM
 2000 complexes were added to the 
corresponding well of a 6-well plate to be transfected with the siRNA. The plate was then 
centrifuged at 500 x g for 5 min at room temperature, and cells were incubated in a humidified 
incubator at 37°C/5% CO2. 8 h later, 2 ml of DME medium containing 10% FCS (Gibco BRL, Life 
Technologies, California, USA) was added to each well and the cells were incubated in a 
humidified incubator at 37°C/5% CO2 for 24 h.  
 
To determine the knockdown efficiency of SETX with siRNA, 24 h post-transfection with control 
and SETX siRNA, total cell extracts were made and immunoblotted as described in section 2.12. 
Immunostaining using anti-senataxin (Ab-1) antibody was also performed as described in section 
2.5. 
 
2.14 Treatment of HeLa and U2OS cells with Camptothecin and Actinomycin D  
 
U2OS cells transfected with control (Ctrl siRNA) and SETX siRNAs were first treated with 5μg/ml 
of Actinomycin D (Sigma Aldrich, Missouri, USA) and incubated in a humidified incubator at 
37°C/5% CO2 for 2 h. After the 2 h incubation, 25 μM of camptothecin (Sigma Aldrich, Missouri, 
USA) was added to the cells and incubated in a humidified incubator at 37°C/5% CO2 for another 2 
h. Subsequently, cells were fixed with 4% PFA in 1 X PBS, immunostained with R-loop antibody 
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(S9.6, gift from Dr. Stephen Leppla, USA) and imaged using a 63X Plan Apochromat 1.4 oil 
differential interference contrast objective (Carl Zeiss, Jena, Germany).  
 
2.15 DNA:RNA immunoprecipitation assay (DRIP)  
 
Genomic DNA and RNA extraction from Setx
+/+
 and Setx
-/-
 mice testes, LCLs and HeLa cells were 
performed using the DNeasy Blood & Tissue Kit (Qiagen, Limburg, Netherlands) following the 
manufacturers’ instructions. Protein extracts were sonicated (maximum voltage, constant output, 
microtip limit) for 3 min with 1 min incubation on ice within each min. 40 μl of Protein G beads 
(50:50 slurry) (Merck Millipore, Massachusetts, USA) was added to the extracts and pre-cleared. In 
a separate tube, 15 μg of anti-R-loop antibody (S9.6) and 40 μl of Protein G beads (50:50 slurry) 
(Merck Millipore, Massachusetts, USA) were added together and incubated at 4ºC overnight on a 
rotating wheel to allow binding of antibody to beads. Anti-c-Abl antibody (Cell Signaling 
Technology, Massachussetts, USA) and 40 μl of Protein G beads (50:50 slurry) (Merck Millipore, 
Massachusetts, USA) were also added together to serve as a non-specific (species-specific) control 
for our experiment. The next day, the tubes were centrifuged at 5400 x g for 2 min to pellet the 
beads. The supernatant was then divided equally into 3 tubes- 1 was left untreated, 1 was treated 
with 200 U of S1 Nuclease (Promega, Wisconsin, USA) and the other was treated with 10 U of 
RNAse H (New England BioLabs, Massachusetts, USA). Extracts were incubated at 37ºC for 2 h, 
heat inactivated for 20 min at 65ºC then added on to the antibody-bound Protein G beads and 
incubated at 4ºC overnight on a rotating wheel to allow binding of R-loops fragments to antibody-
bound beads. The next day, the beads were pelleted at 5400 x g for 2 min and the supernatant was 
discarded. The beads were washed once with the IP Wash Buffer 1 (20 mM Tris-HCl pH 8.1, 2 mM 
EDTA, 50 mM NaCl, 1% Triton X-100, 0.1% SDS), twice with the High Salt Wash Buffer (20 mM 
Tris-HCl pH 8.1, 2 mM EDTA, 500 mM NaCl, 1% Triton X-100, 0.1% SDS), once with the IP 
Wash Buffer 2 (10 mM Tris-HCl pH 8.1, 1 mM EDTA, 0.25 M LiCl, 1% NP-40, 1% Deoxycholic 
Acid) and twice with TE Buffer (20 mM Tris-HCl pH 8.0, 1mM EDTA). The immunoprecipitates 
were incubated at 4ºC on a rocker for 3 min between each wash. The nucleic acids were then eluted 
twice with 100 μl of Elution Buffer (100 mM NaHCO3, 1% SDS). 3 μl of Proteinase K (20 mg/ml) 
was then added to each sample and incubated at 55°C. The samples were then diluted to 400 μl with 
TE Buffer and 3 μl of Glycogen (20 mg/ml) (Roche, Basel, Switzerland) was added. The nucleic 
acids were extracted using 400 μl of phenol-chloroform (1:1) (Life Technologies, California, USA) 
and vortexed for 1 min. The samples were centrifuged at 16, 000 x g for 5 min and the aqueous 
phase containing the nucleic acids were retained. These were extracted again using 400 μl of 
chloroform (Life Technologies, California, USA) under the same conditions. 2.5X of 100% EtOH 
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was added to the samples and these were incubated at -80ºC for 20 min. The samples were 
centrifuged at 16, 000 x g for 20 min and the supernatant was decanted. The pellet was washed with 
70% EtOH, centrifuged at 16, 000 x g for 20 min and the supernatant was decanted. The pellet was 
air-dried and resuspended in EB Buffer (Qiagen, Limburg, Netherlands).  
 
2.16 PCR analyses for DRIP assay 
  
Primers for the RLFS region in mouse Ube1y1 gene were Ube1y1F and Ube1y1R. PCR cycling 
conditions were as follows: 35 cycles, initial denaturation at 95ºC for 3 min, denaturation at 95ºC 
for 45 sec, annealing at 58 ºC for 45 sec, extension at 72ºC for 1 min, with a final cycle and 
extension of 7 min at 72ºC. The PCR product size for the RLFS region in Ube1y1 was 183 bp. 
Primers for the RLFS region in mouse Tktl1 gene were Tktl1F and Tktl1R. PCR cycling conditions 
were as follows: 35 cycles, initial denaturation at 95ºC for 3 min, denaturation at 95ºC for 45 sec, 
annealing at 55 ºC for 45 sec, extension at 72ºC for 1 min, with a final cycle and extension of 7 min 
at 72ºC. The PCR product size for the RLFS region in Tktl1 was 179 bp. See table 2.8 for 
description of primers used for DRIP assay. 
 
PCR products were electrophoresed at 100V for 30 min on 2% TAE Agarose (Boehringer 
Mannheim, Amresco, Lewes, UK) stained with Ethidium bromide and visualised with UV 
transillumination using a GelDoc
TM 
XR (Biorad Laboratories Inc, California, USA).  
 
Regions Primer name Primer sequence 
Ube1y1 
Ube1y1F 5’-CACAGAAGTTCAGGGCATGA-3’ 
Ube1y1R 5’-GCCCAGTCTGCTGTGAAAAGT-3’ 
Tktl1 
Tktl1F 5’-CATAAGCCTCCATAAGCAAGC-3’ 
Tktl1R 5’-CTGCTTGCCTCAGCTTCC-3’ 
Wwox 
Wwox1F 5’-GACCGAGGGTGGAGCTGTAG-3’ 
Wwox1R 5’-AGCCAAGTGTTACATGGAGTTAGT-3’ 
HS44.2 
mHS44.2 1F 5’ AGCGGGTTTACGGAATGCTT-3’ 
mHS44.2 1R 5’-AGTCTTCAGAGAGGAGATTAGAGGA-3’ 
Foxo4 
mFoxo4 F 5’-GGTTTCTGGTTTCTGCTGCC-3’ 
mFoxo4 R 5’-AGGGCTGGAGTGAACACTTG-3’ 
 
Table 2.8 Description of primers used for DRIP assay. 
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CHAPTER 3 Characterization of the Setx
-/-
 Mouse 
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3.1 Introduction 
 
Ataxia oculomotor apraxia type 2 (AOA2) belongs to a wide class of autosomal recessive cerebellar 
ataxias (ARCA), and is a neurological disorder characterized by the onset of progressive cerebellar 
degeneration and oculomotor apraxia during adolescence
49,69
. AOA2 patients also display axonal 
sensorimotor neuropathy and elevated alpha-fetoprotein serum levels
184
. 
 
The protein mutated in AOA2 is senataxin (SETX), which is encoded on chromosome 9q34
61
. 
Senataxin is approximately 300kDa in size and contains a classical seven-motif domain belonging 
to the superfamily I of helicases
61
. These helicases are motor proteins involved in the unwinding of 
DNA or RNA strands and play central roles in nucleic acid metabolic activities such as DNA 
replication, recombination and repair, as well as transcription and mRNA splicing
185
. It has 
previously been reported that cells lacking senataxin showed higher levels of oxidative damage, 
increased chromosomal instability following treatment with DNA damaging agents such as H2O2, 
camptothecin and mitomycin C, as well as impaired DNA repair
63
. Senataxin deficient cells were 
also reported to show defects in transcription termination, splicing efficiency and splice site 
selection
71
. 
 
To further investigate the role of senataxin in vivo, our lab generated the first Setx
-/-
 mouse model. 
This was achieved by using a highly-efficient recombineering-based method
186
 and deleting exon 4 
of the Setx gene. This creates an unstable transcript that is quickly degraded. 
 
Briefly, a loxP-F3-PGK-EM7-Neo-F3 (Neo) selection cassette was inserted into a bacterial artificial 
chromosome (BAC) clone (RP23-389D11, Children’s Hospital Oakland Research Institute) 
corresponding to mouse chromosome 2 and covering the mouse Setx genomic sequence. The Neo 
cassette, which provides positive selection in embryonic stem cells (ESC), was flanked by a 5’-
homology arm of 6.8 kb and a 3’-homology arm of 3 kb. ESCs were then transfected with the 
linearized targeting vector and selected with 150 µg/ml of G418. Successful recombinant ESC 
clones were determined by Southern Blotting with a specific probe as well as with PCR genotyping. 
Targeted cells (+Neo) were subsequently microinjected into C57BL6/129Sv mouse blastocysts, 
generating chimeras. Excision of the Neo cassette was obtained by crossing the chimeras with a Cre 
deleter strain, generating Setx
-/-
 mice containing only a single LoxP site (Fig 3.1). 
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Fig 3.1: Targeted disruption of mouse Setx gene. Diagram of the Setx wild type allele (WT), 
targeting vector, and mutant alleles (neo+ and KO). Primers used for PCR genotyping (In3F, In3R, 
LoxPR). E, exon; I, intron. NeoR represents the neomycin cassette, and triangles represent the LoxP 
sites. 
 
While no neurological defects were observed in Setx
-/- 
mice, multiple attempts to breed male Setx
-/-
 
mice with each other or with Setx
+/+ 
mice were unsuccessful. Male Setx
-/-
 mice had normal 
development of secondary sexual characteristics and were capable of the mechanics of mating, but 
were completely sterile. This Chapter describes the essential role of senataxin in DNA repair and 
meiotic recombination in spermatogenesis. 
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3.2 Results  
 
3.2.1 Generation of Setx
-/-
 mice 
 
To show the disruption of the Setx gene in our mouse model, an immunoprecipitation (IP) using an 
antibody against senataxin from total cell extracts made from Setx
+/+ 
and Setx
-/-
 mouse testes was 
performed (Fig 3.2A). As a positive control for the IP, human lymphoblastoid cell (hLCLs) protein 
extracts from a normal subject (C3ABR) and an AOA2 patient (SETX2RM) were used to confirm a 
similar-sized protein. Indeed, the mouse senataxin protein is only 31 amino acids shorter (2646 aa) 
compared to human senataxin protein (2677 aa), therefore a difference in protein migration by SDS-
PAGE electrophoresis is not detectable. As expected, senataxin was immunoprecipitated from WT 
mouse testes and normal hLCLs. In contrast, senataxin was not detected in the Setx
-/- 
mouse 
extracts. A strong signal was observed in C3ABR as compared to that observed in Setx
+/+
 mouse 
testes extracts, indicating a greater sensitivity for the human protein due to the fact that the anti-
senataxin antibody was raised against human senataxin. A weak signal was observed in SETX2M 
cell extracts, indicating that the mutant senataxin protein is expressed at very low levels in the 
AOA2 patient. As expected, senataxin was not detected in the Setx
-/- 
mouse testes extracts, 
confirming the disruption of the Setx gene and the lack of senataxin protein production. 
Additionally, the non-specific (NS) sheep IgG used as a negative control did not pull down 
senataxin from Setx
+/+
 mouse testes extracts.  
 
As expected, crosses between Setx heterozygotes produced all 3 genotypes (wild type, 
heterozygotes and homozygote knockouts) (Fig 3.2B) and a Mendelian inheritance pattern was 
observed (wild type 25%; heterozygote 54%; knockout 21%; n = 87). Primers used for genotyping 
were In3F, In3R and LoxPR (Table 2.1). Disruption of the Setx gene was also confirmed by 
Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) where the expression of Setx mRNA 
was observed only in Setx
+/+
 mice (Fig 3.2C). 
 
It was observed that Setx
-/- 
mice were of normal body sizes and weights with comparable life spans 
to those of their wild type and heterozygote littermates.  
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Fig 3.2: Disruption of the Setx gene in Setx
-/-
 mice. A. Senataxin immunoprecipitation (IP) from 
total cell extracts from Setx
+/+
 and Setx
-/-
 mouse testes. Extracts from human lymphoblastoid cells 
(hLCLs) from a normal subject (C3ABR) and an AOA2 patient (SETX2RM) were used as positive 
controls during the immunoprecipitation and to confirm a similar sized protein for the mouse and 
the human senataxin. A species-matched, sheep non-specific IgG (NS) was used as a negative 
control. B. Representative image of Setx PCR genotyping using In3F, In3R and LoxPR primers. 
Wild type (+/+), heterozygotes (+/−) and knockout (−/−) alleles generate PCR products of 600 bp, 
600 bp and 339 bp, and 339 bp, respectively. A negative control (-ve, no template) for the PCR 
reaction is also shown. M, 100 bp marker. C. RT-PCR of total RNA extracted from 35 day-old 
Setx
+/+
 and Setx
-/-
 mouse testes using primers specific to Setx cDNA indicated the absence of Setx 
expression in Setx
-/-
 testes. Gapdh was used as an internal standard for loading control. 
 
3.2.2 Absence of neurological phenotype in Setx
-/-
 mice 
 
Because AOA2 is characterized by ataxia, behavioral analyses on these mice using a phenotypic 
scoring system that is commonly used to evaluate mouse models of neurodegeneration was 
performed
187
. This system has been used previously to assess several models of neurological 
disorders such as spinocerebellar ataxias, Huntington's disease and spinobulbar muscular 
atrophy
188,189
. 
 
These analyses include the ledge test, observation of hindlimb clasping, overall gait and kyphosis. 
Briefly, the ledge test is a direct measure of balance and coordination, and is the most comparable 
test to human symptoms of cerebellar degeneration. This test involves placing a mouse on the ledge 
of their cage, and their overall balance while crossing the ledge and their descent back into their 
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cage is observed. A normal mouse does not lose balance and would descend into their cage landing 
first on their front paws without difficulty. The hindlimb clasp test is an indicator of the progression 
of cerebellar degeneration. A mouse is picked up by the base of its tail and held up in the air for 
approximately 10 seconds. During this time, a normal mouse would have its hindlimbs fully splayed 
outwards and not withdrawn towards its abdomen. The gait test looks at muscle function and 
coordination. A mouse is placed on a flat surface facing away from the investigator, and its walking 
pattern is observed. A normal mouse should have its weight evenly distributed on all 4 paws 
without its abdomen dragging on the surface. Lastly, kyphosis of the mouse is observed. This test 
looks at the curvature of the dorsal spine of a mouse due to loss of muscle tone. To do this, a mouse 
is placed on a flat surface and its ability to straighten out its spine easily is observed
187
. These tests 
were repeated thrice and a score of between 0 to 3 is assigned to each mouse, with 0 being the score 
for mice without the relevant ataxic phenotype and 3 being the score for mice displaying the most 
severe manifestation of the phenotype
187
. The average cumulative scores of these tests for mice 
aged between 3 and 17 months was tabulated and no behavioral differences was observed between 
Setx
+/+
 and Setx
-/-
 mice (Fig 3.3). 
 
 
Fig 3.3: Absence of neurological phenotype and ataxia in Setx
−/−
 mice. Behaviour analyses 
include ledge test, hindlimb clasp test, gait and kyphosis. Each mouse was scored between 0 and 3, 
with 0 representing the absence of the relevant phenotype and 3 being most severe manifestation of 
the phenotype. The average cumulative score for Setx
+/+
 and Setx
−/−
 mice at the various age was 
calculated. Neither abnormal behaviour nor ataxic phenotype progression was observed in Setx
−/−
 
mice. Number of animals (n ≥ 3). 
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Given the lack of abnormal motor behavior in Setx
-/-
 mice, the overall morphological structure of 
the brain and cerebellum of both Setx
+/+
 and Setx
−/−
 mice was determined to assess for the presence 
of a subtle neurological phenotype. As shown in Fig 3.4, no gross cellular and structural differences 
between the mice were observed.  
 
 
Fig 3.4: No gross cellular or structural differences in brain or cerebellum of Setx
-/-
 mice. H&E 
stained cross sections of brain and cerebellar tissue viewed at 10X magnification. Black arrows, 
Purkinje cells. ML, molecular layer. GL, granular layer. Number of animals (n ≥ 3). 
 
As aforementioned, progressive cerebellar degeneration is characteristic of patients suffering from 
AOA2 due to the loss of Purkinje cells, which are neurons in the cerebellum that control motor 
movement
61,69
. To observe whether this phenomenon was occurring in our Setx
-/-
 mice, an 
immunofluorescence assay was performed using an antibody against calbindin, a marker for 
Purkinje cells, on cerebellar tissue sections taken from Setx
+/+
 and Setx
-/-
 mice. TUNEL staining, a 
marker for apoptotic cells was performed simultaneously. However, no structural alterations, 
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general cerebellar degeneration, nor the specific loss of Purkinje cells in Setx
−/−
 mouse cerebella 
was detected (Fig 3.5).  
 
 
Fig 3.5: Setx
-/-
 mice have normal Purkinje cell arrangement. Immunostaining using an anti-
calbindin (marker of Purkinje cells) antibody and TUNEL (marker for apoptotic cells) on Setx
+/+
 
and Setx
-/-
 cerebellar sections revealed neither differences in numbers nor arrangement of Purkinje 
cells between the mice. No signs of apoptosis were observed in either Setx
+/+
 and Setx
-/-
 sections. 
Number of animals (n ≥ 3). 
 
Both behavioral studies and molecular analysis of brain and cerebellum structure and architecture 
provided evidence for an absence of neurological phenotype in Setx
-/-
 mice. 
 
3.2.4 Senataxin is essential for male germ cell development and fertility 
 
Common findings in ARCA patients as well as in their corresponding mouse models are 
oligospermia and testicular abnormalities
20
. Therefore, whether these phenomena also occur in the 
Setx
−/−
 mice was investigated. Multiple attempts to breed male Setx
−/−
 mice with female Setx
+/+
or 
Setx
-/-
 mice were unsuccessful. Setx
−/−
 male mice exhibited normal development of secondary 
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sexual characteristics and were capable of the mechanics of mating, but were infertile. The 
development of the testes and seminiferous tubules from Setx
−/−
 mice with those from Setx
+/+
 mice 
was subsequently compared. It was observed that testes from Setx
−/−
 mice were smaller in size (50–
60% reduction) than their Setx
+/+
 littermates (Fig 3.6A). Histological examination of testes sections 
from 35 day-old adult Setx
−/−
 males also revealed a severe disruption of the seminiferous tubules 
and the absence of mature germ cells as compared to Setx
+/+
 males (Fig 3.6B-E).  
 
 
Fig 3.6: Defect in spermatogenesis in Setx
-/ 
mouse: A. Testes from 35-day-old Setx
+/+
 and Setx
−/−
 
mice. Testes from Setx
−/−
 mice were significantly smaller than that of Setx
+/+
 mice. B–C. 
Haematoxylin and Eosin (H&E)-stained sections of testes from 35-day-old Setx
+/+
 and Setx
−/−
 mice. 
Scale bar, 100 µm. D–E. Enlarged images of regions in (B) and (C). Asterisks in (C) and (E) show 
vacuolated seminiferous tubules of Setx
−/−
 mice in which both spermatids and spermatozoa are 
absent. Scale bar, 100 µm. Number of animals (n ≥ 3). 
 
In contrast to male Setx
-/-
 mice, female Setx
-/-
 mice were fertile. Histological examination of ovarian 
sections from female Setx
−/−
 mice did not exhibit any gross morphological differences from their 
Setx
+/+
 littermates. Normal ovarian structure, presence of follicles at various stages and the ability 
to ovulate was observed (Fig 3.7). However, a closer inspection of this revealed the sub-fertility of 
female Setx
−/−
 mice. Superovulation and timed-mating to harvest embryos at the fertilized, one-cell 
stage [0.5 days post coital (dpc)] was carried out. It was observed that the yield of these viable 
embryos was very low. A > 3.5-fold reduction in the yield of 0.5 dpc embryos from female Setx
−/−
 
mice (10-20 embryos) was detected as compared to Setx
+/+ 
mice (50–70 embryos). Furthermore, 
only approximately 23% of these viable embryos from Setx
−/−
 mice survived in culture, indicating 
that Setx
−/−
 females have a reduced fertility. These data are in line with previous reports on female 
AOA2 patients presenting with fertility issues such as premature ovarian failure
66,190
.  
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Fig 3.7: Normal ovarian structure in Setx
-/- 
mice: A. Haematoxylin and Eosin (H&E)-stained 
sections ovarian tissue sections from adult, 35-day-old female Setx
+/+
 and Setx
−/−
 mice. Pre-antral 
and antral follicles (F) are present in all sections and many follicles contain oocytes (asterisks). All 
sections also contain corpora lutea (CL), suggesting ovulation has occurred. Scale bar, 200 µm. 
Number of animals (n ≥ 3). 
 
In this report, focus will be on the infertility phenotype observed in male Setx
-/ 
mice, which is the 
most apparent phenotype observed in these mice. 
 
Spermatogonia, or primordial germ cells, undergo 4 stages during meiotic prophase I of 
spermatogenesis, namely leptotene, zygotene, pachytene and diplotene, before entering 
spermiogenesis to form mature spermatids. These various stages can be visualized by staining for 
synaptonemal complex protein 3 (SCP3), a protein member of the axial element on chromatin 
essential for the synapsis of homologous chromosomes required for recombination (Fig 3.8A)
112
. 
Briefly, during the leptotene and zygotene stages, sister chromatids start to come together and 
condense into visible threads within the nucleus. In the pachytene stage, sister chromosomes are 
fully synapsed and the exchange of genetic material through homologous recombination (HR) 
occurs. Finally, in the diplotene stage, HR is completed, the synaptonemal complex degrades and 
sister chromatids begin to separate from one another, leaving only the sites of crossing over 
visible
113
. 
 
Immunostaining using an antibody against SCP3 revealed that Setx
-/-
 mice did not carry diplotene-
staged spermatocytes (Fig 3.8B). Setx
−/−
 mice displayed a significant decrease in the percentage of 
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leptotene- and zygotene-staged spermatocytes but had comparable levels of pachytene-staged 
spermatocytes as compared to Setx
+/+
 mice. No diplotene-stage spermatocytes were observed in 
Setx
−/−
 mice. These data indicate that the disruption of meiosis is due to a block at the pachytene-
diplotene transition, contributing to the defect in spermatogenesis observed in the Setx
-/-
 male mice.  
 
 
Fig 3.8: Block in meiosis at pachytene stage in Setx
−/−
 spermatocytes. A. Immunostaining for 
SCP3 on spermatocyte spreads made from Setx
+/+
 and Setx
-/-
 mouse testes show the various stages 
in meiosis prophase I. Organisation and structure of the synaptonemal complex allows clear 
distinction between the different meiotic phases. Scale bar, 20 µm. B. Graph showing the 
distribution of the different meiotic prophase I stages (leptotene, zygotene, pachytene, diplotene) in 
adult 35-day-old Setx
+/+
 and Setx
−/− 
mice. A comparable number of leptotene-, zygotene- and 
pachytene-staged spermatocytes were observed in both mouse types, but a complete absence of 
diplotene-staged spermatocytes in Setx
−/−
 mice was observed, indicating a block at pachytene stage. 
Data is plotted as the mean ± standard deviation obtained from 3 mice. 2000 spermatocytes were 
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counted for each Setx
+/+
 and Setx
−/− 
mouse. Student's t-test, p<0.01. Data was plotted by Evelyn 
Y.H. Heng as the mean ± standard error, n = 6000.* indicates p<0.01.  
 
Using the TUNEL assay as a marker for apoptotic cells, elevated levels of apoptosis were detected 
in seminiferous tubules of Setx
−/−
 mice (Fig 3.9), suggesting that these arrested spermatocytes are 
eliminated via this pathway. 
 
 
Fig 3.9: Increased apoptosis of germ cells in Setx
-/-
 mice: A. TUNEL-stained (green) tissue 
sections of testes from Setx
+/+
 and Setx
−/−
 mice. An increased number of TUNEL-positive cells 
were observed in the testes of Setx
−/−
 mice as compared to that from Setx
+/+
 mice. Scale bar, 50 µm. 
B. Increased percentage of seminiferous tubules containing apoptotic germ cells in Setx
−/−
 mice 
(tubules with ≥8 TUNEL-positive cells per tubule). Data is plotted as the mean ± standard 
deviation, n = 1330. Number of animals (n ≥ 3). 
 
3.2.5 Defects in homologous recombination in Setx
-/-
 spermatocytes 
 
To better understand the meiotic defect that is observed in Setx
-/- 
male mice, differences between the 
meiotic prophase I stages in spermatocyte in both Setx
+/+ 
and Setx
-/- 
mice was analyzed, using 
different key markers involved in homologous recombination (HR).  
 
Briefly, the initiation of HR during spermatogenesis begins with the induction of programmed DNA 
DSBs by the SPO11 endonuclease during the leptotene and zygotene stage in meiosis prophase I
120
. 
Proper formation and repair of these programmed DSBs ensures legitimate pairing and segregation 
of homologous chromosomes
191
. These DNA DSBs subsequently trigger the phosphorylation of 
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histone H2AX at Ser139 and phosphorylated H2AX (γH2AX) is a well-established marker for 
DNA DSBs
116
. γH2AX immunostaining has also been used extensively to monitor the formation 
and kinetics of DNA DSB repair in various cell types including human and mouse cells
118
. By the 
pachytene stage, the majority of DSBs on the autosomes have been repaired, leaving only breaks 
marked by γH2AX on the XY chromosomes that are required for meiotic sex chromosomes 
inactivation (MSCI) (which will be discussed further in section 3.2.6). 
 
In order to determine whether there were differences in the initial production and repair of 
programmed DNA DSBs in Setx
-/-
 mice, immunostaining using an antibody against γH2AX was 
performed on Setx
+/+ 
and Setx
-/- 
spermatocytes. As expected, DNA DSBs were induced in Setx
+/+
 
spermatocytes during the leptotene and zygotene stages (Fig 3.10). These DSBs were repaired by 
the pachytene stage, leaving only γH2AX staining on the XY body. This 2nd wave of H2AX 
phosphorylation on the XY chromosomes occurs as a natural phenomenon that is essential for XY 
silencing during MSCI
126
. In contrast, while DNA DSBs were also induced in leptotene- and 
zygotene-staged spermatocytes of Setx
-/-
 mice, residual breaks were still observed on the autosomes 
during the pachytene stage, indicating the persistence of unrepaired DNA DSBs (Fig 3.10).  
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Fig 3.10: Persistence of DNA DSBs (γH2AX) in Setx-/- spermatocytes. DNA DSBs as denoted by 
γH2AX staining of spermatocytes spreads from Setx+/+ and Setx−/− mice. Initiation of programmed 
DNA DSBs occurs normally in both Setx
+/+
 and Setx
−/−
 mice. At pachytene stage, DSBs on the 
autosomes are repaired, leaving only γH2AX staining restricted to the XY chromosomes in Setx+/+ 
spermatocytes required for meiotic sex chromosome silencing. In contrast, γH2AX staining 
remained on the autosomes of Setx
−/−
 mice during the pachytene stage, indicating the persistence of 
unrepaired DSBs. Normal γH2AX staining of the XY chromosomes was observed in both Setx+/+ 
and Setx
−/−
 pachytene stage spermatocytes. Dotted circle, XY chromosomes. Scale bar, 20 µm. 
Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
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The repair of these programmed meiotic DNA DSBs subsequently occurs via homologous 
recombination (HR) and this involves the participation of various DNA repair factors including 
RPA, DMC1 and RAD51
125
. Both RAD51 and DMC1 play key roles in the initial steps of HR by 
mediating strand invasion and homologous pairing. These proteins are normally observed as 
multiple foci along the chromosomes, first appearing during the leptotene stage then sharply 
decreasing by the pachytene stage
192
.  As expected, normal activity of Rad51 in spermatocytes from 
Setx
+/+
 mice was observed, with foci labelling only observed along the axial element of the 
unsynapsed XY chromosomes (Fig 3.11A). In contrast, multiple Rad51 foci along the SC of 
autosomal chromosomes still persisted during the pachytene stage in spermatocytes from Setx
−/− 
mice. Quantitation of the number of Rad51 foci on the autosomes at pachytene stage revealed a 6-
fold increase of these foci in Setx
−/−
 mice compared to Setx
+/+
 mice (Fig 3.11B). These data indicate 
a defect in the disassembly of Rad51 filaments potentially hindering the repair of DNA DSBs. This 
is then likely to interfere with the progression of HR in Setx
−/−
mice.  
 
 
Fig 3.11: Persistence of DNA DSBs (Rad51) in Setx
-/-
 spermatocytes. A. Retention of Rad51 foci 
at pachytene stage in Setx
−/−
 spermatocytes indicates the persistence of unrepaired DSBs on the 
autosomes. Normal retention of Rad51 seen on XY body in both Setx
+/+
 and Setx
−/−
 mice. Scale bar, 
20 µm. B. Quantitation of Rad51 foci revealed a 6-fold increase in the number of foci in 
spermatocytes at pachytene stage from Setx
−/−
 as compared to that from Setx
+/+
 mice. Dotted circle, 
XY chromosomes. Student's t-test, n = 50. * indicates p<0.05. Number of animals (n ≥ 3), a total of 
50 cells per animal were analysed. 
 
64 
 
Next, to assess whether meiotic recombination proceeds normally in the spermatocytes of Setx
−/−
 
mice despite the persistence of DNA DSBs, the distribution of the mismatch repair protein Mlh1 
was examined. Mlh1 normally forms foci and marks the sites of chiasmata corresponding to sites of 
crossing over. An average of 22 foci per pachytene-staged spermatocyte in Setx
+/+
 mice was 
observed, and this is in agreement with previous reports
193,194
. In contrast, no Mlh1 foci were 
observed in Setx
−/−
 pachytene-staged spermatocytes (Fig 3.12), indicating the absence of crossing 
over. 
 
 
Fig 3.12: Absence of crossing-over in Setx
−/−
 spermatocytes. Formation of chiasmata at 
pachytene stage in Setx
+/+
 spermatocytes was observed as shown by Mlh1 staining. In contrast, no 
Mlh1 foci were detected in Setx
−/−
 spermatocytes, indicating that crossing-over does not occur in 
these mice. Scale bar, 20 µm. Number of animals (n ≥ 3), a total of 50 cells per animal were 
analysed. 
 
Given the increased staining of Rad51 and the lack of Mlh1 foci observed in the spermatocytes of 
Setx
−/−
 mice, reverse transcription polymerase chain reaction (RT-PCR) was performed to 
investigate the expression levels of these genes. 
 
It was observed that the retention of Rad51 foci in spermatocytes of Setx
−/−
 mice was not due to an 
overexpression of Rad51 since comparable Rad51 mRNA levels were observed in both Setx
+/+
 and 
Setx
−/−
 mice (Fig 3.13A). Interestingly, immunoblotting of total protein extracts revealed reduced 
levels of Rad51 protein in Setx
−/−
 mice testes as compared to Setx
+/+
 mice. This indicates that the 
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absence of senataxin affects the synthesis or stability of Rad51 protein (Fig 3.13B). Although there 
are less Rad51 molecules in the Setx
-/-
 spermatocytes, these appear to be sufficient for coating sites 
of DNA DSB to initiate HR repair. Furthermore, the lack of Mlh1 foci in spermatocytes of Setx
−/−
 
mice does not appear to be due to the low expression of the Mlh1 gene as similar levels of Mlh1 
mRNA were detected in both Setx
+/+
 and Setx
−/−
 mouse testes (Fig 3.13A). In contrast to Rad51, 
similar levels of Mlh1 protein in both Setx
+/+
 and Setx
−/−
 mice were observed as shown by 
immunoblotting of total protein extracts from testes (Fig 3.13B), indicating that Mlh1 protein is not 
the limiting factor for crossing-over formation. The lack of senataxin prevents completion of 
meiosis which in turn is likely to result into germ cell apoptosis. This is in agreement with our 
observation of increased apoptosis levels in Setx
-/-
 testes section. Overall, these results thus confirm 
an essential role for senataxin in meiotic recombination during spermatogenesis.  
 
 
Fig 3.13: Similar expression levels of Rad51 and Mlh1 in Setx mice. A. Expression of Rad51 and 
Mlh1 via RT-PCR revealed that the increased staining of Rad51 foci in Setx
−/−
 spermatocytes was 
not due to an upregulation of the Rad51 gene as similar levels of Rad51 mRNA were detected in 
both Setx
+/+
 and Setx
−/−
 testes. Likewise, the absence of Mlh1 foci in Setx
-/-
 spermatocytes was not 
due to a downregulation of the Mlh1 gene as similar levels of Mlh1 mRNA were detected in both 
Setx
+/+
 and Setx
−/−
 testes. B. Immunoblotting of total protein extracts from both Setx
+/+
 and Setx
−/−
 
mouse testes for either Rad51 or Mlh1 showed reduced levels of Rad51 protein in Setx
−/− 
mice as 
compared to Setx
+/+
 mice whereas similar protein levels for Mlh1 were observed for both Setx
+/+
 
and Setx
−/−
 mice. Gapdh was used as a loading control for both assays. 
 
3.2.6 Defect in meiotic sex chromosome inactivation (MSCI) in Setx
-/-
 spermatocytes 
 
During pachytene, another important event known as meiotic sex chromosome inactivation (MSCI) 
takes place. This is when the X and Y chromosomes are transcriptionally silenced and 
compartmentalized within the peripheral nuclear region known as the XY- or sex body
126
. Although 
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the exact mechanism and reason as to how and why MSCI occurs remains unclear
126,129
, it has been 
hypothesized that the silencing of the X and Y chromosomes is essential to prevent the illegitimate 
recombination of the non-homologous chromosomes
128
,  or that the expression of certain X genes 
may be toxic to the cell
195
. Additionally, defects in or failure of MSCI can cause germ cell 
elimination via apoptosis
196,197
.  
 
The arrest at pachytene stage observed in the spermatocytes of Setx
-/-
 male mice led us to 
investigate whether this was partially caused by the failure of MSCI. Hence, to first observe 
whether senataxin has a role MSCI, its localization was investigated by performing immunostaining 
on Setx
+/+
 mouse spermatocyte spreads. It was observed that senataxin localized mostly over the 
XY chromosomes as a diffused cloud during the pachytene stage (Fig 3.14). Some background 
staining was also observed over the autosomes, consistent with a role for senataxin in meiotic 
recombination. As expected, no senataxin labeling was detected in spermatocytes of Setx
−/−
 mouse 
(Fig 3.14).  
 
 
Fig 3.14: Senataxin localizes to the XY chromosomes during meiosis. A. Immunostaining for 
senataxin (Setx) revealed its localization to the XY chromosomes as a diffused cloud during the 
pachytene stage in spermatocytes of Setx
+/+
 mice. Some background staining was also observed on 
the autosomes. As expected, no senataxin was detected in Setx
−/−
 spermatocytes. Dotted circle, XY 
chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
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The preferential localization of senataxin to the XY chromosomes thus indicated a possible role for 
senataxin in MSCI. To investigate whether the absence of senataxin has an effect on the silencing of 
the XY body during MSCI, active transcription via immunostaining using an antibody against the 
activated form (Phospho-S2) of RNA polymerase II was studied. Studying the localization of RNA 
Pol II is commonly performed to look at XY silencing during MSCI
198,199
. The results revealed a 
lack of staining over the XY body in Setx
+/+
spermatocytes, confirming transcriptional silencing (Fig 
3.15A), whereas staining was observed over the XY body in Setx
−/−
 spermatocytes (Fig 3.15A), 
indicating that active transcription was still occurring on the XY body in these mice. A graph plot 
(Fig 3.15B) of the fluorescence intensity of RNA Pol II S2 from the representative image showed 
similar levels of the protein over the autosomes in both Setx
+/+
 and Setx
−/−
 spermatocytes, with an 
abnormal 5 fold increase over the XY chromosomes in Setx
-/- 
spermatocytes. 
 
Investigating the expression levels of sex-linked genes is also another commonly employed method 
for looking at MSCI defects
200,201
. To confirm that aberrant transcription of XY genes was 
occurring in the spermatocytes of Setx
−/−
 mice, the expression levels of several XY genes in both 
Setx
+/+
 and Setx
−/−
 spermatocytes was analyzed using reverse transcription polymerase chain 
reaction (RT-PCR). Shown in Fig 3.15C and D, an anomalous increase in the expression of X-
linked genes such as Usp26 (2.55 fold), Fthl17 (2.33 fold), Tktl1 (10.98 fold) and Ube1x (1.48 
fold), was observed in spermatocytes of Setx
−/−
 mice as compared to that from Setx
+/+
 mice. Similar 
results were also observed for several Y-linked genes such as Ube1y (1.82 fold) and Rbmy (2.15 
fold). These data thus confirmed a defect in the silencing of XY chromosomes in Setx
−/− 
mice 
during MSCI. Comparable expression of autosomal genes that include Actinb, Dazl, and Gapdh 
were observed in spermatocytes from both Setx
+/+
 and Setx
-/-
 mice, serving as loading controls as 
well as confirming the specific nature of the MSCI defect observed in Setx
-/-
.  
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Fig 3.15: Aberrant meiotic sex chromosome inactivation (MSCI) in Setx
−/− 
spermatocytes A. 
Immunostaining for the transcriptionally-active form of RNA Pol II (phospho-S2) revealed active 
transcription occurring over the XY chromosomes in Setx
−/−
 spermatocytes. In contrast, no signal 
for active Pol II was visible over the XY chromosomes in Setx
+/+
 spermatocytes confirming the 
normal, programmed silencing of the XY chromosomes during MSCI. Scale bar, 20 µm. Dotted 
circle, XY chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
B. A representative graph plot of the fold difference in RNA Pol II fluorescence intensity between 
autosomes and XY chromosomes in Setx
+/+
 and Setx
-/-
 mice.  C. Levels of mRNA transcripts of X 
& Y-linked germ cell specific genes from Setx
+/+
 and Setx
−/−
 testes were determined by RT-PCR to 
assess MSCI. mRNA transcript levels of Actb, Dazl and Gapdh were used as loading controls. D. A 
representative graph plot of the fold differences in genes used for the RT-PCR. Dotted line across 
represents baseline expression. 
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3.3 Discussion 
 
In this Chapter, the characterization of the Setx
-/-
 mouse model was reported. No neurological 
phenotype in the Setx
-/-
 mouse was observed as shown by behavioural analyses and histological 
examinations of tissues of the central nervous system. Gross morphology of the brain and 
cerebellum as well as the Purkinje cell distribution was comparable between Setx
+/+
 and Setx
-/-
 
mice.  
 
The major phenotype observed was the sterility of Setx
-/- 
male mice and this study has provided 
compelling evidence for an essential role of senataxin in spermatogenesis. Loss of senataxin leads 
to the persistence of DNA DSBs, which subsequently prevents homologous recombination between 
sister chromosomes, as well as failure in MSCI that lead to germ cell apoptosis. Testicular atrophy, 
depletion of germ cells and sterility are common features of animal models with defects in meiotic 
proteins such as Spo11
193,202
, strand exchange protein Dmc1
203,204
, Brca1
205
, mismatch repair 
proteins Msh4, Msh5, Mlh3 and Mlh1
206-208
. The phenotype observed in Setx
-/- 
male mice overlaps 
with but is distinct from that described for these mutant mice. Unlike that in Setx
+/+ 
mice
 
where 
DNA DSBs were confined to the XY chromosomes during the pachytene stage, breaks were still 
present in the autosomes as well as on the XY body in Setx
-/-
 mice, indicating a defect in repair of 
DNA DSBs and consequently a defect in meiotic recombination. This was confirmed by persistence 
of the DNA damage repair protein Rad51 on autosomes and a failure to detect chiasmata via Mlh1 
staining at late meiotic stages in pachytene-staged cells from Setx
-/-
 mice. Failure to remove Rad51, 
as seen in Setx
-/- 
mouse spermatocytes, could possibly have prevented the completion of meiotic 
DNA DSB repair via crossing over and homologous recombination. The persistence of Rad51 foci 
on the autosomes may influence the recruitment of certain DDR proteins to the XY chromosomes 
and therefore titrate those proteins which would lead to a defect in in MSCI due to a lack of/reduced 
recruitment of those DDR proteins. Given also that Rad51 has been implicated in R-loop formation, 
the persistence of Rad51 foci on the chromosomes may also influence transcription regulation of 
certain genes involved in XY silencing.  We cannot exclude the possibility that the 2 phenotypes 
(Rad51 removal and MSCI defect) are related as both homologous recombination and MSCI 
involve common DDR proteins. 
 
During meiosis, two waves of H2AX phosphorylation occur. The first wave results from the 
programmed induction of DNA DSBs by the endonuclease Spo11 and are processed and repaired 
through homologous recombination, to allow the exchange of genetic material between sister 
chromatids as mentioned above. The second wave of phosphorylation occurs only on the XY 
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chromosomes and is completely essential for meiotic sex chromosome inactivation (MSCI)
122,192
. In 
the leptotene and zygotene stages of meiosis prophase I, the XY chromosomes are transcriptionally 
active
126
. However, at pachytene stage when meiotic chromosomal synapsis is complete, MSCI 
occurs and the XY chromosomes are silenced
127,128
. MSCI then persists throughout the pachytene 
and diplotene stages
126
. Although this second wave of H2AX phosphorylation occurs normally on 
the XY chromosomes in spermatocytes of Setx
-/-
 mice, a failure in MSCI is still observed. This is 
possibly due to the lack of XY silencing in spermatocytes of Setx
-/-
 mice as observed by RNA Pol II 
(phospho-S2; active form of elongating RNA Pol II) staining where active transcription was 
observed over the XY chromosomes. This was subsequently confirmed by the aberrant transcription 
of selected X- and Y-linked genes thus indicating a defect in MSCI in Setx
-/- 
mice. Thus, the 
compounding effects of having defective meiotic recombination due to the persistence of unrepaired 
DNA DSBs, the lack of crossing-over formation, together with the failure of MSCI appear to be 
responsible for the increased rate of germ cell apoptosis observed in the seminiferous tubules of 
Setx
-/-
 mice, and consequently the sterility in Setx
-/-
 male mice. This defect in MSCI will be 
discussed in greater detail in Chapter 4. 
 
The findings in this chapter are briefly summarized in Table 3.1.  
 
 
Table 3.1: Essential role for senataxin in spermatogenesis and germ cell maturation.  
 
Although it would be worthwhile to corroborate the male sterility observed in the Setx
-/-
 mouse with 
that in AOA2/ALS4 patients, there is however a lack of fertility data in the human population for 
this disorder. Indeed, there are no records till date about male AOA2/ALS4 patients fathering 
children. Interestingly, there have been reports on female patients having early onset 
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menopause
62,67
, premature ovarian failure
190,209
 and hypogonadotrophic hypogonadism
69
, supporting 
our observation of sub-fertility in the female Setx
-/-
 mice. 
 
It was previously shown that senataxin is involved in RNA transactions such as transcriptional 
regulation and RNA processing
71
. Senataxin was found to interact with RNA polymerase II and the 
lack of senataxin altered RNA polymerase II binding to specific gene loci
71
. Similar observations 
have been found with the yeast homolog of senataxin (Sen1p). Use of a ChIP–Chip analysis of 
RNA polymerase distribution, showed that a single amino acid substitution of Sen1p, within its 
helicase domain, altered the genome-wide distribution of RNA polymerase II in non-coding and 
protein-coding genes
72
. Furthermore, mutant senataxin has previously been reported to alter gene 
expression in a disease-specific manner in cells derived from patients with AOA2 and these changes 
in gene expression likely underlie the phenotypic difference between AOA2 and ALS4
210
. Novel 
genes and cellular pathways related to senataxin function in nervous tissues have also been recently 
identified
210
. In collaboration with Dr Brent Fogel (UCLA, USA) evidence for differential gene 
expression from Setx
+/+
 and Setx
-/-
 testes using genome-wide microarray analysis have been 
obtained (Dr Brent Fogel, Dr Olivier Becherel, unpublished data). Differential gene expression 
analysis revealed that 72.5% (174/240) of X-linked genes were up-regulated in Setx
-/-
 as compared 
to Setx
+/+
 demonstrating on a genome-wide scale the MSCI defect, thus providing compelling 
evidence for a role for senataxin in transcriptional regulation. It is possible that the transcriptional 
regulation that occurs during meiosis is specific to the XY chromosomes.  The most apparent 
feature of the XY body is its chromatin structure, which is visibly different even at the light 
microscope level, from that of the autosomal domain of the spermatocyte nucleus. Although the 
exact mechanism of this regulation remains unclear, it has been hypothesized that an aspect of this 
unique chromatin domain sequesters an interesting array of proteins, many of which are not found 
elsewhere in the nucleus and are typically associated with heterochromatin, and some of which are 
post-translationally modified
132
. 
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CHAPTER 4: Senataxin regulates Atr activity and chromatin 
remodeling during MSCI 
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4.1 Introduction 
 
Given that the absence of senataxin leads to defects in meiotic sex chromosome inactivation 
(MSCI), further dissection of the mechanism was necessary. As previously mentioned, meiotic sex 
chromosome inactivation (MSCI) is the process during meiosis in which the X and Y chromosomes 
are transcriptionally silenced
126
. This phenomenon has been shown to be critical for the completion 
of spermatogenesis
126
. Indeed, defects in MSCI can trigger germ cell apoptosis during pachytene 
stage
211
.  
 
MSCI is initiated by the recruitment and accumulation of Brca1 (breast cancer, early onset) to the 
unsynapsed axes of the XY chromosomes
192,196
, however the mechanism of this recruitment 
remains unclear
212
. Brca1 subsequently recruits Atr (Ataxia-telangiectasia and Rad3 related kinase), 
which then phosphorylates histone variant H2AX (γH2AX)126. Phosphorylated H2AX plays a 
central role during spermatogenesis, not only by recruiting DNA damage repair proteins to sites of 
programmed DNA DSBs induced by the Spo11 endonuclease during the leptotene and zygotene 
stages, but also by controlling gene expression via post-translational modifications (PTM) and the 
subsequent altering of chromatin structure
122
. MSCI consists of two genetically separable steps that 
involve a series of DNA damage repair (DDR) proteins. The first step is the MDC1-independent 
recognition of the unsynapsed axes by DDR factors such as ataxia telangiectasia and Rad3-related 
(ATR), TOPBP1, and γH2AX213. The second step is the MDC1-dependent chromosome-wide 
spreading of DDR factors to the entire chromatin
213
. 
 
SUMO (small ubiquitin-like modifiers) are covalently-attached post-translational modifications 
(PTM) that are involved in numerous cellular activities such as transcription regulation, intracellular 
transport, heterochromatin formation, protein-protein interaction and stability, and DNA damage 
recognition and repair
 121,125,126
. Evidence that SUMOylation precedes accumulation of 
phosphorylated H2AX on sex chromosomes during their meiotic inactivation was provided by a 
very early appearance of SUMO-1, which preceded γH2AX accumulation on the XY chromosomes, 
suggesting a possible specific role for SUMO-1 in the initiation of MSCI
131
. In this chapter, the 
localization and recruitment of SUMO-1, SUMO-2/3 and other key DDR factors involved in XY 
silencing were compared between Setx
+/+
 and Setx
-/-
 spermatocytes, as a way of studying the 
molecular events that take place during MSCI. 
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4.2 Results 
 
4.2.1 Defect in SUMOylation in spermatocytes of Setx
-/-
 mice during MSCI 
 
The progression of meiotic events via DDR factors as well as XY chromosome silencing are also 
tightly regulated by SUMOylation, where SUMO-1 and 2/3 have been shown to localize as a 
diffuse cloud over the XY chromosomes
138
. Given the preferential localization of senataxin over the 
XY body and the MSCI defect observed in Setx
-/-
, whether the lack of senataxin would affect 
SUMOylation signaling was investigated.   
 
To observe for differences in SUMOylation patterns of the XY chromosomes between Setx
+/+
 and 
Setx
-/-
 spermatocytes, immunostaining against SUMO-1 and 2/3 was performed on spermatocytes 
spreads. As expected, diffuse SUMO-1 (Fig 4.1A) and 2/3 (Fig 4.1B) localization to the XY 
chromosomes in spermatocytes of Setx
+/+
 mice was observed as a cloud, which is in agreement with 
the staining pattern reported in wild type mouse models
138
. Conversely, it was observed that in Setx
-
/-
 spermatocytes, decreased signals of SUMO-1 and 2/3 were detected and localized only to the 
axial element of the XY chromosomes, indicating that the absence of senataxin affects 
SUMOylation per se and/or SUMOylated-molecules distribution over the XY chromosomes. 
 
75 
 
 
Fig 4.1: SUMO is confined to the axial element of the XY chromosomes in Setx
-/-
 
spermatocytes. Immunostaining for SUMO-1 (A) and SUMO-2/3 (B) in Setx
+/+
 and Setx
−/−
 
spermatocytes revealed a diffuse staining over the XY chromosomes in Setx
+/+ 
spermatocytes. In 
contrast, staining was largely restricted to the axes of the XY chromosomes in Setx
−/− 
spermatocytes. Interesting, a similar staining pattern was observed for both SUMO-1 and SUMO-
2/3. Dotted circle, XY chromosomes. Scale bar, 20 µm. Number of animals (n ≥ 3), a total of 50 
cells per animal were analysed. 
76 
 
 
4.2.2 Senataxin is SUMOylated 
 
Since senataxin is also observed to localize over the XY body, whether senataxin is SUMOylated 
during MSCI was investigated. A bioinformatics tool, GPS-SUMO (http://sumosp.biocuckoo.org/), 
which predicts sites of SUMOylation and SUMO-interacting motifs (SIM) based on consensus 
sequences
214
 was employed. This program predicted three sites of SUMOylation and three SIMs for 
senataxin (Fig 4.2A). Further evidence for the SUMOylation of senataxin has also been provided by 
Hecker et al. 2006 whereby senataxin was identified via a yeast two-hybrid screen as a novel 
SUMO-interacting partner that binds to both SUMO-1 and SUMO-2/3
215
.  However, the early 
appearance of SUMO-1, preceding the accumulation of γH2AX on the sex chromosomes, and the 
lack of SUMO-2/3 detection in zygotene spermatocytes, suggested a more specific role for SUMO-
1 in the initiation of XY inactivation
131
. Therefore, SUMO-1 was chosen for further investigation. 
 
To study this phenomenon in vivo, co-immunoprecipitation of senataxin and SUMO-1 was first 
performed on total cell extracts made from Setx
+/+
 and Setx
-/-
 testes. Results showed the 
SUMOylation of endogenous senataxin in Setx
+/+
 spermatocytes (Fig 4.2B). Subsequently, a 
proximity ligation assay (PLA) for both senataxin and SUMO-1 on Setx
+/+
 spermatocyte spreads 
was performed to observe for this interaction. Briefly, PLA allows the visualization of in situ 
endogenous protein-protein interactions via fluorescent dots due to the amplification and 
subsequent incorporation of fluorescent nucleotides on complementary strands that are conjugated 
to target antibodies. Results showed that senataxin and SUMO-1 interacted with one another on the 
XY chromosomes with the majority of the positive signals (red spots) focused over the XY 
chromosomes (Fig 4.2C). A negative control without primary antibody was included. Altogether, 
this is consistent with a preferential XY localization pattern of both SUMO-1 and senataxin. In 
addition, several positive signals were also observed over the autosomes in agreement with the 
diffuse localization of senataxin over the autosomes and its role in meiotic recombination. 
 
77 
 
 
Fig 4.2: Senataxin interacts with SUMO-1 at the XY chromosomes in Setx
+/+
 spermatocytes. 
A. GPS-SUMO, a bioinformatics tool, performed an in silico prediction and found three potential 
SUMOylation sites (labeled in black) and three SUMO-interaction motifs (labeled in green) for 
senataxin. B. Endogenous senataxin and SUMO-1 were co-immunoprecipitated and immunoblotted 
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separately, showing the SUMOylation of senataxin in Setx
+/+
 spermatocytes. C. Through a 
Proximity Ligation Assay (PLA), an interaction between Setx and SUMO-1 was observed over the 
XY chromosomes as red foci (middle panels). Red foci were also observed over the autosomes. A 
negative control without primary antibody (top panels) as well as a positive control (bottom panels) 
using antibodies against Brca1 and Atr, two proteins known to interact directly
216
 was performed 
alongside. Dotted circle, XY chromosomes. Scale bar, 20 µm. Number of animals (n ≥ 3), a total of 
50 cells per animal were analysed. 
 
 
4.2.3 Identification of SUMOylated proteins- Candidate selected: Atrip 
 
Based on the differential SUMO staining patterns between Setx
+/+
 and Setx
-/- 
spermatocytes, and 
given that senataxin associates with SUMO-1, the identification of various SUMOylated proteins in 
these mice was carried out.  
 
To identify these proteins, SUMO-1 immunoprecipitation (IP) from Setx
+/+
 and Setx
-/- 
testes protein 
extracts
 
followed by mass spectrometry (MS) identification were performed. Immunoprecipitates 
were electrophoresed on a SDS-PAGE denaturing gradient gel and ten bands of interest were 
excised (Fig 4.3). Following tryptic digest, the bands were sent to Dr. Mark Graham (Children’s 
Medical Research Institute, University of Sydney) for liquid chromatography MS (LC-MS/MS) 
analysis. 
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Fig 4.3: Excision of bands following SUMO-1 immunoprecipitations from Setx
+/+
 and Setx
-/-
 
testes extracts. SUMO-1 immunoprecipitates from Setx
+/+
 and Setx
-/-
 testes extracts were separated 
on a 4-12% SDS-PAGE denaturing gradient gel and stained using Coomassie Blue (R250). 10 
bands that were different in abundance or presence between Setx
+/+
 and Setx
-/-
 were excised, 
digested and sent for identification via liquid chromatography mass spectrometry (LC-MS/MS) (Dr. 
Mark Graham, CMRI, NSW). A non-specific sample (NS) using rabbit IgG was performed 
alongside as a control. Bovine serum albumin (BSA) was also separated on the gel for protein 
concentration estimation. 
 
According to proteomic standards for protein identification via LC-MS/MS, a stringent threshold 
for protein was set at 99%, the false discovery rate (FDR) was set at 0.02% and the minimum 
number of peptides for each protein was set at 2. The software used to display the protein/peptide 
identification results from tandem MS was Scaffold Q+S (Proteome Software, Portland, OR, 
USA)
217
.  
 
Several candidates involved in chromatin remodeling (such as Atrx and Ruvb2) and transcription 
regulation (such as Dhx15 and Ybox3) were identified to be SUMOylated in Setx
+/+
 spermatocytes 
80 
 
but not in Setx
-/-
 spermatocytes. However in this Report, the focus will be on Atrip, a protein that 
was found to be SUMOylated in Setx
+/+
 but not in Setx
-/-
 spermatocytes (Fig 4.4).  
 
 
Fig 4.4: Atrip is SUMOylated in spermatocytes of Setx
+/+
 but not Setx
-/-
 mice. Mass 
spectrometry on immunoprecipitation from Setx
+/+
 and Setx
-/-
 mouse testes using SUMO-1 antibody 
revealed Atrip as a candidate protein that is SUMOylated in Setx
+/+
 but not in Setx
-/-
 spermatocyte. 
Protein identification was visualized on the Scaffold Q+S application (Proteome Software, Portland, 
OR, USA). 
 
Atrip (Atr interacting protein) is the binding partner of Atr (Ataxia-telangiectasia and Rad3 related 
kinase), and the Atr-Atrip heterodimer plays an important role in DDR by signalling the presence of 
damage and activating cell cycle checkpoints
218
. The Atr signaling pathway is activated during 
replication fork stalling and is recruited by Atrip to replication protein A (Rpa)-coated ssDNA
219
. 
Atr is subsequently activated by DNA topoisomerase-2 binding protein 1 (TopBp1), triggering the 
cascade of phosphorylation of other downstream effector proteins such as Chk1
220
. The Atr-Atrip 
dimer is also essential for MSCI, where it is required for the phosphorylation of histone H2AX on 
the XY chromosomes, an epigenetic event that leads to silencing
132
. It was recently reported that the 
SUMOylation of Atrip plays an essential role in the Atr signaling pathway by facilitating the 
interactions between several DDR factors, such as Rpa, TopBP1, the MRN (Mre11, Rad50, Nbs1) 
complex as well as with Atr itself, during DNA repair
221
. Wu et al. 2014 also showed that the 
SUMOylation of Atrip is required for proper localization to sites of DNA damage and function 
following DNA damage
221
. During MSCI, the initial recruitment and activation of Atr-Atrip is 
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dependent on Brca1 and TopBP1 respectively
211
, and the following sections will dissect the Atr-
Atrip DDR pathway involved in MSCI to elucidate the mechanistic defect leading to abnormal 
MSCI observed in Setx
-/- 
mice. 
 
4.2.4 Normal recruitment of Brca1 and TopBP1 observed in spermatocytes of Setx
-/-
 mice 
during MSCI 
 
The initiation of MSCI begins with the crucial recruitment of the tumor suppressor protein, Brca1 to 
the axial element of the XY chromosomes. To observe whether this initial recruitment occurs 
normally in the spermatocytes of Setx
-/-
 mice, immunostaining using an antibody against Brca1 was 
performed. The results showed a normal recruitment of Brca1 to the axes of the XY chromosomes 
in the spermatocytes of both Setx
+/+
 and Setx
-/-
 mice (Fig 4.5), indicating that the initiation of MSCI 
occurs normally in these mice and suggesting that the defect in MSCI leading to germ cell apoptosis 
in Setx
-/-
 spermatocytes lies further downstream. 
 
 
Fig 4.5: Normal recruitment of Brca1 in Setx
+/+ 
and Setx
−/− 
spermatocytes. Immunostaining for 
Brca1 revealed the normal accumulation of Brca1 along the axial element of the XY chromosomes 
in the spermatocytes of Setx
+/+ 
and Setx
−/− 
mice. Scale bar, 20 µm. Dotted circle, XY chromosomes. 
Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
 
Given that both senataxin and Brca1 were observed to localize to the XY chromosomes during the 
pachytene stage and its essential role in initiating MSCI, whether the recruitment of senataxin to the 
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XY chromosomes was dependent on Brca1 was subsequently performed via immunostaining using 
spermatocyte spreads obtained from Brca1
Δ11/Δ11
 (p53
+/−
) mutant mice. Incidentally, Brca1
Δ11/Δ11
 
mice show an overlapping phenotype with Setx
-/-
 mice where the males are sterile due to a defect in 
MSCI
222
. The results in Fig 4.6 show that while senataxin localized to the XY chromosomes in 
Brca1
+/+
 mice, it failed to do so in the Brca1
Δ11/Δ11
 mutant mice. Thus, the recruitment of senataxin 
to the XY chromosomes during MSCI depends on functional Brca1. 
 
 
Fig 4.6: Recruitment of senataxin is dependent on Brca1. Immunostaining for senataxin in 
spermatocytes of Brca1
+/+
 Brca1
Δ11/Δ11
 mice showed that without functional Brca1, senataxin was 
not localized to the XY chromosomes. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number 
of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
 
Consequently, to determine whether senataxin and Brca1 interacted with one another, a Proximity 
Ligation Assay (PLA), which allows for the in situ detection of endogenous protein-protein 
interactions was performed. However, a direct interaction between these two proteins was not 
observed (Fig 4.7). Attempts to co-immunoprecipitate endogenous senataxin and Brca1 also did not 
reveal an interaction between these proteins (data not shown). Although the recruitment of 
senataxin to the XY chromosomes is dependent on Brca1, it does not appear to be through a direct 
protein-protein interaction between the two proteins. 
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Fig 4.7: No direct interaction between senataxin and Brca1. PLA using antibodies against 
senataxin and Brca1 showed no direct interaction between these 2 proteins (middle panels). An 
appropriate negative control containing no primary antibodies (top panels) as well as a positive 
control using antibodies against Brca1 and Atr, two proteins known to interact directly
216
, was used 
(bottom panels). Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a 
total of 50 cells per animal were analysed. 
 
Given that Brca1 recruitment was normal despite the absence of senataxin, TopBP1, a regulator and 
an activator of Atr
211,223
, was subsequently investigated. During meiosis, TopBP1 was shown to 
localize with Atr on the unsynapsed chromosomes during pachytene. It was also shown to be 
required in DDR, meiotic recombination and Atr binding to chromatin
223
. Immunostaining on Setx 
mice showed that TopBP1 localized predominantly on the unsynapsed XY chromosomes in Setx
+/+
 
spermatocytes as expected whereas a much fainter signal was observed in Setx
-/-
 spermatocytes, 
despite a similar localization to Setx
+/+ 
(Fig 4.8). These results gave the first indication of a potential 
defect in Atr function and other downstream signaling pathways. 
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Fig 4.8: Decreased levels of TopBP1 on XY chromosomes in Setx
−/− 
spermatocytes. TopBP1 
was observed to localize predominantly to the axial element of the XY chromosomes in Setx
+/+ 
spermatocytes. In contrast, decreased staining intensity for TopBP1 was observed in Setx
−/− 
spermatocytes. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a 
total of 50 cells per animal were analysed. 
 
 
4.2.5 Defect in Atr-Atrip signaling in Setx
-/-
 mice 
 
Apart from coordinating DNA damage repair, Atr is required for the phosphorylation of histone 
H2AX on the XY chromosomes during MSCI
134
. Although the exact purpose of this 
phosphorylation remains unclear, it has been hypothesized that it is necessary for initiating 
chromatin condensation and repression of transcription
115
.  
 
Since the localization of Brca1, which is required for the subsequent recruitment of Atr, was 
normal, Atr localization was then studied. It was observed that in Setx
+/+ 
spermatocytes, Atr formed 
a diffuse cloud over the XY chromosomes as previously reported
224
 whereas Atr was localized 
predominantly over the axial element of the XY chromosomes in Setx
−/− 
spermatocytes (Fig 4.9). 
Thus the absence of senataxin affects the diffusion of Atr on the XY chromosomes which may 
ultimately impact on MSCI. 
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Fig 4.9: Lack of diffusion of Atr over XY chromosomes in Setx
−/− 
spermatocytes. 
Immunostaining for Atr showed a cloud over the XY chromosomes in Setx
+/+ 
spermatocytes as 
expected, whereas Atr was largely retained on the axial element of the XY chromosomes in Setx
−/− 
spermatocytes. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a 
total of 50 cells per animal were analysed. 
 
To determine whether the altered localization of Atr may reflect a difference in its activity, 
immunostaining against the active form of Atr, phospho-Atr S428 (p-Atr) was performed. Results 
showed that similar to total Atr, p-Atr formed a cloud over the XY chromosomes in Setx
+/+ 
spermatocytes whereas p-Atr was retained on the axial element of the XY chromosomes in Setx
-/-
 
spermatocytes (Fig 4.10). These data indicate a defect in the diffusion of Atr as well as its active 
form, p-Atr which could lead to alterations in the downstream DDR signaling that occurs during 
MSCI. 
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Fig 4.10: Lack of diffusion of p-Atr (S428) over XY chromosomes in Setx
−/− 
spermatocytes. 
Immunostaining for p-Atr showed a cloud over the XY chromosomes in Setx
+/+ 
spermatocytes as 
expected, whereas p-Atr was retained on the axial element of the XY chromosomes in Setx
−/− 
spermatocytes. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a 
total of 50 cells per animal were analysed. 
 
The stability and activity of Atr is modulated by its binding partner, Atrip
218
, hence the status of 
Atrip in spermatocytes of these mice was investigated. A strong signal for Atrip that localized 
largely to the axial element of the XY chromosomes in Setx
+/+ 
pachytene spermatocytes was 
observed. Additionally, some background staining for Atrip was observed on the autosomes.  
Although the localization of Atrip was similar to that observed in Setx
+/+ 
spermatocytes, a much 
fainter signal was observed in Setx
-/-
 spermatocytes (Fig 4.11). Furthermore, a lack of background 
staining was also observed in Setx
-/-
 spermatocytes. Thus, a reduction in Atrip protein levels and/or 
a lack of recruitment to the XY chromosomes appear to occur in Setx
-/-
 pachytene-staged 
spermatocytes. This data combined with the defect in Atr diffusion in Setx
-/-
 spermatocytes could 
possibly lead to deficiencies in the Atr signaling pathway and in turn account for the MSCI defect 
observed in Setx
-/-
 mice. 
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Fig 4.11: Decreased levels of Atrip on XY chromosomes in Setx
−/− 
spermatocytes. 
Immunostaining for Atrip revealed a strong signal on the axial element of the XY chromosomes in 
Setx
+/+ 
spermatocytes. On the other hand, decreased staining intensity for Atrip was observed in 
Setx
−/− 
spermatocytes. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 
3), a total of 50 cells per animal were analysed. 
 
Atr and Atrip play key roles in the DNA damage response and are mutually dependent partners in 
cell cycle checkpoint signaling pathways
218
.  Atrip has been shown to be phosphorylated by Atr and 
also to regulate Atr expression
218
.  
 
Given the abnormal localization of Atr and Atrip on the XY chromosomes, defective MSCI may be 
expected due to impaired Atr signaling. To ascertain this possibility, the functionality of the Atr 
pathway during MSCI in the absence of senataxin was investigated. To do this, immunostaining for 
three DDR proteins substrates that are phosphorylated by Atr, namely Rpa, Chk1 and Smc1
225,226
, 
was performed.  
 
Phospho-Rpa S33 (p-Rpa) was observed to form a diffuse cloud over the XY chromosomes in 
Setx
+/+ 
spermatocytes whereas p-Rpa was found to localize predominantly on the axial element of 
the XY chromosomes instead in in Setx
−/− 
spermatocytes (Fig 4.12). This staining pattern is 
reminiscent of the Atr and p-Atr staining patterns observed in Fig 4.9 and Fig 4.10 and are not 
unexpected, given that Atr phosphorylates Rpa. 
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Fig 4.12: Lack of diffusion of p-Rpa (S33) over XY chromosomes in Setx
−/− 
spermatocytes. 
Immunostaining for p-Rpa showed a cloud over the XY chromosomes in Setx
+/+ 
spermatocytes as 
expected, whereas p-Rpa was largely retained on the axial element of the XY chromosomes in 
Setx
−/− 
spermatocytes; a pattern similar to those of Atr and p-Atr. Scale bar, 20 µm. Dotted circle, 
XY chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
 
The localization of Chk1, a kinase required for cell cycle checkpoint activation and a well-
documented downstream target of Atr for phosphorylation
227,228
, was next studied. Here, both un-
phosphorylated and the Atr-phosphorylated forms of Chk1 (S317) was investigated. Un-
phosphorylated Chk1 localization pattern was comparable between Setx
+/+
 and Setx
-/-
 spermatocytes 
(Fig 4.13A). However, while the localization of phospho-Chk1 (p-Chk1) formed a diffuse cloud 
over the XY chromosomes in Setx
+/+ 
spermatocytes, a reduced signal that was largely retained on 
the axial element was observed in Setx
−/− 
spermatocytes (Fig 4.13B). Again, as expected, p-Chk1 
staining pattern resembled that of Atr and p-Atr. Taken together, these data indicate a defect in Atr 
downstream signaling that could potentially contribute to the failure in MSCI observed in Setx
−/− 
mice. 
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Fig 4.13: Decreased levels of p-Chk1 over XY chromosomes in Setx
−/− 
spermatocytes. A. Un-
phosphorylated Chk1 localization pattern was comparable in spermatocytes of both Setx
+/+
 and 
Setx
-/-
 mice. B. Reduced levels of active Chk1, p-Chk1 (S317), over the XY chromosomes in Setx
-/-
 
spermatocytes were observed, localizing mainly to the axes of the XY chromosomes, a pattern 
similar to that of Atr and p-Atr. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of 
animals (n ≥ 3), a total of 50 cells per animal were analysed. 
 
Given the differences in the labeling pattern and intensity of the various DDR proteins involved in 
MSCI investigated thus far, whether or not these were caused by changes in protein levels was 
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examined. Western blotting on total cell extracts from Setx
+/+
 and Setx
−/−
 mice testes was 
performed. A slight reduction in Atr and p-Atr protein levels and a marked reduction in TopBP1 
protein levels was observed in Setx
−/−
 as compared to Setx
+/+
 spermatocytes, which is in agreement 
with the previous immunostaining data (Fig 4.9 and 4.10). Additionally, differential gene 
expression data obtained from microarray analyses revealed no significant differences in the levels 
of TopBP1 gene expression germ cells of Setx
+/+
 and Setx
-/-
 mice (unpublished data). Strikingly 
Atrip was not detected in Setx
−/−
 testes extracts (Fig 4.14). Note that a faint Atrip protein signal was 
detected by immunostaining in Setx
−/− 
indicating a greater sensitivity for the antibody for 
immunostaining as compared to western blotting. Similar to TopBP1, RT-PCR performed for Atrip 
revealed no significant differences in mRNA levels in the testes of Setx
+/+
 and Setx
-/-
 mice.  
Collectively, these data point to either a defect in translation or stability of these proteins. 
 
Similar levels of total Chk1 protein were observed between the mice. Gapdh was used as a loading 
control to ensure equivalent protein loading. Western blotting for p-Chk1 and p-Rpa could not be 
achieved despite multiple attempts. 
 
Altogether, these findings support the reduced Atr activity and subsequent signaling defects 
observed in Setx
−/−
 spermatocytes. 
 
 
Fig 4.14: DDR protein levels in Setx
+/+
 and Setx
-/-
 testes. Western blotting for Atr, p-Atr, Atrip, 
Chk1 and TopBP1. A slight reduction in Atr and p-Atr protein levels was observed in Setx
−/−
 as 
compared to Setx
+/+
. A lack of Atrip in Setx
−/−
 spermatocytes was seen. Similar levels of Chk1 both 
Setx
+/+
 and Setx
−/− 
was observed. Gapdh was used as a loading control. 
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The inability to detect Atrip in total cell extracts from testes of Setx
+/+
 and Setx
-/-
 mice was 
particularly interesting. A recent report by Liu et al. 2013 showed that a protein member of the 
Never-in-Mitosis A (NIMA) related kinase family, Nek1, was important for the activity of the Atr-
Atrip heterodimer
229
. Cells deficient in Nek1 failed to support autophosphorylation of Atr as well as 
the phosphorylation of several Atr substrates. They also showed that when Nek1 was knocked down 
using siRNA, Atrip protein levels were decreased but not that of Atr’s, supporting the findings in 
Fig 4.17. Additionally, Nek1 is also highly expressed in meiotic germ cells
230
. 
 
The localization of Nek1 was subsequently investigated via immunostaining on spermatocyte 
spreads. Results showed that Nek1 localized to the axial element of the autosomes, with a stronger 
signal on the XY chromosomes in Setx
+/+
 spermatocytes. In contrast, Nek1 localized neither to the 
autosomes nor the XY chromosomes but formed a diffuse staining pattern throughout the nucleus in 
Setx
-/-
 spermatocytes (Fig 4.15A). Western blotting for Nek1 protein from total cell extracts from 
testes of Setx
+/+
 and Setx
-/-
 mice revealed a decreased level in Setx
-/- 
as compared to Setx
+/+ 
(Fig 
4.15B). The decreased protein level of Nek1 as well as its mis-localization in Setx
-/-
 spermatocytes 
suggests that senataxin may modulate the expression and/or localization of Nek1, and that a 
deficiency in Nek1 may account for the defect in Atr signaling observed in Setx
-/-
 spermatocytes. 
 
 
Fig 4.15: Mis-localization of Nek1 in Setx
−/− 
spermatocytes. Nek1 was observed to localize 
specifically to the axial element of the autosomes with a stronger intensity on the XY chromosomes 
in Setx
+/+ 
spermatocytes whereas Nek1 in Setx
−/− 
spermatocytes was granulated and scattered 
throughout the nucleus. Scale bar, 20 µm. Dotted circle, XY chromosomes.  B. Western blotting for 
Nek1 from total cell extracts from testes of Setx
+/+
 and Setx
-/-  
mice showed lower loves of Nek1 in 
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Setx
-/-
 spermatocytes
 
.α-Tubulin was used as a loading control. Number of animals (n ≥ 3), a total of 
50 cells per animal were analysed. 
 
 
4.2.6 Defect in XY heterochromatin formation in Setx
-/-
 mice 
 
MSCI triggers chromatin conformation changes via post-translational modification that leads to the 
transcriptional silencing of the XY body. One such modification is the ubiquitination of histone 
H2A (ubH2A), which has been shown to be associated with transcriptional silencing of XY 
chromatin regions
231
. Because of the continued presence of RNA Pol II on the XY chromosomes in 
Setx
−/−
 spermatocytes as previously described in section 3.2.6 and the abnormal Atr localization and 
signaling, it was hypothesized that the ubiquitination of histone H2A would be defective in 
Setx
−/−
mice. The results in Fig 4.16 revealed the distinct accumulation of ubH2A as a diffuse cloud 
over the XY chromosomes in spermatocytes of Setx
+/+
 mice, consistent with heterochromatin 
formation and transcriptional repression. In contrast, reduced labeling for ubH2A over the XY 
chromosomes of Setx
−/−
 spermatocytes was observed, and unlike that in the spermatocytes of 
Setx
+/+
 mice, ubH2A was also not localized to the XY chromosomes but distributed across the 
autosomes in Setx
−/− 
mice as well.  
 
The lack of ubH2A on the XY chromosomes is in agreement with the defective XY silencing 
observed in Setx
-/-
 spermatocytes and suggests a differential conformation of chromatin, 
predominantly in the formation and distribution of heterochromatin. These findings indicate a major 
difference in ubH2A and heterochromatin distribution in Setx
−/−
 spermatocytes, which may reflect a 
genome-wide abnormal transcriptional regulation in these cells. Indeed, this is supported by the 
observation of genome-wide differential gene expression following microarray analysis for Setx
+/+
 
and Setx
−/−
 mouse testes (Dr Brent Fogel, Dr Olivier Becherel, unpublished data). 
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Fig 4.16: Differential localization of ubH2A in Setx
−/− 
spermatocytes. Immunostaining against 
ubH2A revealed localized staining over the XY chromosomes as a diffused cloud in spermatocytes 
of Setx
+/+
 mice. In contrast, ubH2A was observed to be distributed on the autosomes of Setx
-/-
 
spermatocytes, indicating a general defect in heterochromatin formation and transcription 
repression. Scale bar, 20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a total of 
50 cells per animal were analysed. 
 
To provide additional evidence for a major difference in chromatin conformation in Setx
-/-
 
spermatocytes, another epigenetic marker believed to be associated with transcription repression, 
H3K4me1
232
 was examined. Immunostaining against this marker revealed a strong signal over the 
XY chromosomes in Setx
+/+
 spermatocytes, consistent with transcriptional repression. Some signal 
over the autosomes was also observed. In contrast, signal for H3K4me1 was not observed on the 
XY chromosomes of Setx
-/-
 spermatocytes. A brighter signal on the autosomes of this marker was 
only observed, indicating a general defect in chromatin topology in Setx
+/+
 mice that could possibly 
have contributed to the differences in transcription repression observed in these mice (Fig 4.17). 
Together with the presence of active RNA Polymerase II staining over the XY chromosomes and 
the increased expression of X- and Y-linked genes (Fig 3.15), these data provide substantial direct 
evidence for the lack of XY silencing. 
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Fig 4.17: Differential formation of heterochromatin of XY chromosomes in Setx
−/− 
spermatocytes. Immunostaining for the epigenetic marker H3K4me1 showed that suggesting a 
difference in chromatin topology between the mice. Scale bar, 20 µm. Dotted circle, XY 
chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal were analysed. 
 
Changes in the conformation of chromatin required for activation or silencing of transcription are 
dependent on chromatin remodelers. Through connectivity mapping of senataxin (Dr. Derek 
Richard, Queensland University of Technology, personal communication) as well as from previous 
findings by senataxin co-immunoprecipitation
233
,  the chromodomain helicase binding DNA protein 
4 (Chd4), a  member of the nucleosome remodeling and deacetylase (NuRD) complex
234
, is thought 
to be an interacting partner of senataxin. Interestingly, Chd4 has also been reported to interact with 
Atr
235
, suggesting a link between Atr's role in mediating checkpoints induced by DNA damage and 
chromatin modulation via remodeling and deacetylation
236
. The abnormal Atr localization and 
defective  downstream signaling together with the lack of XY silencing subsequently prompted us 
to investigate the status of Chd4 in Setx
+/+
 and Setx
-/-
 spermatocytes. 
 
Immunostaining for Chd4 revealed similar localization to the pseudo-autosomal region (PAR) of 
the XY chromosomes in Setx
+/+
 and Setx
-/-
 spermatocytes, however, a much stronger signal was 
observed in Setx
+/+
 spermatocytes (Fig 4.18A). To examine whether the faint Chd4 staining at the 
XY chromosomes in Setx
−/−
 resulted from reduced protein levels, western blotting was performed 
on total protein extracts. Similar levels of Chd4 were observed in both Setx
+/+
 and Setx
−/−
 testes 
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extracts indicating that the faint Chd4 staining on the XY chromosomes in Setx
−/−
 spermatocytes 
result from the lack of recruitment rather than reduced levels of the protein (Fig 4.18B). These data 
suggest that it is the mis-localization in the absence of senataxin, and not the lack of Chd4, which 
could possibly contribute to the defect in chromatin remodeling observed in Setx
-/-
 spermatocytes. 
 
 
Fig 4.18: Lack of recruitment of Chd4 over XY chromosomes in Setx
−/− 
spermatocytes. 
Immunostaining for Chd4 revealed a strong signal on the XY chromosomes in Setx
+/+ 
spermatocytes whereas decreased levels of Chd4 were observed in Setx
−/− 
spermatocytes. Scale bar, 
20 µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal 
were analysed. 
 
While Chd4 was shown to interact with senataxin by co-immunoprecipitation in somatic cells
233
, it 
was important to determine whether senataxin and Chd4 interact in vivo in spermatocytes. PLA was 
performed between senataxin and Chd4 to assess for an in situ interaction between the two proteins. 
As shown in Fig. 4.19, an interaction between Chd4 and senataxin was observed at the XY 
chromosomes in Setx
+/+
 spermatocytes. This interaction suggests that senataxin, together with Atr 
and Chd4 (and potentially as a part of the NuRD complex), are important for chromatin remodeling 
required for XY silencing. Furthermore, it is possible that absence of senataxin and/or Atr signaling 
prevents the recruitment of Chd4 to the XY chromosomes in Setx
−/−
 spermatocytes. 
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Fig 4.19: In situ interaction of senataxin with Chd4 at the XY chromosomes during MSCI. 
PLA between senataxin and Chd4 revealed an interaction between these proteins at the XY 
chromosomes in spermatocytes of Setx
+/+
 mice (middle panels). An appropriate negative control 
containing no primary antibodies (top panels) as well as a positive control using antibodies against 
Brca1 and Atr, two proteins known to interact directly
216
, was used (bottom panels). Scale bar, 20 
µm. Dotted circle, XY chromosomes. Number of animals (n ≥ 3), a total of 50 cells per animal were 
analysed.  
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4.3 Discussion 
 
In this chapter the localisation of several key DDR factors involved in MSCI was investigated to 
better understand the molecular mechanism involved and to elucidate the defect in MSCI observed 
in Setx
-/-
 mice. 
 
Protein post-translational modifications (PTM) are important and participate in nearly all aspects of 
cellular physiology. Amongst PTMs such as glycosylation and phosphorylation, SUMOylation 
[small ubiquitin-like modifier (SUMO)] has emerged as a major regulator of nuclear functions; 
playing a key role in transcriptional regulation and in organising the trafficking of DDR proteins at 
sites of DNA damage
237
. As a consequence, SUMO modifications have been associated with many 
disease conditions, ranging from neurodegeneration to diabetes and inflammation
238
. Four major 
SUMO paralogues have been identified: SUMO-1, 2, 3 and 4, all being abundantly expressed in 
different tissues. SUMO-1 and SUMO-2/3 have been studied during mouse and human 
spermatogenesis, where they were shown to localize to different sub-domains of germ cells
131,133,138
. 
The differential localization patterns suggest multiple roles for SUMO during germ cell 
development. SUMO was found to localise to sites of DNA DSBs during spermatogenesis and is 
involved in the stress response
239
, in particular, the appearance of SUMO-1 was reported to precede 
the accumulation of γH2AX on the XY chromosomes, indicating a specific role for SUMO-1 in 
initiating MSCI
131
. SUMO-1 localized only to the axial element of the XY chromosomes in Setx
-/-
 
spermatocytes as opposed to the diffused cloud pattern observed in Setx
+/+
 spermatocytes, 
suggesting possible DDR protein trafficking disruption which could account for impaired MSCI 
observed in Setx
-/-
. Furthermore, it was shown in this Chapter that endogenous senataxin is 
SUMOylated, which is in agreement with previous reports
215,240
 and that SUMOylated senataxin 
was present on the XY chromosomes. This is relevant given the recent findings from Richard et al. 
2013 showing a SUMO-dependant interaction between senataxin and Rrp45, a subunit of the 
exosome at sites of transcription-related DNA damage
240
. The exosome complex 3’-5’ exonuclease 
is an important multi-subunit component of the RNA processing machinery that monitors RNA 
turnover and quality
241
.  Hence, it is possible that in Setx
+/+
 pachytene-staged spermatocytes, 
SUMOylated senataxin interacts with this exosome complex on the XY chromosomes to ensure 
proper RNA processing and degradation, and to facilitate MSCI. In contrast, the absence of 
SUMOylated senataxin in Setx
-/- 
spermatocytes could possibly disrupt this interaction and in turn 
impact on RNA processing and degradation, potentially leading to the expression of unstable RNA 
species, failure in MSCI and germ cell apoptosis. The ideal demonstration to confirm the 
SUMOylation of senataxin would be to mutate putative SUMOylation sites in senataxin to ablate 
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SUMOylation. However, our primary aim is to study the in vivo role of senataxin in meiosis and 
this by definition imposes certain limitations on the types of experiments that can be performed, in 
particular, the study of post-translational modifications. This includes the re-expression of senataxin 
constructs mutated in putative SUMO sites in germ cells.  
 
Senataxin specifically localizes to the XY body in pachytene partially co-localizing with Brca1 and 
Atr, suggesting that it may have a role in MSCI. While Brca1 coats the unsynapsed axis of the XY 
chromosomes, senataxin appears as a more diffuse distribution on the XY chromatin. The diffuse 
staining pattern of senataxin over the XY body is reminiscent of other DNA repair proteins that 
include Atr, Mdc1 and TopBp1
126,192,197
. Prior to MSCI initiation, Brca1 is targeted to the 
unsynapsed axial elements of the X and Y chromosomes where it remains throughout 
spermatogenesis
134
. It subsequently recruits ATR to the axial elements where it phosphorylates 
histone H2AX. Atr localization to the XY chromosomes at the onset of MSCI was disrupted in mice 
with a mutant form of the tumour suppressor protein Brca1 (Brca1
Δ11/ Δ11
). In the mutant pachytene 
cells, there is evidence of MSCI failure since Atr is mostly present at autosomal, non-XY sites, 
where it co-localizes with aberrant sites of H2AX phosphorylation. The meiotic phenotype 
observed in Setx
-/-
 mice resembles that seen in Brca1
Δ11/Δ11 
p53
+/-
 mice where although 
chromosomal synapses occur normally and spermatocytes progress through to pachytene stage, no 
chiasmata were observed as well
242
. Similarly, DNA DSBs were not repaired in the correct temporal 
framework, as demonstrated by persistent γH2AX foci in Brca1Δ11/Δ11 p53+/- spermatocytes242.  
 
The failure to complete meiosis due to the persistence of unrepaired DSB, the lack of crossing-over 
and defective MSCI is common to the Setx and Brca1 mutants and this prompted us to investigate 
whether the recruitment of senataxin to the XY chromosomes would depend on Brca1. It was 
observed that the recruitment of senataxin is indeed Brca1-dependent since senataxin was not 
recruited to the XY chromosomes in Brca1
Δ11/Δ11
 p53
+/-
 mutant mice even though the smaller Brca1 
mutant protein lacking exon 11 still localized to the axes of these chromosomes
243
. Brca1-dependent 
senataxin recruitment to the XY body may be indirect since an in situ direct endogenous protein-
protein interaction through a proximity-ligation assay (PLA) and co-immunoprecipitations of the 
endogenous proteins was not detected. How Brca1-dependent recruitment of senataxin to the XY 
body occurs remains unclear. In contrast to our findings, Hill et al. 2014 recently reported the 
interaction of senataxin with the C-terminus of BRCA1 using the yeast two-hybrid system and 
tandem-affinity purification followed by mass spectrometry identification (TAP-MS)
244
. The 
difference may result from overexpression employed as in the case of Hill et al. 2014 versus 
endogenous protein in situ interaction and co-immunoprecipitation. 
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Once Brca1 localizes to the axial elements of the XY chromosomes, it recruits Atr which in turn 
diffuses out into XY chromatin and phosphorylates histone H2AX, triggering MSCI
120,134
. Loss of 
senataxin does not change the overall distribution of Brca1 on the XY chromosomes however Atr is 
no longer diffusely distributed over the XY chromosomes but is instead retained on the axial 
element of the XY chromosomes, similar to that of Brca1 as visualized by immunostaining. The 
axial staining of Atr in Setx
-/-
 mouse spermatocytes suggests that (1) meiosis proceeds only to early 
/mid pachytene in these mice and/or (ii) that Atr re-localization is dependent on senataxin. Given 
the key role of Atr in MSCI initiation, the localization of an active, phosphorylated form of Atr was 
determined. Several phosphorylated forms of Atr have been reported
245
. Nam et al. 2011 have 
shown that phosphorylation of Atr on threonine 1989 (p-Thr1989) is regulated by DNA damage, 
depends on Atr kinase activity, and appears concurrently with Atr-dependent phosphorylation of 
Chk1
246
.  Phosphorylation of Thr1989 relies on Rpa, Atrip, and Atr kinase activity, but 
unexpectedly not on the Atr stimulator TopBp1
245
. Recruitment of Atr-Atrip to Rpa-ssDNA leads to 
congregation of Atr-Atrip complexes and promotes p-Thr1989 in trans. p-Thr1989 is directly 
recognized by TopBp1, enabling TopBp1 to engage Atr-Atrip, to stimulate the Atr kinase, and to 
facilitate Atr substrate recognition. Functionally, p-Thr1989 is not essential for the Atr-Chk1 
signalling axis following replication stress but supports cellular viability
246
. Hence, p-Thr1989 may 
not be important for ATR function and the low conservation of Thr1989 even among vertebrate Atr 
orthologs and the lack of noticeable activation and signalling defects support this conclusion.  
Interestingly, Thr1989 is not a conserved residue in the mouse, thus preventing its monitoring 
during MSCI. .  
 
The lack of conservation of this residue in the mouse suggests that another residue may possibly 
take up the function of Thr1989. Several other phosphorylation sites in human ATR protein include 
Ser428, 435, 436, 437
245
. Out of these sites, only Ser428 has been functionally characterized for Atr 
activation
245,247,248
 and is conserved in the mouse sequence
247
 (equivalent to murine S431). 
Therefore to determine Atr activation during MSCI, immunostaining with an anti-phospho Ser428 
Atr (p-Ser428) antibody was performed. As expected, a similar pattern to that of un-phosphorylated 
Atr was seen in Setx
+/+
 and Setx
-/-
 spermatocytes, respectively. Relevant to MSCI and transcription 
regulation, recent evidence support a role for Atr/Chk1 signalling pathways in the alternative 
splicing of the TAF1 pre-mRNA
249
. Indeed, experiments with pharmacological inhibitors also 
indicate that Atr kinase activity is necessary to signal alternative splicing of the TAF1 pre-mRNA in 
response to camptothecin treatment
249
, highlighting a novel role for the Atr/Chk1 signalling 
pathway in regulating alternative splicing. More recently, Chandris et al. 2010 studied the 
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distribution and localization of active, p-Ser428-Atr in regards to the regulation of mRNA splicing 
and polyadenylation
250
. They reported a distinctive pattern of p-Ser428-Atr in the nucleus of 
senescent cells when mRNA splicing and polyadenylation was perturbed, implicating this phospho-
site in mRNA processing
250
. Hence, the role of Atr in MSCI may not only be restricted to the 
phosphorylation of H2AX to initiate MSCI, but it may also play a role in the RNA processing of X- 
and Y-linked genes. 
 
While a role for active p-Ser428 Atr in mRNA processing during MSCI remains unclear, its lack of 
diffusion in the XY chromatin domain suggest a possible defect in the Atr/Chk1 signalling pathway. 
Indeed, two substrates for phosphorylation by Atr, phospho-Rpa and phospho-Chk1 were observed 
to be restricted to the axes of the XY chromosomes in Setx
−/−
 spermatocytes. This is in contrast to 
the expected, diffuse cloud seen in Setx
+/+
 spermatocytes, thus indicating a defect in Atr signalling 
in Setx
−/− 
spermatocytes during meiosis. In addition to the abnormal Atr localization pattern over 
the XY chromosomes in Setx
−/−
 spermatocytes, a reduction in Atrip, the obligate partner of Atr, was 
shown. Although a very faint signal for Atrip was detected on the axes of the XY chromosomes by 
immunostaining, western blotting revealed an absence of the protein. It is important to note that 
western blotting was performed on whole testes extracts which contain multiple cell types such 
Sertoli cells, Leydig cells, spermatogonia and spermatocytes at various stages, hence a dilution of 
the signal can be expected and this may explain the absence of Atrip protein observed in Setx
−/−
 
testes extracts. While a reduction in Atrip was observed in Setx
−/−
, comparable levels of Atr protein 
to that in Setx
+/+
 was detected. A similar observation regarding Atr and Atrip levels was found after 
the down-regulation of NIMA (never in mitosis gene a)-related kinase 1 (Nek1), a Ser/Thr kinase 
involved in cell cycle regulation
229
. Nek1 is involved in the DNA damage response and has been 
shown to associate with and stabilize the Atr-Atrip complex. Nek1 also promotes the activation of 
Atr with its kinase activity and is required for maintaining Atrip levels in cells
229
. Interestingly, 
Nek1 is highly expressed in germ cells, with a distribution consistent with a role in meiosis
230
.  
Evidence of Nek1 mis-localization as well as a reduction in its protein levels in Setx
−/−
 
spermatocytes was obtained via immunostaining and western blotting respectively, which may 
account for the reduction in Atrip protein levels and contribute to the defect in the Atr/Chk1 
signalling pathway during MSCI. To demonstrate whether Nek1 is responsible for the defect in Atr 
signaling, the re-expression of Nek1 in germ cells would be expected rescue this phenotype. 
However, limitations exist on the types of experiments that can be performed to study this in vivo.  
 
Another factor that could have contributed to the defect in the Atr/Chk1 signalling pathway in 
Setx
−/−
 spermatocytes is the lack of SUMOylation on Atrip. It was recently reported that the 
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SUMOylation of Atrip was shown to enhance protein-protein interactions along the ATR pathway 
during DNA damage signalling
221
. Hence, having reduced levels of Atrip or even SUMOylated 
Atrip in Setx
−/−
 spermatocytes is likely to affect the diffusion of DDR factors on the XY 
chromosomes in the Atr pathway during MSCI.  
 
Several histone modifications that allow for changes in chromatin topology have been reported to 
occur over the XY chromosomes during MSCI and these include acetylation, methylation and 
ubiquitination
232,251
. Chromatin topology modification is important as it allows access of key 
binding sites to essential factors involved in meiotic-related processes such as recombination, DDR 
and MSCI
252
. One such modification associated with XY silencing during MSCI is the 
ubiquitination of histone H2A (ubH2A)
253
. In contrast to Setx
+/+
 spermatocytes, a reduction of 
ubH2A over the XY chromosomes and the increase of ubH2A on the autosomes in Setx
-/-
 
spermatocytes indicate extensive anomalies in chromatin structure and transcriptional activity in the 
absence of senataxin in these cells. Another histone modification associated with transcriptional 
silencing of the XY chromosomes during MSCI is the mono-methylation of histone H3 on lysine 4 
(H3K4me1). H3K4me1 has been reported to be evenly distributed over the entire nucleus of 
spermatocytes during the leptotene and zygotene stages, intensely labelling only the XY 
chromosomes during pachytene and diplotene stages
232
. In Setx
-/-
 pachytene-staged spermatocytes, 
H3K4me1 labelling was not only more intense on the autosomes but was also excluded from the 
XY chromosomes, further supporting the evidence found with ubH2A. Additionally, genome-wide 
gene expression profiling using microarray has similarly confirmed a widespread transcription 
deregulation in spermatocytes of Setx
-/-
 mice (Dr Brent Fogel, Dr Olivier J. Becherel, personal 
communication). 
 
Several protein complexes also participate in chromatin remodelling via histone modifications and 
these include the Sin3a, SWI/SNF, and nucleosome remodelling deacetylase (NuRD) 
complexes
254,255
. The NuRD complex is associated with transcription regulation via chromatin 
remodelling, cell cycle progression and differentiation, as well as overall genomic stability
255,256
. 
The chromodomain helicase DNA binding protein 4 (Chd4) is the major catalytic subunit of the 
NuRD complex and is involved in epigenetic transcription silencing via deacetylation of histones as 
well as in DNA damage repair. Reports have shown that in the absence of Chd4, cells are 
hypersensitive to ionizing radiation and accumulate DNA DSBs
257,258
. It was also shown that Chd4 
not only promotes DNA repair but also suppresses transcription at sites of damage
257
. Chd4 was 
recently reported to be SUMOylated
259
, and given that SUMOylation has been associated with 
DNA repair and heterochromatin formation
238,239,260
, the localization of Chd4 to the XY 
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chromosomes might suggest its role in modulating chromatin topology and XY silencing during 
meiosis. Interestingly, Chd4 was also reported to interact with Atr as well as with senataxin
233,261
. 
Chd4 as a phosphorylation target of the Atm/Atr kinase family could link the Atm/Atr pathways to 
chromatin remodelling, in particular heterochromatin and gene silencing. Hence, the defect in 
Atr/Chk1 signalling and the altered Chd4 distribution in Setx
-/-
 spermatocytes are likely to be 
responsible for the defect in MSCI observed in these mice.  
 
Altogether, the findings presented in this Chapter highlight the molecular mechanism and the 
different components that can contribute to the defect in MSCI observed in male Setx
-/-
 mice, 
thereby providing evidence for a crucial role of senataxin in coordinating DNA damage repair, 
particularly through the Atr/Chk1 signalling pathway, chromatin remodelling and transcription 
silencing during MSCI (Fig 4.20).  
 
 
Fig 4.20: Molecular mechanism of MSCI failure in Setx
-/-
 mice. A summary of the consequence 
of the absence of senataxin on the diffusion of different DDR proteins during MSCI. 
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CHAPTER 5: Senataxin & R-loop Resolution 
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5.1 Introduction 
 
As previously mentioned in section 1.2.3, senataxin is a protein found to be involved in 
transcription regulation, several RNA processing activities such as in mRNA splicing and splice site 
selection, splicing efficiency, termination of transcription, and more recently, R-loop 
resolution
63,71,73
. A recent report by Yüce and West 2013 showed that senataxin forms distinctive 
foci in nuclei of HeLa and U2OS cells upon exposure to replication stress.  They also showed the 
loss of these foci following transcription inhibition and R-loop resolution. Their results indicate that 
senataxin not only localizes to sites of collision between the replication and transcription 
machinery, but that it is also targeted to R-loops, where it plays an important role at the interface of 
transcription and the DNA damage response
233
. 
 
R-loops are naturally occurring DNA/RNA hybrid structures that form behind elongating RNA 
polymerase by the interaction between the nascent mRNA and its ssDNA template from which it 
was transcribed, particularly over G-rich regions
150,151,152
. Although the exact function of these R-
loop structures remains unclear, it has been hypothesized that they are required for efficient 
transcription initiation and termination and that they induce transcription-associated recombination 
and other mutagenic events such as immunoglobulin class-switch recombination and somatic hyper-
recombination in B lymphocytes
74,75
.  
 
Replication and transcription are fundamental features of DNA metabolism that can occur on the 
same DNA template strand
262
. It has been postulated that collisions between the DNA replication 
and transcription machinery can cause DNA SSBs/DSBs, chromosomal rearrangements, R-loop 
formation and consequently genomic instability
233,262
. Additionally, it was also suggested that 
conflicts between replication and transcription are not restricted to the physical interaction or 
collision between polymerases but that the transcription process itself can also hamper replication 
through the natural formation of R-loops at pause sites during transcription
150,262
. R-loops 
potentially stall RNA polymerase during transcription, thereby interfering with the progression of 
replication forks through the collision of these two processes
165
. To protect the genome from 
abortive replication-transcription encounters, various mechanisms exist within a cell that prevent 
this phenomenon and these include the activities of several helicases (e.g. Rrm3 and Dhx9) and 
DNA topoisomerases (e.g. Top1 and Top2)
165,263
.  
 
Several other proteins involved in DNA damage repair (DDR), such as ataxia-telangiectasia 
mutated (ATM), aprataxin (APTX) and tyrosyl-DNA phosphodiesterase 1 (TDP1) in addition to 
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senataxin (SETX), have also been implicated in transcription processes
260,264,265
. ATM has been 
shown to be a regulator of two genes, MCL1 and Gadd45α, in response to histone deacetylation 
(HDAC) inhibition
266
; nucleolar localization and function of APTX was shown to be dependent on 
rRNA transcription
56
; TDP1 is known to facilitate transcription by RNA Polymerase I in 
trypanosomes
267
 and SETX, as discussed previously, is involved in RNA processing
63,71
. Mutations 
in the genes encoding these DDR proteins (ATM, APTX, TDP1 and SETX) also cause autosomal 
recessive cerebellar ataxias (ARCA) in humans and knockout mouse models for these disorders 
have been generated, providing further insight into the roles of these proteins in the DNA damage 
response. Given that unresolved R-loops can cause DNA breaks
75,268
, the absence of these key DDR 
proteins required for repairing DNA breaks may then lead to increased genomic instability. 
 
To determine whether R-loops can contribute to the genomic instability observed in these ARCA 
models, whether R-loop formation is a general phenomenon across tissues, it’s accumulation and 
how it can lead to genomic instability and cell death were investigated. It was first hypothesized 
that the lack of gross neurological phenotype in the ARCA mouse models may be related to a 
threshold effect in the nervous tissue. It was therefore decided to expose these mice to topotecan 
hydrochloride (TPT), a DNA damaging agent that readily induces R-loop formation in cells
269
, to 
assess whether additional DNA damage can trigger the formation of R-loops in the nervous tissue 
of these mutant animals.  
 
Section 5.2 is a publication that reports the findings from our study where it is shown for the first 
time, R-loops accumulate along candidate genes from Setx
-/-
 mice using a DNA/RNA 
immunoprecipitation (DRIP) assay. These findings also show that treatment of ARCA mouse 
models with TPT (2mg/kg/day) induces the formation of R-loops structures only in proliferative 
tissues and not in post-mitotic tissues, further supporting a dependence of R-loop formation on the 
concomitant activity of replication and transcription. Hence, it is hypothesized that R-loops may 
represent a currently neglected widespread lesion and the presence of unresolved R-loops may 
contribute to overall genomic instability observed in DNA damage mouse models.  
 
Additional data from this study that were not included in the publication are described in Section 
5.3. 
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Introduction
The autosomal recessive cerebellar ataxias (ARCAs) are a
diverse group of disorders arising from defects in genes involved in
the response to DNA damage; mitochondrial function and those
controlling different levels of metabolic and other cellular
processes [1,2]. These are a class of progressive neurodegenerative
diseases that result from cerebellar atrophy and spinal tract
dysfunction [3]. A subgroup of these are characterised by defects
in proteins that recognise and/or repair various forms of damage
to DNA [4,5]. The best characterised of these is ataxia-
telangiectasia (A-T) which arises due to mutations in the ATM
gene [6]. ATM is recruited to DNA double strand breaks (DSB) by
the Mre11/Rad50/NBN (MRN) complex where it is activated to
phosphorylate a multitude of proteins involved in the response to
DNA damage [7]. Disorders arising due to mutations in members
of the MRN complex are also characterised by defects in the
response to DNA DSB [8]. Hypomorphic mutations in Mre11
give rise to A-T like disorder (ATLD), which overlaps in its clinical
phenotype with A-T and also features radiosensitivity and cell
cycle defects [9]. Nijmegen breakage syndrome (NBS) is caused by
mutations in NBN and is characterised by microcephaly, cell cycle
checkpoint defects and ionizing radiation sensitivity [10]. Muta-
tion in the third member of the MRN complex, Rad50, has been
reported for a single patient who has an NBS-like disorder as well
as a defect in the response to DNA DSB [11,12]. Failure to resolve
DNA single strand breaks (SSB) is also associated with a number of
cerebellar atrophies [13] and these include ataxia oculomotor
apraxia type 1 (AOA1) and spinocerebellar ataxia with axonal
neuropathy (SCAN1). AOA1 is an autosomal recessive cerebellar
ataxia syndrome that lacks the extraneurological features of A-T
and related disorders [14]. The protein defective in AOA1,
aprataxin, resolves abortive DNA ligation intermediates as part of
the process of repair of DNA SSB [15,16]. Mutations in another
gene, tyrosyl DNA phosphodiesterase 1 (TDP1) gives rise to
SCAN1. TDP1 removes the Topoisomerase (Topo1) complex
from DNA terminii primarily at DNA SSB that arise due to
collision of the transcription machinery with Topo1 intermediates
or due to oxidative stress [17]. Disruption of this gene in mice
leads to age-dependent cerebral atrophy and neurons from Tdp12/
2 cells fail to rapidly repair DNA SSB at Topo1 complexes [18].
Another member of this group, ataxia oculomotor apraxia type 2
(AOA2) is also characterised by sensitivity to DNA damaging
agents [19,20]. However, the genomic instability that occurs in
AOA2 cells appears to result from the accumulation of DNA/
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RNA hybrids (R-loops) following collisions between the transcrip-
tion apparatus and DNA replication forks [21]. In addition,
evidence for a role in transcriptional regulation which could also
impact on genomic stability has also been reported for senataxin
[22]. Recently, we generated the first Setx knockout mouse model
to investigate the physiological role of senataxin. Setx2/2 mice are
defective in spermatogenesis, meiotic recombination and meiotic
sex chromosome inactivation [23]. DNA DSBs persist in Setx2/2
spermatocytes as well as R-loops, which appear to collide with
Holiday junctions, thus preventing crossing-over. Skourti-Stathaki
et al 2011 demonstrated that senataxin resolves R-loops formed at
transcriptional pause sites to enable transcription initiation and
termination [24]. This is in agreement with previous data
providing evidence for transcription readthrough and defects in
RNA splicing in senataxin-depleted cells [22]. The yeast ortholog
of senataxin, Sen1, has also been shown to resolve R-loops to
protect the genome against transcription-associated instability
[25–28]. R-loops constitute a novel trigger for genomic instability
and the accumulation of these structures may represent an
underlying and contributing mechanism in autosomal recessive
ataxias characterised by defective responses to DNA damage.
Accumulating evidences have shown correlations between tran-
scription deregulation, defective RNA processing, genome insta-
bility and neurodegeneration [29,30]. Here, we investigated for
the presence of R-loops in both proliferating and non-proliferating
tissues in order to address the potential role of R-loops in the
neuropathology in autosomal recessive cerebellar ataxias.
Results
Accumulation of R-loops in germ cells of ARCA mouse
models correlates with infertility
Since infertility is frequently associated with these disorders, we
initially examined the testes for evidence of these structures. Testes
sections from four ARCA mouse models (Atm2/2, Setx2/2, Aptx2/
2, Tdp12/2) were screened for the presence of R-loops. Initial
histological examination of testes sections revealed a severe
disruption of the seminiferous tubules, vacuolation and absence
of mature germ cells in both Setx2/2 and Atm2/2 testes (Figure 1A)
which is expected given that these mice have been reported to be
sterile [23,31]. On the other hand, tubules were grossly normal for
both Aptx2/2 and Tdp12/2mice. Testes size was reduced in
Setx2/2and Atm2/2 mice but these were of normal size in the
other two mutant animals (data not shown). Immunofluorescent
labelling with an antibody (S9.6) specific for R-loops revealed high
levels of staining in the testes sections of both Setx2/2 and Atm2/2
mice (Figure 1B). R-loops staining was distributed across the entire
cell nucleus in agreement with previous report indicating the
genome wide distribution of R-loops [25–28]. R-loops were also
detected albeit at a lower level in both Aptx2/2 and Tdp12/2mice.
To determine whether the accumulation of R-loops may impact
on cell viability, co-staining with TUNEL (marker of apoptotic
cells) was performed. It was observed that most cells positive for R-
loops were also undergoing apoptosis (Figure 1B). Treatment of
sections with RNase H prior to staining significantly reduced
staining with S9.6 antibody, providing further evidence of the
specificity of this antibody and that R-loops are being detected in
this assay (Figure S1 A). Another characteristic of genomic
instability and infertility results from a defective repair of
programmed DNA DSB occurring during meiosis [23,31]. In
addition to R-loop accumulation, we also stained for cH2AX, a
well-described marker for DNA DSBs [32]. DNA DSBs were
detected in spermatocytes for all sections as part of the process of
meiotic recombination (Figure 1C). However, the intensity of
staining for cH2AX was higher in Setx2/2, Atm2/2 and Aptx2/2
sections. It is also evident that in the spermatocytes from Atm2/2
and Setx2/2mice, the intense staining for DNA DSBs coincides
with the appearance of marked TUNEL labelling (Figure 1C).
These data provide evidence for the accumulation of R-loops in
the presence of DNA DSBs arising as a consequence of absence of
defects in proteins that are involved in the DNA damage response.
Quantitative analysis demonstrated that a significantly higher
number of tubules from all 4 mutant mice (,30–45%) contained
R-loops as compared to control (,10%) (Figure 2A). This was also
the case for apoptosis, with the highest levels of apoptosis observed
in Setx2/2 and Atm2/2 mice, followed by Aptx2/2 and Tdp12/
2mice (Figure 2B). It was also clear that in the case of the wildtype
testes where there are only a few apoptotic cells, the great majority
of these did not stain for R-loop. When tubules were differentiated
based on the number of R-loop-containing spermatocytes per
tubule, a clear distinction appeared. Only Setx2/2 and Atm2/
2mice scored in the high range with tubules containing .11 R-
loop & TUNEL-positive cells per tubule (Figure 2C).Combining
both high (.11 affected cells per tubule) and low (6–10 affected
cells per tubule) categories, Setx2/2mice had an average of 40% R-
loop-containing cells per tubule and Atm2/2mice had 30%. In the
lower range, Aptx2/2mice had significantly greater numbers than
wildtype mice whereas that of Tdp12/2mice were less markedly
elevated (Figure 2C). Interestingly, while Atm2/2 mice showed the
highest numbers of cH2AX-positive cells, only ,25% of those
stained for TUNEL (Figure 2D). This was also observed in
Tdp12/2mice (Figure 2D). In contrast, in Setx2/2 and Aptx2/2,
,50% of the cells were positive for both cH2AX and TUNEL.
These data indicate that there is a higher proportion of germ cells
containing DNA DSBs that undergo apoptosis in Setx2/2 and
Aptx2/2mice compared to Atm2/2 and Tdp12/2. The elevated
levels of apoptosis in the spermatocytes of Tdp12/2, Aptx2/2,
Setx2/2 and Atm2/2 mice suggest that a significant amount of
DNA DSBs are not processed/repaired properly, thus triggering
apoptosis. As expected in wildtype, there were low levels of
apoptosis which is in agreement with the formation and then
effective repair of programmed DNA DSBs that occur during
meiosis [33].
R-loops do not form in post-mitotic tissues
To date R-loops have been detected in cells/tissues where active
transcription and replication occur [34,35]. However, the most
debilitating aspect of autosomal recessive cerebellar ataxias is
caused by the progressive loss of post-mitotic nerve cells, leading to
cerebellar atrophy and peripheral neuropathy [5]. Post-mitotic
neurons are metabolically highly active due to the synthesis of
neurotransmitters to ensure proper function of the nervous system
and therefore possess a high transcriptional activity [36]. Given
that R-loops form normally during transcription at RNA
Polymerase II pause sites and that post-mitotic neurons display
high levels of transcription and RNA processing, it raises the
question as to whether R-loops form or accumulate in the nervous
tissues of disorders characterized by the defects in proteins
involved in the DNA damage response. Given the role of
senataxin in resolving these structures [24], we initially examined
brain sections from Setx2/2 mice for the presence of R-loops.
However, we did not detect any R-loops in either whole brain or
cerebellum sections from Setx2/2mice (Figure 3A & 3B).
Furthermore, there was also no evidence of cells undergoing
apoptosis in these tissues (Figure 3A & 3B). This is in agreement
with the fact that no neurological anomalies or neurodegeneration
were present in these animals [23]. Testes sections from Setx2/2
animals were included as positive control for R-loop staining
R-Loops Form in Cycling & Not Post-Mitotic Cells
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(Figure 3C). Accumulation of R-loops observed in Setx2/2 germ
cells and their absence in the brain and cerebella was supported
using DRIP (DNA/RNA immunoprecipitation) assays for Setx+/+
and Setx2/2 testes, brain, and cerebella. In order to perform DRIP
assays, we first searched for R-loop prediction using the R-loop
forming sequence (RLFS) model to predict location of RLFSs on
the mouse genome [37]. Given the role of R-loops in transcription
termination [24], we selected candidate genes where RLFSs
localized ,500 bp downstream of the poly(A) signal(s) for further
analyses. Among these genes, the HS44.2 locus, a region of
recombination hot spot located on the chromosome 19 [38] was
selected. The RLFS-containing region was located downstream
the Pkd2l1gene located in the HS44.2 locus (Figure 4A). We
observed similar background levels of R-loop formation in both
Setx+/+ and Setx2/2 brain and cerebellum. However, a significant
increase (.1.6-fold) in R-loop formation was observed in Setx2/2
testes compared to wildtype supporting our immunofluorescence
findings (Figure 2). In addition, given the meiotic sex chromosome
inactivation (MSCI) defect previously observed in Setx2/2 [23] we
selected a second locus on the X chromosome to perform the
DRIP analysis. We selected the Foxo4 gene based on the same
criteria. Similar results were obtained for Foxo4, confirming
background levels of R-loops in brain and cerebellum and a
significant increase of R-loop formation (.1.8 fold) in Setx2/2
testes (Figure 4B). Figure 4C shows the Bioanalyzer Spectra of
untreated, S1 Nuclease-treated, and RNAse H-treated DRIP
samples to confirm the specificity of the S9.6 antibody (R-loop) for
DNA/RNA hybrids as shown by the reduction of fluorescence
intensity after RNAse H treatment. Altogether, these data
confirmed the specific accumulation of R-loops in Setx2/2 germ
cells and the presence similar normal background levels of R-loops
in Setx+/+ and Setx2/2 brain and cerebellum, in agreement with
the fact that no neurological anomalies or neurodegeneration were
present in these animals [23]. Thus, S9.6 immunofluorescence
staining represents a simple and reliable method to detect R-loop
formation and screen for aberrant RNA metabolism in tissues.
To determine whether this was also the case in other ARCA
models, we screened for R-loop accumulation in the brains and
cerebella of Atm2/2, Aptx2/2 and Tdp12/2 mice. Similar to that
in Setx2/2, we did not detect these structures in these tissues
(Figure S1 A and B). The lack of R-loops in the nervous tissues of
these autosomal recessive cerebellar ataxias may not be entirely
unexpected due to the lack of major neurological defects in these
animals.
DNA damage induces R-loops accumulation in
proliferating cells not in post-mitotic cells
The accumulation of unrepaired DNA damage in post-mitotic
neurons can lead to genome instability, abnormal transcriptional
regulation and thus ultimately to neurodegeneration [30]. The
lack of R-loop formation in the nervous tissues of these mutants
under normal living conditions prompted us to investigate whether
additional DNA damage exposure may trigger the formation of
these structures. To address this, we first knocked down SETX in
Figure 1. Evidence of DNA/RNA hybrids (R-loops) accumulation in spermatocytes of ARCA mouse model. A. Histological cross-sections
of seminiferous tubules from ARCA mouse models Setx2/2, Atm2/2, Aptx2/2, Tdp12/2 and wildtype (WT) littermates. Sections were H & E stained.
Scale bar, 100 mm. B. Immunostaining of testes sections with R-loop (S9.6) antibody (red) and TUNEL (green). Nuclei were stained using Hoechst
33342 (blue). Scale bar, 100 mm. Magnified views of the tubules are also shown. Representative spermatocytes staining positive for both R-loop and
TUNEL are indicated by white arrows. C. Immunostaining of testes sections with cH2AX (red), a marker of DNA DSBs, and TUNEL (green). Scale bar,
100 mm.
doi:10.1371/journal.pone.0090219.g001
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HeLa cells (Figure S2) and monitored R-loop formation in these
cells. As shown in Figure 5A, R-loops were primarily detected in
nucleoli. This is compatible with R-loop formation at highly
transcribed and R-loop-prone ribosomal arrays as previously
reported [39]. The major nucleolar R-loops staining observed here
is consistent with the staining pattern found in previous studies that
reported the genome wide distribution of R-loops using DRIP
assays [40]. Ribosomal DNA transcription represents the vast
majority of transcriptional activity in the cell thus explaining the
strong R-loop signal observed in nucleoli. The detection of R-
loops in nucleoli does not mean that R-loops only form in nucleoli
but may reflect a difference in sensitivity between immunofluo-
rescence and DRIP assays. As shown in Figure 4, we detected the
formation of R-loops at non-rDNA loci on two different
chromosomes using DRIP assays thus confirming that R-loops
occur on a genome wide scale. Extra-nuclear staining for R-loops
was also observed in agreement with the formation of R-loops
during mitochondrial replication as previously reported [41,42].
These data confirm the role for senataxin in resolving R-loops as
previously described [21,23,24]. Exposure of cells to the DNA
damaging agent, camptothecin (CPT), a DNA topoisomerase I
inhibitor, led to the appearance of R-loops in nucleoli in control
cells and a further increased levels of R-loops in SETX knockdown
cells, in keeping with the higher basal level in these cells
(Figure 5A). The accumulation of positive supercoiling ahead of
the transcription bubble resists opening of the DNA, which can
slow or impede transcription elongation by RNA Polymerase I
[43], as seen following treatment with CPT [44]. In contrast,
negative supercoiling behind the transcription bubble can lead to
the unwinding of DNA. When this happens, the nascent RNA
may hybridize to the transcribed strand, creating R-loops [44].
The additional increase in R-loop formation observed after CPT
treatment supports previous findings, showing that the blocking of
DNA topoisomerase I leads to R-loop-mediated transcriptional
stalling during ribosomal RNA synthesis [39,40]. To confirm that
R-loop formation requires active transcription, we employed the
use of Actinomycin D (AD), a transcription inhibitor that binds
DNA at the transcription initiation complex and prevents
elongation of RNA by RNA polymerases [45]. Following AD
treatment, R-loop levels decreased in both control siRNA- and
SETX siRNA-treated cells (Figure 5A and 5B), confirming the
involvement of active transcription in R-loop formation.
Having established that CPT-induced DNA damage can
stimulate R-loop formation; we then treated wildtype, Setx2/2
and Tdp12/2 mutant mice with topotecan (TPT), a water-soluble
analogue of CPT [46]. Knockout mice of both models treated with
this agent lost approximately 30% of body weight over a 10-day
period (Figure 6). This may have resulted from damage to the
mucosal tissue in the lower intestine, causing disruption to nutrient
absorption. It has also been shown that TPT can cause
gastrointestinal toxicity in mice [18,47]. However, no abnormal
neurological behaviour was observed in TPT-treated animals as
Figure 2. R-loop formation, apoptosis, and DNA damage quantitation in ARCAs mouse testes. A. Percentage of seminiferous tubules
containing R-loops. B. Average number of apoptotic spermatocytes per tubule in testes from ARCA mice. C. Percentage of R-loop & TUNEL-positive
cells. D. Average number of apoptotic cells containing DNA DSBs (cH2AX). For each panel, 200 tubules were examined per animal and cells were
counted in each tubule (n = 3). Error bars represent SEM.
doi:10.1371/journal.pone.0090219.g002
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compared to untreated controls over the treatment period. We
then screened for the presence of R-loops in both proliferating and
post-mitotic tissues of these mice using the R-loop-specific S9.6
antibody together with the Ki67 antibody, which was used as a
marker of proliferation. As expected, in the testes of Setx2/2 mice,
coinciding R-loop and Ki67 signals were detected under untreated
conditions [23] and this increased after TPT treatment (Figure 7).
However, examination of the brain and cerebella tissues from both
treated and untreated Setx2/2 mice failed to reveal evidence of R-
loop formation (Figure 7). Although TPT is able to readily cross
the blood-brain barrier and has been demonstrated to be active in
brain metastases from small cell lung cancer [48], it did not induce
the formation of R-loops in these animals. Since increased R-loop
levels were only observed in a proliferative tissue such as the testes,
we then investigated for the presence of R-loops in other highly
proliferative tissues such as the intestine and the spleen. Increased
levels of coinciding R-loop and Ki67 signals were detected in these
tissues after TPT treatment (Figure 8). Similar results were found
in Tdp12/2 mice (Figure 9). Quantitation of the number of R-
loop-, TUNEL- and R-loop & TUNEL-positive cells is shown in
Figure 10. Only a very small number of R-loop positive cells (,
0.4% of cells) were detected in Setx+/+ intestine, spleen and testes.
Treatment of Setx+/+ mice with TPT lead to a 2.7-fold, 1.5-fold,
and 6.8-fold increase in the number of R-loop formation cells in
intestine, spleen and testes, respectively (Figure 10A). As antic-
ipated, Setx2/2 mice exhibited higher levels of R-loop formation in
intestine, spleen and testes, with testes showing the highest number
of R-loop-positive cells (6.9% of cells). Following TPT treatment,
the number of R-loops-containing cells in Setx2/2 mice drastically
increased in all three tissues by a 17.3-fold in the intestine, 10.5-
fold in the spleen, and 1.5-fold in the testes which remained the
tissue containing the highest number of R-loops-positive cells
(Figure 10B). Similar results were observed for Tdp12/2mice
(Figure 10C). Less than 0.5% of R-loops-positive cells were
detected in Tdp12/2 mice under normal conditions. TPT
treatment of Tdp12/2 mice lead to a drastic increase in the
number of R-loops-positive cells with intestine and testes
displaying a 19-fold and 34.4-fold increase, respectively
(Figure 10C). As a consequence of the TPT-induced R-loop
accumulation, the number of double-positive cells (R-loop &
TUNEL) after TPT treatment dramatically increased in Setx+/+,
Setx2/2 and Tdp12/2 mice further supporting the effect of R-loop
accumulation in genome stability. We next examined the levels of
senataxin protein in these tissues using immunoblotting. We failed
to detect senataxin protein using western blotting of wildtype total
tissue extracts, suggesting very low levels of senataxin in these
tissues and/or weak sensitivity of the senataxin antibody. We thus
performed senataxin immunoprecipitation from wildtype and
Setx2/2 tissues extracts. As seen in Figure S4 A, a weak signal for
senataxin was only detected in Setx+/+ testes extracts. This is
Figure 3. Absence of R-loops in Setx2/2 nervous tissues. A. Whole brain sections from wildtype (Setx+/+) and Setx2/2 were stained for R-loop
(Red) and apoptosis (TUNEL, Green). Nuclei were labelled with DAPI. B. Wildtype and Setx2/2 cerebellar sections staining with R-loops and TUNEL.
DAPI stained nuclei. C. As a control for R-loop and TUNEL staining, both wildtype and Setx2/2 testes sections are shown. Scale bar, 100 mm.
doi:10.1371/journal.pone.0090219.g003
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agreement with the GEO expression data, which showed the
highest expression for senataxin in testes as compared to other
tissues. Using RT-PCR, we confirmed the low levels of senataxin
in brain, cerebellum, spleen and intestine compared to testes
(Figure S4 B).
Altogether, these data indicate that R-loops form preferentially
in replicating cells of proliferative tissues due to the collision of the
replication fork and the transcription machinery [21,27], and not
in post-mitotic cells such as the neurons in the brain and
cerebellum even after DNA damage exposure.
Given that the loss of TDP1 leads to an age-dependant and
progressive cerebellar atrophy, and that cerebellar neurons or
primary astrocytes derived from Tdp12/2 mice display an inability
to rapidly repair DNA SSBs associated with Top1-DNA
complexes or oxidative damage [18], we generated Setx2/
2Tdp12/2 double mutants to investigate whether the compound-
ed defects would induce or exacerbate R-loop formation and
trigger a neurological phenotype. However, while male sterility
was observed in the double knockout, no neurological defects were
observed. Similar results to the single Setx2/2 and Tdp12/2
knockout TPT-treated mice were observed in the double
knockout, with similar levels of R-loop accumulation seen in the
testes, spleen and intestine but not in the brain or cerebellum (data
not shown).
Discussion
Recent evidence suggests that senataxin plays a central role at
the interface between transcription, DNA replication and genetic
recombination in resolving R-loops to minimise the risk of genome
instability [21,23,24]. In this report, we demonstrate that the
disruption of a number of DNA damage response genes including
Setx and Tdp1 in mice led to the accumulation of R-loops in
proliferating cells consistent with collision between transcription
and DNA replication forks when DNA lesions were not repaired
[21,27]. However, there was no evidence of the accumulation of
R-loops in the nervous tissues of these gene-disrupted animals even
when DNA damage was inflicted. These data suggest that in post-
Figure 4. R-loops forming sequences (RLFS) prediction and R-loops detection using DRIP assay.) UCSC Genome browser shows
chromosome mapping of RLFS and poly(A) signal location at 39 UTR of studied genes. RFLS (red box), and PCR products (black vertical lines
connected by horizontal lines) are indicated on the diagram. A. RLFS prediction in the 39 UTR of the mouse Pkd2l1 gene located in the HS44.2 locus
on chromosome 19. See Figure S5 for sequence details. DRIP quantitation from Setx+/+ and Setx2/2 showed similar background levels of R-loops in
brain and cerebellum. Only a significant increase in R-loop formation was observed in Setx2/2testes as compared to Setx+/+(Students t-test, p,0.05,
n = 3). B. RLFS prediction in the 39UTR of the mouse Foxo4 gene located on the X chromosome. DRIP quantitation from Setx+/+ and Setx2/2 showed
similar background levels of R-loops in brain and cerebellum. Similarly, a significant increase in R-loop formation was only observed in Setx2/2testes
(Students t-test, p,0.05, n = 3). C. Treatment of Setx2/2 DRIP samples with S1 Nuclease and RNAse H confirmed the specificity of the S9.6 (R-loop)
antibody towards DNA/RNA hybrids as shown by reduced fluorescence intensities on Bioanalyzer Spectra.
doi:10.1371/journal.pone.0090219.g004
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mitotic cells, where transcription is highly active, only basal levels
of R-loops exist and they do not accumulate even in the presence
of DNA damage. Thus this is a phenomenon that appears to be
restricted to proliferating cells. We have previously shown that the
disruption of Setx in mice caused persistence of DNA DSB, a defect
in Rad51 disassembly, accumulation of R-loops and a failure of
crossing-over in spermatocytes [23]. Here, we showed that R-loops
accumulate in the testes even when other DNA damage response
genes were disrupted. Mutations in the ATM gene give rise to
ataxia-telangiectasia (A-T), which is characterised by immunode-
ficiency, cancer predisposition, neurodegeneration and also
infertility [5]. Atm2/2 spermatocytes halt development largely at
Figure 5. Induction of R-loop after DNA damage exposure. A. Knock down of senataxin in HeLa cells using short interfering RNA (siRNA)
induced the accumulation of R-loops in nucleoli. Knock down efficiency for senataxin is shown in Figure S2. Treatment of these cells with 25 mM of
camptothecin (CPT) led to the accumulation of R-loops in control cells (Ctrl siRNA) and a further increase in senataxin knockdown cells (SETX siRNA).
Pre-treatment of these with RNA polymerase inhibitor Actinomycin D (AD, 5 mg/ml), ablated the CPT-induced formation of R-loop in both cell types.
B. Quantitation of R-loops formation in control and senataxin knockdown cells. No R-loops were detected in ctrl siRNA-treated cells under normal
growing conditions. CPT induced the formation of R-loops in both cell types and pre-treatment these cells with AD prevented the induction of R-
loops following DNA damage exposure. Levels of R-loops returned to basal levels in SETX siRNA-treated cells after addition of AD.
doi:10.1371/journal.pone.0090219.g005
Figure 6. Treatment of Setx and Tdp1 mice with Topotecan induces severe weight loss. Wiltype (WT), Setx2/2 and Tdp12/2 mice were
treated with a daily dose of topotecan (TPT, 2 mg/kg/day) over a period of 9 days in order to exacerbate the formation of R-loops in these mice. Mice
of each genotype were injected daily with a dose of TPT (2 mg/kg/day) and weights were recorded daily (n = 3). Controls were injected with an
equivalent volume of purified water.
doi:10.1371/journal.pone.0090219.g006
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Figure 7. Topotecan treatment does not induce R-loops formation in post-mitotic nervous tissues in Setx2/2 mice. Histological
sections of brain, cerebellum, and testes were immunostained for R-loops (Red) and TUNEL (Green). No R-loops were detected in brain and
cerebellum sections after TPT treatment. In contrast, an increase in the number of R-loop-containing cells was observed in wildtype and Setx2/2 after
TPT exposure suggesting that R-loop preferentially form in proliferating cells, most likely due to collision between the DNA replication machinery and
the transcription apparatus. DAPI stained nuclei and Ki67 (Red) was used as a marker for proliferation. Scale bar, 100 mm.
doi:10.1371/journal.pone.0090219.g007
Figure 8. Induction of R-loops in proliferating cells after topotecan treatment. Wildtype and Setx2/2histological sections of intestine and
spleen, two tissues with a high proliferative capacity, were stained for R-loops, TUNEL, and Ki67. TPT induced the formation of R-loops and apoptosis
in both intestine and spleen. TPT disrupted the structure of the small intestine in Setx2/2 animals supporting the severe weight loss observed in these
mice. R-loop (red), TUNEL (green) and Ki67 (red). DAPI (blue) stained nuclei. Scale bar, 100 mm.
doi:10.1371/journal.pone.0090219.g008
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leptotene stage of meiotic prophase 1 and ovaries from females
contain no primary oocytes or follicles [49]. The integrity of axial
elements and synaptonemal complexes were disrupted and DNA
DSB persisted in Atm2/2spermatocytes consistent with a role for
ATM in monitoring DNA DSB during meiotic recombination in
early leptotene. ATM responds to the presence of excess breaks by
inducing apoptosis. In this study we detected excess DNA DSB in
testes sections from Atm2/2mice and these co-localised with R-
loops suggesting that a combination of blocked transcription
together with unrepaired DNA DSBs is responsible for the
disrupted spermatogenesis. It is also evident that the majority of R-
loop-containing spermatocytes are undergoing apoptosis. Muta-
tions in TDP1 give rise to spinocerebellar ataxia with axonal
neuropathy (SCAN1) [17]. Mice disrupted for this gene display an
inability to rapidly repair SSB [18]. There is also a requirement for
this enzyme in the removal of acutely elevated levels of Topo1-
associated DNA strand breaks in intestinal and haematopoietic
progenitor cells. Although Tdp12/2mice are fertile and do not
exhibit the same high level of R-loop accumulation and cell death
in testes sections as Setx2/2 and Atm2/2 mice, we did detect levels
of R-loops that were significantly higher than wildtype and there
was concordance between these and apoptosis. This suggests that
there is elevation in DNA breaks in Tdp12/2mouse spermatocytes
or increased DNA replication blockage that leads to R-loop
accumulation. Mutations in the APTX gene lead to ataxia
oculomotor apraxia type 1 (AOA1). APTX codes for aprataxin,
which is an enzyme that catalyzes the removal of abortive DNA
ligation intermediates and is important for DNA SSB repair
[15,16]. The fourth mutant mouse model, Aptx2/2 which also
exhibits normal fertility, had elevated numbers of R-loops in the
testes as compared to wildtype and similar to the Tdp12/2mouse.
However it was not to the same extent as that seen in the Setx2/2
and Atm2/2mice. These data indicate that in the absence of
proteins involved in recognition and/or repair of DNA damage,
R-loops occur in proliferating cells due the presence of unrepaired
DNA lesion that can stall the transcription machinery. In addition,
the extent of R-loop accumulation can exacerbate genomic
instability, trigger apoptosis and is indicative of the fertility status.
All four mutants studied here correspond to autosomal recessive
ataxias characterised by cerebellar atrophy and loss of Purkinje
cells [50]. While the syndromes vary in the extent of extra-
neuronal involvement, they are all characterised by neurodegen-
eration. Although the mouse models for the disorders described
here do not recapitulate the neurodegeneration seen in human
patients, some neurological abnormalities can be observed. For
example, in the case of Tdp12/2mice, there is an accumulation of
Topo1-linked breaks in astrocytes and an age-dependent reduction
in cerebellar size [18]. Atm2/2mice also exhibit cerebellar
pathology, neuronal cell death in vitro, reduced synchronization
persistence in neural networks, vascular abnormalities and
degeneration of the nigro-striated pathway [51]. Neuronal cells
are characterised by active transcription and high levels of
metabolic activity [36]. As such, it seemed likely that in the
presence of unrepaired DNA breaks, R-loops would accumulate in
the brains of these mutant mice. Only background levels of R-
loops were detected in either the brain as a whole or cerebellum
using the more the sensitive DRIP assay. However, treatment of
any of these animals with TPT, which is a compound that readily
crosses the blood-brain barrier and induces DNA damage, did not
trigger accumulation of R-loops in post-mitotic tissues. This
suggests that while R-loops occur normally at pause sites during
transcription [52], their accumulation is only observed in cells
where transcription collides with either DNA replication forks [21]
or with DNA recombination intermediates during meiosis
Figure 9. Induction of R-loops only in proliferative tissues in Tdp12/2 after topotecan treatment. Histological sections from Tdp12/2mice
were stained for R-loops, TUNEL and Ki67 after topotecan exposure. Similar to Setx2/2, TPT induced the formation of R-loops formation only in
proliferative tissues testes, intestine and spleen). No R-loops were detected in post-mitotic tissues (brain and cerebellum). Scale bar, 100 mm.
doi:10.1371/journal.pone.0090219.g009
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(Figure 11) [23]. Clearly neither of these events occur in post-
mitotic neurons. While R-loops have been identified as a substrate
for senataxin [24], it is possible there are other substrates which
might be more important in post-mitotic cells. In this context, it
has been shown that senataxin functions at different stages during
transcription [22]. For instance, the binding of RNA polymerase II
to candidate genes was significantly reduced in senataxin deficient
cells and consequently the expression of these genes. Transcription
termination was also abnormal as determined by transcript
readthrough [22]. This was demonstrated in senataxin-depleted
cells where an over-expression of RNAse H resolved R-loops and
caused transcriptional readthrough [24]. Suraweera et al 2009 also
demonstrated that the splicing efficiency of specific mRNAs and
alternate splice site selection were altered in senataxin-deficient
cells [22]. The absence of R-loops in post-mitotic tissues may
reflect a regulatory role for senataxin in transcription and/or RNA
processing that does not involve the resolution of R-loops per se.
Vantaggiato et al. 2011 reported a role for senataxin in neuronal
differentiation through fibroblast growth factor 8 (FGF8) signalling
where they found that an overexpression of senataxin was sufficient
to trigger neuronal differentiation in primary hippocampal
Figure 10. Increased R-loop formation in TPT-treated knockout Setx and Tdp1 mice. Graphs show the percentage of apoptotic (TUNEL)
cells only, cells containing R-loops only and apoptotic cells containing R-loops in the different tissues of Setx (A and B) and Tdp1 mice (C). Counts
were performed using 5 fields of view per tissue per animal (n = 3). Higher levels of these three cell types were observed in TPT-treated knockout
animals.
doi:10.1371/journal.pone.0090219.g010
Figure 11. R-loops preferentially form in cycling but not in
post-mitotic cells. Model depicting the requirements for R-loops
formation in the various ARCAs model. While transcription is implied in
the formation of R-loops, active replication appears to be a necessary
condition too. Thus R-loops accumulation does not appear to
contribute to the neurodegenerative phenotype observed in autosomal
recessive cerebellar ataxias.
doi:10.1371/journal.pone.0090219.g011
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neurons or in P19 cells treated with retinoic acid [53]. FGF8 is one
of several growth factors that regulate neurogenesis, neuronal
differentiation, survival and synaptic plasticity, both during
development and in adulthood [53].
Cellular viability depends on the well-orchestrated functions
carried out by numerous protein-coding and non-coding RNAs, as
well as RNA-binding proteins. Mutations or abnormalities that
disrupt RNA or protein components of RNP complexes can be
deleterious to cells and cause disease states. During the last decade,
it has become increasingly evident that abnormalities in RNA
processing represent a common feature among many neurode-
generative diseases. For instance, some neurodegenerative diseases
result from mutated coding and non-coding RNAs, and mis-
regulation of long non-coding RNA transcription [54,55].
‘‘RNAopathies’’ include diseases caused by non-coding repeat
expansions and RNAs that exert toxicity via diverse mechanisms
such as RNA foci formation, bidirectional transcription, and the
production of toxic RNAs and proteins by repeat associated non-
ATG translation [29]. Much work remains in order to elucidate
the mechanisms underlying ‘‘RNA-binding proteinopathies’’, such
as amyotrophic lateral sclerosis (ALS) in which the RNA-binding
protein TDP-43 plays a prominent role [54]. The absence of R-
loops formation in post-mitotic neuronal cells as observed here in
this study suggests that AOA2 may represent a novel ‘‘RNAo-
pathy’’ in which defects in senataxin can affect the fidelity of the
transcriptome. Further investigation of transcriptional regulation,
RNA processing, and gene expression in AOA2 awaits the
generation of an appropriate neuronal model for this disease.
Materials and Methods
Ethics Statement
All animal work and experiments have been approved by The
QIMR Berghofer Medical Research Institute Animal Ethics
Committee and all efforts were made to minimize suffering.
Animal housing, husbandry and genotyping
The Setx (C57Bl6/129Sv), Tdp1 (C57Bl6), Aptx (C57Bl6) and
Atm (C57Bl6/129Sv) mouse strains were bred in house (QIMR
Berghofer Medical Research Institute Animal House) and have
previously been characterised and described [18,23,56,57].
Heterozygote mice for Setx+/2 and Atm+/2 were crossed to
generate homozygote knockouts since both knockouts animals are
sterile. Tdp12/2 and Aptx2/2 were used for breeding since these
animals are fertile. The mice were housed in a specific pathogen
Free (SPF) PC2 facility in OptiMICE caging system (Opti-
Polycarbonate cages) with artificial bedding material and subjected
to a light/dark cycle of 12 h/12 h. Temperature of the animal
facility was maintained constant (21uC–23uC) and the mice had
permanent access to food and water (24 h/7days). Mice were
housed with 2–5 companions per cage and had an enriched
environment composed of shredded paper and toilet rolls.
Welfare-related assessments were carried out prior to, during
and after the experiment to ensure minimal suffering. The mice
were ear clipped for identification at 10 days post-partum,
genotyped, and weaned at 21 days post-partum. Genotyping was
carried out by PCR on genomic DNA isolated from tail tips.
Genotyping for the Setx, Tdp1, Aptx and Atm mice has been
previously described [18,23,56,57]. Primer pairs are detailed in
Figure S3. All experiments were carried out on adult (1 month-old)
male animals. Tissue collection was performed after euthanasia
(CO2 gas) as instructed by Animal welfare guidelines. Animal
colonies were regularly screened every 3 months for health and
immune status.
Histological analysis of ARCAs mice testes
Testes from adult (1 month-old) male mice were collected and
fixed in PBS buffered 10% formalin, embedded in paraffin block
and sectioned at 4 mm. Sections were stained with Hematoxylin
and Eosin (H&E). Slides were examined under light microscope
and then scanned using Scanscope CS system (Aperio Technol-
ogies, Vista, USA). Images corresponding to 610 and 620
magnification were captured and assembled into Adobe Photo-
shop 7 (Adobe Systems Inc, USA).
TUNEL assay for apoptosis
Paraffin sections from testes, brain, cerebellum, spleen and
intestines were dewaxed and rehydrated with Shandon Varistain
Gemini ES (Thermo Scientific, USA). Apoptotic cells were
detected by Terminal deoxynucleotidyl transferased UTP Nick
End Labelling (TUNEL) assay using the Fluorescence in situ Cell
Death Detection Kit (Roche, Switzerland) following the manu-
facturer’s instructions. TUNEL is a method for detecting DNA
fragmentation by labelling the terminal end of nucleic acids and a
common method for detecting DNA fragmentation that results
from apoptotic signalling cascades. DNA was stained with DAPI
(1:10,000; Sigma-Aldrich) for 10 min at room temperature, and
slides were mounted in Celvol 603 medium. Images were captured
at room temperature using a digital camera (AxioCamMrm, Carl
Zeiss Microimaging Inc., Germany) attached to a fluorescent
microscope (Axioskop 2 mot plus, Carl Zeiss Microimaging Inc.,
Germany) and the AxioVision 4.8 software (Carl Zeiss, Micro-
imaging Inc. Germany). The objectives employed were a Zeiss
Plan Neofluar610/0.30 (mt10 magnification) or a 636Zeiss Plan
Apochromat 1,4 Oil DIC (Carl Zeiss, Germany). Images were
subsequently assembled in Adobe Photoshop 7 (Adobe Systems
Inc, USA), and contrast and brightness were adjusted on the whole
image panel at the same time. For double staining, TUNEL was
carried out first followed by immunostaining as described below.
R-loop and DNA damage immunostaining on tissue
sections
Slides with tissue sections were dewaxed and enzymatic antigen
retrieval was performed by incubating the sections with 1:10
Trypsin dilution in PBS for 20 min at 37uC. Slides were washed 3
times for 5 min with PBS at room temperature for 5 min each.
Tissues sections were blocked in (20% FCS, 2% BSA, 0.2% Triton
X-100) for 1 h at room temperature. Slides were incubated with
anti-R-loop (1:100, S9.6), anti-cH2AX (1:100, Y-P1016, Milli-
pore) or anti-Ki67 (1:100, ab15580, Abcam) antibodies overnight
at 4uC in a humidified chamber. Slides were washed 5 times with
16 PBS containing 0.5% Triton X-100 for 5 min each at room
temperature. Alexa-Dye488 or Alexa-Dye594-conjugated second-
ary antibody (Molecular Probes, Life technologies) was added for
1 h at 37uC in a humidified chamber. Subsequently, slides were
washed 3 times as before and DAPI (1:10,000; Sigma-Aldrich) was
added for 10 min to staining nuclei. Slides were finally washed
twice and glass coverslips were mounted in Celvol 603 medium for
imaging. Imaging was performed as described above. Confirma-
tion of R-loop specific staining was obtained by pre-treating Setx2/
2 testes sections with RNAse H (New England Biolabs, USA)
(Figure S1 A).
siRNA transfection into HeLa cells and CPT treatment
HeLa cells (ATCC) were transfected with Stealth RNAi
Negative Control LO GC (#12935200) (Invitrogen) and Stealth
RNAi specific for the knock-down of SETX (Invitrogen): SETX 1
(CCAUCUAACUCUGUACAACUUGCUU) and SETX 3
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(CCAAUUGCUCCUUUCAGGUGUUUGA). Approximately
2.5–106105 cells were transiently transfected in a six-well plate
with control/SETX RNAi oligoribonucleotide (5 ml of a 20 mM
stock) using Lipofectamine 2000 (Invitrogen) as described by the
manufacturer. Knock-down efficiency of SETX was determined
48 h post-transfection by immunoblotting of whole cell extracts
and immunostaining using and anti-senataxin (1:2000, Ab-1)
antibody [20]. PARP-1 protein levels (1:1000, MCA1522G,
Serotec) were used as the loading control. Control and SETX
siRNA-tranfected cells were treated with 25 mM of camptothecin
(CPT, Sigma-Aldrich) for 2 hours at 37uC/5% CO2 to induced
DNA damage and then fixed with 4% PFA and processed for
immunostaining as previously described to detect R-loop forma-
tion [20,23]. Control and SETX siRNA-transfected cells were also
treated with actinomycin D (5 mg/ml for 2 hours at 37uC/5%
CO2, Sigma-Aldrich) to transiently inhibit transcription prior to
the addition of camptothecin to confirm the transcription-
dependant formation of R-loops.
Topotecan treatment of ARCA mouse models
In order to exacerbate the formation of R-loops and determine
whether R-loop could form in post-mitotic tissues upon DNA
damage accumulation, ARCA mouse models were treated with
Topotecan (TPT) (Sigma-Aldrich), a water-soluble derivative of
camptothecin for a period of 9 days. Topotecan was administered
daily (approximately at 10:00 am) as an intraperitoneal injection
following a brief anaesthesia using Isofluorane gas (2.5% at 3 L/
min). Isofluorane is one of the safest methods recognised for
rodents anaesthesia. For each genotype group, 3 mice were
injected daily either with carrier solution (Sterile Injection Water
BP, Pfizer) or TPT (2 mg/Kg/Day) and weight was monitored
and recorded daily prior and 24 hours post injection. Animal
weights were recorded prior, during, and after the treatment
regimen. General health and behaviour of the mice was monitored
daily until the end of the treatment when the animals were
sacrificed to assess for R-loop formation, apoptosis levels and
proliferation status.
R-loop forming sequences (RLFS) prediction and DNA/
RNA Immunoprecipitation (DRIP)
R-loop forming sequence (RLFS) model [37] was applied to
predict the location of RLFSs in the mouse genome. RLFS region
located downstream to the poly(A) signal (,500 bp) were selected
for DRIP analysis (Figure S5). Two candidates genes, the
Pkd2l1gene located in the HS44.2 locus on chromosome 19 and
the Foxo4 gene located on the X chromosome, were selected for
DRIP analysis. Genomic DNA and RNA extraction from Setx+/+
and Setx2/2 mice testes, LCLs and HeLa cells were performed
using the DNeasy Blood & Tissue Kit (Qiagen, USA) following the
manufacturers’ instructions. Extracts were sonicated (maximum
voltage, constant output, microtip limit) for 3 min with 1 min
incubation on ice within each min. 40 ml of Protein G beads (50:50
slurry) (Millipore, Germany) was added to the extracts and pre-
cleared. In a separate tube, 15 mg of anti-R-loop antibody (S9.6)
and 40 ml of Protein G beads (50:50 slurry) (Millipore, Germany)
were added together and incubated at 4uC overnight on a rotating
wheel to allow binding of antibody to beads. Mouse anti-IgG
antibody and 40 ml of Protein G beads (50:50 slurry) (Millipore,
Germany) were also added together to serve as a non-specific
control for our experiment. The next day, the tubes were
centrifuged at 54006 g for 2 min to pellet the beads. The
supernatant was then divided equally into 3 tubes- 1 was left
untreated, 1 was treated with 200 U of S1 Nuclease (Promega,
USA) and the other was treated with 10 U of RNAse H (New
England BioLabs, USA). Extracts were incubated at 37uC for 2 h,
heat inactivated for 20 min at 65uC then added on to the
antibody-bound Protein G beads and incubated at 4uC overnight
on a rotating wheel to allow binding of R-loops fragments to
antibody-bound beads. The next day, the beads were pelleted at
54006g for 2 min and the supernatant was discarded. The beads
were washed once with the IP Wash Buffer 1 (20 mM Tris-HCl
pH 8.1, 2 mM EDTA, 50 mM NaCl, 1% Triton X-100, 0.1%
SDS), twice with the High Salt Wash Buffer (20 mM Tris-HCl
pH 8.1, 2 mM EDTA, 500 mM NaCl, 1% Triton X-100, 0.1%
SDS), once with the IP Wash Buffer 2 (10 mM Tris-HCl pH 8.1,
1 mM EDTA, 0.25 M LiCl, 1% NP-40, 1% Deoxycholic Acid)
and twice with TE Buffer (20 mM Tris-HCl pH 8.0, 1 mM
EDTA). The immunoprecipitates were incubated at 4uC on a
rocker for 3 min between each wash. The nucleic acids were then
eluted twice with 100 ml of Elution Buffer (100 mM NaHCO3,
1% SDS). 3 ml of Proteinase K (20 mg/ml) was then added to each
sample and incubated at 55uC. The samples were then diluted to
400 ml with TE Buffer and 3 ml of Glyogen (20 mg/ml) (Roche,
Switzerland) was added. The nucleic acids were extracted using
400 ml of Phenol Chloroform (1:1) and vortexed for 1 min. The
samples were centrifuged at 16, 0006g for 5 min and the aqueous
phase containing the nucleic acids were retained. These were
extracted again using 400 ml of Chloroform under the same
conditions. 2.56 of 100% EtOH was added to the samples and
these were incubated at 280uC for 20 min. The samples were
centrifuged at 16, 0006 g for 20 min and the supernatant was
decanted. The pellet was washed with 70% EtOH, centrifuged at
16, 0006 g for 20 min and the supernatant was decanted. The
pellet was air-dried and resuspended in EB Buffer (Qiagen, USA).
PCR analyses from DRIP assay
Primers for the predicted RLFS of mouse HS44.2 region were
mHS44.2 1F and mHS44.2 1R. Primers for the predicted RLFS of
mouse Foxo4 region were mFoxo4 F and mFoxo4 R. RLFS
regions are detailed in Figure S5. PCR cycling conditions were as
follows: 35 cycles, initial denaturation at 95uC for 3 min,
denaturation at 95uC for 45 sec, annealing at 60uC for 45 sec,
extension at 72uC for 1 min, with a final cycle and extension of
7 min at 72uC. The PCR product size for the HS44.2 and Foxo4
regions were 226 bp was 357 bp respectively. See Figure S3 for list
of primers.
Senataxin immunoprecipitation
Immunoprecipitation of senataxin protein was performed as
previously described [23].
RT-PCR analysis for senataxin gene expression
Total RNA was isolated from 35-day-old wild type and
knockout mice testes using the RNeasy mini kit (Qiagen, USA)
according to the manufacturer’s protocol. RNA concentrations
were determined by UV spectrophotometry using a Nanodrop
ND-2000 (Thermo scientific, USA) and cDNA was made from
1 mg of purified RNA using Super Script III (Life technologies,
USA) according to the manufacturer’s protocol. Gene expression
analysis was performed by PCR in a 2720 Thermal Cycler
(Applied Biosystem, USA). Reactions (25 ml) contained 14.5 ml of
sterile water, 300 ng of cDNA template, 16 PCR Buffer II
(Roche, Switzerland), 2.5 mM MgCl2 (Roche, Switzerland),
20 mM dNTPs, 1 mM of each primer, and 5 ml of AmpliTaq
Gold DNA Polymerase (Roche, Switzerland). The primer pairs
used for gene expression analysis are described in Figure S3.
Amplification was for 30 cycles and cycling conditions were as
follows: denaturation for 5 min at 95uC for 30 sec, annealing at
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65uC for 30 sec, elongation for 1 min at 72uC followed by a final
extension step of 7 min at 72uC. PCR reactions were separated on
2% TAE agarose gels and visualised using Ethidium bromide and
GelDoc system (Biorad, USA).
Supporting Information
Figure S1 Lack of R-loops formation in Atm2/2, Aptx2/
2 and Tpd12/2brain and cerebellar sections. A. Specificity
of the R-loop (S9.6) antibody. Serial testes sections from Setx2/2
animals were either pre-incubated with RNAse H (1 hour at 37uC)
or left untreated and subsequently immunostained for R-loops. As
expected a reduction of R-loop fluorescence intensity is visible in
RNAse H-treated samples thus confirming the specificity of the R-
loop antibody. B. Histological sections of brain and cerebellum
were stained for R-loops (Red) and TUNEL (Green). DAPI
stained nuclei. Scale bar, 100 mm.
(TIFF)
Figure S2 Knockdown of senataxin in HeLa cells using
short interfering RNA (siRNA). A. Following transfection of
Control (Ctrl siRNA) and SETX siRNA, HeLa cells were
immunostained for senataxin (SETX) and also processed for
immunoblotting. As shown in panel A, a reduction in senataxin
fluorescence signal was observed after SETX siRNA treatment. B.
These data demonstrated the effective knock down of senataxin in
HeLa cells via immunoblotting. C. Graph is plotted to show
knockdown efficiency of SETX.
(TIFF)
Figure S3 Primer pairs used for the genotyping of
Atm2/2, Setx2/2, Aptx2/2, Tdp12/2mice, PCR analyses
for HS44.2 and Foxo4 regions from DRIP assay as well
as RT-PCR.
(TIFF)
Figure S4 Senataxin expression in mouse tissues. A.
Senataxin immunoprecipitations from testes, brain, cerebellum,
spleen and intestine were carried out to detect senataxin protein
levels. A faint signal corresponding to senataxin protein was only
detected in Setx+/+ testes indicating lower levels of senataxin in the
others tissues and/or weak sensitivity of the senataxin (Ab-1)
antibody. B. RT-PCR analysis from testes, brain, cerebellum,
spleen and intestine confirmed the lower levels of senataxin
expression in brain, cerebellum, spleen and intestine compared to
testes.
(TIFF)
Figure S5 R-loop prediction and candidate genes selec-
tion. A. An RLFS-containing region was found downstream of
the Pkd2l1 gene located in the HS44.2 locus. The predicted RLFS
was found at the position Chr19: 44,221,689–44,221,838. B. In
chromosome X, the RLFS located in Foxo4 was found nearby a
poly(A) signal. The predicted RLFS was found at the position
ChrX: 98,456,266–98,456,499. For these genes, the predicted
RLFS was located close to poly(A) signals (,500 bp) observed in
mouse testes (by UCSC browser). Nucleotide sequence of the
RLFS is in bold and primers are underlined.
(TIFF)
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Figure S1 
 
 
Fig S1. Lack of R-loops formation in Atm
−/−
, Aptx
−/−
 and Tpd1
−/−
brain and cerebellar sections. 
A. Specificity of the R-loop (S9.6) antibody. Serial testes sections from Setx
−/−
 animals were either 
pre-incubated with RNAse H (1 hour at 37°C) or left untreated and subsequently immunostained for 
R-loops. A reduction of R-loop fluorescence intensity is visible in RNAse H-treated samples thus 
confirming the specificity of the R-loop antibody. B. Histological sections of brain and cerebellum 
were stained for R-loops (Red) and TUNEL (Green). DAPI stained nuclei. Scale bar, 100 µm. 
 
 
 
 
 
 
 
 
 
  
 
Figure S2 
 
 
Fig S2. Knockdown of senataxin in HeLa cells using short interfering RNA (siRNA). A. 
Following transfection of Control (Ctrl siRNA) and SETX siRNA, HeLa cells were immunostained 
for senataxin (SETX) and also processed for immunoblotting. As shown in panel A, a reduction in 
senataxin fluorescence signal was observed after SETX siRNA treatment. B. Effective knockdown 
of senataxin in HeLa cells revealed by immunoblotting. C. Graph is plotted to show knockdown 
efficiency of SETX. 
 
  
 
Figure S3 
 
Fig S3. Primer pairs used for the genotyping of Atm
−/−
, Setx
−/−
, Aptx
−/−
, Tdp1
−/−
 mice, PCR 
analyses for HS44.2 and Foxo4 RLFS regions and RT-PCR for Setx expression. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S4 
 
 
 
Fig S4. Senataxin expression in mouse tissues. A. Senataxin immunoprecipitation from testes, 
brain, cerebellum, spleen and intestine were carried out to detect senataxin protein levels. A faint 
signal corresponding to senataxin protein was only detected in Setx
+/+
 testes indicating lower levels 
of senataxin in the others tissues and/or weak sensitivity of the senataxin (Ab-1) antibody. B. RT-
PCR analysis from testes, brain, cerebellum, spleen and intestine confirmed the lower levels of 
senataxin expression in brain, cerebellum, spleen and intestine compared to testes. 
 
 
 
 
 
 
  
 
Figure S5 
 
 
Figure S5. R-loop prediction and candidate gene selection. A. An RLFS-containing region was 
found downstream of the Pkd2l1 gene located in the HS44.2 locus. The predicted RLFS was found 
at the position Chr19: 44,221,689–44,221,838. B. In chromosome X, the RLFS located in Foxo4 
was found nearby a poly (A) signal. The predicted RLFS was found at the position ChrX: 
98,456,266–98,456,499. For these genes, the predicted RLFS was located close to poly(A) signals 
(<500 bp) observed in mouse testes (by UCSC browser). Nucleotide sequence of the RLFS is in 
bold and primers are underlined. 
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5.3 Results (continued) 
 
The following section contains results of the TPT-treatment experiment performed on Atm and Aptx 
mice, and additional DRIP assays performed on Setx
-/-
 mice. 
 
5.3.1 DNA damage induces R-loop accumulation in proliferative tissues in Atm
-/-
 and Aptx
-
/- 
mice 
 
Similar to that seen in Setx
-/-
 and Tdp1
-/-
 mice, Atm
-/-
 and Aptx
-/-
 mice treated with TPT 
(2mg/kg/day) for 9 days showed approximately 30% weight loss after a 9-day period as compared 
to WT mice (Fig 5.1).  
 
 
 
Fig 5.1 Treatment of Atm and Aptx mice with topotecan hydrochloride induces severe weight 
loss. Wild type (WT), Atm
-/-
 and Aptx
-/-
 mice were treated with topotecan hydrochloride (TPT, 2 
mg/kg/day) over a period of 9 days. Mice of each genotype were injected daily with TPT and 
weights were recorded daily (n = 3). Controls were injected with an equivalent volume of purified 
water. 
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As previously reported, these mice do no display any gross neurological phenotype associated with 
the corresponding human disorders
59,270
. The presence of R-loops and cell death via TUNEL assay 
were assessed in both untreated and TPT-treated animals in highly proliferative tissue and post-
mitotic tissue.  
 
Following TPT treatment, R-loop accumulation was only observed in replicating cells of the 
intestine, spleen and testes [Fig 5.2 and Fig 5.3 (extreme right panels)] and not in post-mitotic cells 
of the brain and cerebellum [(Fig 5.3, extreme left and middle panels)]. Similar results were 
obtained in the Aptx mice. 
 
 
Figure 5.2. Induction of R-loops in proliferating cells after topotecan hydrochloride 
treatment. Atm
+/+
 and Atm
-/- 
histological sections of intestine and spleen, two tissues with a high 
proliferative capacity, were stained for R-loops, TUNEL, and Ki67. TPT induced the formation of 
R-loops and apoptosis in both intestine and spleen. TPT disrupted the structure of the small intestine 
in Atm
-/-
 animals supporting the severe weight loss observed in these mice. R-loop (red), TUNEL 
(green) and Ki67 (green). DAPI (blue) stained nuclei. Scale bar, 100 µm.  
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Figure 5.3. Topotecan hydrochloride treatment does not induce R-loops formation in post-
mitotic nervous tissues in Atm
-/-
 mice. Histological sections of brain, cerebellum, and testes were 
immunostained for R-loops (Red) and TUNEL (Green). No R-loops were detected in brain and 
cerebellum sections after TPT treatment. DAPI stained nuclei and Ki67 (green) was used as a 
marker for proliferation. Scale bar, 100 µm.  
 
The number of R-loops-containing cells in TPT-treated Atm
-/-
 mice increased in all three highly 
proliferative tissues by an 11.83-fold in the intestine, 10.24-fold in the spleen, and 1.45-fold in the 
testes which remained the tissue containing the highest number of R-loops-positive cells (Fig 5.4A 
and B). This is in contrast to treated Atm
+/+
 mice where only a 1.8 fold increase was observed in the 
intestine, a 1.7 fold in the spleen and a 6.4 fold in the testes.  
 
Similar results were observed for Aptx
-/- 
mice (Fig 5.4C). Less than 0.5% of R-loops-positive cells 
were detected in Aptx
-/- 
mice under normal conditions. TPT treatment of Aptx
-/- 
mice also lead to a 
significant increase in the number of R-loops-positive cells with intestine and testes displaying a 
21.3-fold and 25.2-fold increase, respectively. As a consequence of the TPT-induced R-loop 
accumulation, the number of double-positive cells (R-loop & TUNEL) after TPT treatment also 
increased in Atm
+/+
, Atm
-/-
, and Aptx
-/- 
mice further supporting the effect of R-loop accumulation in 
genome stability.  
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Figure 5.4. Increased R-loop formation in topotecan hydrochloride-treated Atm
-/-
 and Aptx
-/-
 
mice. Graphs show the percentage of apoptotic (TUNEL) cells only, cells containing R-loops only 
and apoptotic cells containing R-loops in the different tissues of Atm (A and B) and Aptx mice (C). 
Counts were performed using 5 fields of view per tissue per animal (n = 3). Higher levels of these 
three cell types were observed in TPT-treated knockout animals. 
 
The lack of Atm and Aptx, two proteins involved in the DNA damage response and repair, led to 
the accumulation of R-loops in proliferative tissues after TPT treatment, indicating that besides 
protein involved directly in R-loops processing such as senataxin and RNAse H, mutations in 
proteins associated with various DNA repair can also promote the formation of R-loops. These 
findings provide evidence for a broader, novel role for R-loops in genomic instability, and that 
perhaps the detection of R-loops may represent a useful diagnostic marker to assess for genome 
integrity. 
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5.3.2 R-loops accumulate along the mouse WWOX and XY genes in Setx
-/- 
spermatocytes 
 
Common fragile sites (CSFs) are specific chromosomal regions that have a higher propensity to 
form gaps or breaks under replication stress due to frequent replication fork stalling
271,272
. Such 
lesions can lead to genomic instability, and FRA16D in the WWOX gene is one such site in the 
human genome that is very prone to damage
273
. WWOX encodes the WW domain containing 
oxidoreductase that is known to be a tumor suppressor gene and is an example of a long gene that 
requires more than 1 cycle of replication to complete
271,274
. The FRA16D region encodes a 1.2 kb 
transcript but the gene itself covers over 1 mb in length. Interestingly, the downregulation of 
WWOX has been reported in neurological disorders such as Alzheimer’s disease36, cerebellar 
ataxias
275
 and microcephaly syndromes
276
. 
 
Helmrich et al. 2011 showed that the collision between the replication and transcription machinery 
along the WWOX gene resulted in the formation of R-loops and led to genomic instability
271
. 
Therefore, whether or not a similar phenomenon occurs in the Setx
-/-
 mouse model was investigated. 
FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1
277
; hence an 
R-loop forming site (RLFS) prediction on this region was performed based on the algorithm used 
by Wongsurawat et al. 2012
278
 (Fig 5.5A). A DRIP assay (described in section 2.2) was 
subsequently performed from the testes, brain and cerebellum of WT and Setx
-/-
 mice followed by 
PCR analysis along the predicted RLFS. A similar background level in the WT and Setx
-/-
 brain and 
cerebellum was observed but there was a significantly higher level of R-loop formation in this 
region in the Setx
-/-
 testes as compared to WT (Fig 5.5B).  
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Figure 5.5. Increased R-loop formation at Fra8E1 in testes of Setx
-/-
 mice. A. Predicted RLFS 
denoted in blue (sense) and pink (antisense) bars. Regions on the sense strand were selected for 
DRIP-PCR analysis and are indicated in red boxes. B. Graph shows the DRIP quantitation of 
various tissues taken from WT and Setx
-/-
 mouse. Similar background levels of R-loops were 
observed in brain and cerebellum, with a significant increase observed in the testes of Setx
-/-
 mice. 
 
These data are comparable to those presented in Section 5.2 for the HS44.2 locus and the X 
chromosome FOXO4 gene, where increased levels of R-loops were observed only in the testes. 
These data further support that hypothesis that both ongoing transcription and replication are 
necessary and that the collision between replication and transcription causes R-loop formation and 
can lead to genomic instability. 
 
Spermatocytes from male Setx
-/-
 mice show an accumulation of R-loops at the pachytene stage of 
meiosis and the failure of meiotic sex chromosome inactivation (MSCI) during spermatogenesis, 
which could contribute to the male sterility observed in Setx
-/-
 mice. It was also shown in Chapter 3, 
via RT-PCR, that X- and Y-linked genes were being transcribed in the testes of Setx
-/-
 mice instead 
of being repressed as in MSCI. Aberrant gene expression could be due to the lack of methylation 
along these genes as reported by Ginno et al. 2012, where it was shown that the methylation of CpG 
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island promoters was hampered by the formation of R-loops along these GC-rich regions
170
. Hence, 
R-loop accumulation along X- and Y-linked genes in Setx
-/-
 spermatocytes was examined. Two XY 
genes that were found to be highly expressed in Setx
-/-
 mouse testes (see Chapter 2), Ube1y and 
Tktl1, were selected for the DRIP analysis. In addition to the R-loop prediction described by 
Wongsurawat et al. 2012, RLFSs in these genes were also predicted using an online bioinformatics 
tool, QuadFinder (http://miracle.igib.res.in/quadfinder/), which predicts likely regions of R-loop 
formation based on G-quadruplexes-forming sequences. G-quadruplexes are non-canonical four-
stranded nucleic acid structures formed by G-rich sequences. Although their physiological roles 
remain unclear, they have been implicated in transcription regulation and translation among other 
functions
279,280
. A region on each of the sense strands of Ube1y1 and Tktl1were selected for the 
DRIP analysis (Fig 5.6).  
 
 
Fig 5.6: R-loop formation sites predicted by QuadFinder on the mouse XY genes Ube1y and 
Tktl1. Predicted R-loops formation sites are indicated with a green (sense, positive strand) bar and a 
purple (antisense, negative strand) bar. Regions on the sense strand were selected for DRIP-PCR 
analysis and are indicated in red boxes. 
 
Subsequent PCR (primers described in Appendix B) performed for predicted RLFSs in both 
Ube1y1 and Tktl1 on mouse testes after the DRIP assay showed a significant increase in R-loop 
accumulation in Setx
-/-
 as compared to WT (Fig 5.7). RNase H (RH) treatment prior to the DRIP 
assay was also performed as a quality control for the S9.6 (R-loops antibody) used in the assay. As 
expected, RH pre-treatment dramatically reduced the amount of DNA/RNA hybrids pulled down in 
the DRIP assay confirming the specificity of the R-loops antibody. These data showed that the 
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formation of R-loops can occur on the XY chromosomes which may also contribute to the defects 
in MSCI observed in Setx
-/-
 mice. 
 
 
Fig 5.7: PCR amplification of predicted R-loop formation sites from DRIP assay performed 
on Setx
-/-
 mouse testes. (A) Amplification of the RLFS region of Ube1y1 (B) Amplification of the 
RLFS region of Tktl1. DRIP signal quantitation was performed using the ImageJ software 
(Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2014) and normalized against the input. Gapdh was used as an 
additional loading control. RH, RNase H. 
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5.4 Discussion 
 
Sen1, the yeast homolog of senataxin, restricts co-transcriptionally formed R-loops which 
accumulate in sen1 mutant in a transcription-dependent manner
76
. Furthermore, Mischo et al. 2011 
observed a genetic interaction between sen1 and various factors involved in HR such as rad50, 
mre11, sgs1 and rad52 and concluded that sen1 plays a pivotal role in preventing genomic 
instability by transcription-mediated recombination
76
. More recently, Skourti-Stathaki et al (2011) 
provided evidence that senataxin, like sen1, resolves DNA/RNA hybrid structures known as R-
loops, which form naturally at transcriptional pause sites to ensure effective transcription initiation 
and/or termination. This Chapter has described the in vivo accumulation of R-loops in Setx
-/-
 mouse 
seminiferous tubules and in pachytene-stage spermatocytes, supporting a role for senataxin in 
resolving such structures during meiosis. Furthermore, co-localization between R-loops and 
TUNEL staining in Setx
-/-
 mouse germ cells indicates that accumulation of these structures may 
contribute to cell death and the sterility phenotype observed in Setx
-/-
 male mice. It is possible that 
the phenotype observed results from a combination of different factors including but not limited to 
R-loop formation. An experiment that would provide stronger evidence for the causal role of R-loop 
accumulation in sterility/cell death would be to overexpress RNase H1, which digests R-loops, in 
germ cells of Setx
-/-
 animals to rescue the phenotype, however such an experiment is not currently 
feasible in vivo. 
 
Following its transcription from DNA, RNA undergoes a series of complex processing events that 
can affect its stability and function, and a deregulation in any of these processes can compromise 
genomic integrity. An accumulation of R-loops can cause problems in transcription regulation. 
Efficient transcription initiation and termination depends on the resolution of R-loops, which are 
potentially harmful if left unresolved, as they can stall transcription and/or cause DNA breaks
74,150
. 
Gene expression can also be affected as R-loops have been shown to prevent the methylation of 
CpG island promoters
170,172
. Transcriptional R-loop formation in eukaryotes is also highly 
correlated with DNA recombination and is capable of inducing hyper-recombination
160,281
, leading 
to mutations and genomic instability. R-loop accumulation can also cause DNA damage by 
impeding transcription elongation and termination
74,160,282
, in turn resulting in cell death (Fig 5.8). 
Thus, R-loop formation can be an intrinsic threat to genomic integrity throughout evolution and 
species have evolved a variety of co-transcriptional processes to prevent the formation of these 
structures 
159
.  
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Fig 5.8: Problems that can arise from R-loop accumulation. Flowchart shows the different ways 
in which R-loop accumulation can affect genomic instability and cause cell death. 
 
Senataxin represents a novel factor that minimizes the impact of R-loops that arise as part of normal 
transcription processes
73
 and/or DNA-damage-induced transcription stalling
282
. In the case of Setx
-/-
 
spermatocytes, accumulation of R-loops occur throughout leptotene and zygotene which are the 
stages where DNA DSBs are being repaired by crossing over and/or other mechanisms. R-loop 
staining was observed on autosomes at all stages and persisted up to pachytene stage indicating a 
widespread genomic distribution.  Consequently, it is likely that R-loops may form in the vicinity of 
meiotic recombination hotspots and collide with Holliday Junctions, thus interfering with the 
resolution of DNA DSBs and in turn, meiotic recombination. This Chapter has provided evidence of 
R-loop formation at a recombination hotspot, the H44.2 locus located on chromosome 19
283
. 
Additionally, the accumulation of R-loops throughout the chromatin would also affect the repair of 
DNA DSBs that are repaired through non-crossover mechanisms. The accumulation of R-loops 
observed in Setx
-/-
 germ cell further supports their role as a trigger of genome instability. 
Furthermore, an increase in the formation of R-loops at the loci of two XY genes (Ube1y1 and 
Tktl1) found to be abnormally expressed in Setx
-/-
 mouse testes, was reported here. In addition, the 
formation of R-loops in GC-rich promoter regions have previously been shown to prevent the 
methylation of CpG islands and disrupt transcriptional repression
171
, thus the formation of R-loops 
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on the XY chromosomes may affect the methylation status of XY genes promoter regions and 
hinder their silencing, thereby contributing to the defective MSCI observed in Setx
-/-
 spermatocytes. 
 
Interestingly, accumulation of R-loops was neither detected in the brain nor cerebellum of Setx
-/- 
mice and other ARCA models, indicating that R-loop formation preferentially occur in 
transcriptionally active replicating cells. Indeed, increased R-loop formation was also detected in 
spleen and intestine, in addition to the testes, which are all highly proliferative tissues. Using DRIP 
analysis, a more sensitive assay to detect R-loop formation, a similar background level of R-loops 
in nervous tissues of Setx
+/+ 
and Setx
-/- 
mice was observed and this confirmed the significant 
accumulation of R-loops in Setx
-/-
 testes. This hypothesis was supported by showing that R-loop 
accumulation was present only in highly proliferative tissue of mice treated with the DNA-
damaging agent, topotecan hydrochloride, and not in post-mitotic tissues. It was also shown that 
cells treated with DNA damaging agents such a camptothecin, a DNA Topoisomerase I inhibitor, 
led to the formation of R-loops mostly visible in the nucleolus indicating that R-loops formation 
preferentially occur at highly transcribed genes, such as rDNA. This is in agreement with the 
nucleolar localization of DNA Topoisomerase I and the presence of GC-rich regions on the rDNA 
which are pre-requisite for R-loop formation
265
.  
 
The difference observed between the detection of R-loops using immunostaining and DRIP 
highlighted a difference in sensitivity for both assays with a greater sensitivity for the DRIP. 
However, with greater sensitivity, a greater background was also observed (as seen in levels of R-
loops in Setx
+/+
 and Setx
-/-
 brain and cerebellum) which dramatically reduced the signal/noise ratio. 
Although immunostaining for R-loops is a less sensitive assay, it provides a quicker and better 
discrimination and thus may represent a valuable tool for screening samples for potential 
transcription deregulation and/or genomic instability. 
 
The formation of R-loops at the fragile site of a long gene, WWOX, where replication forks tend to 
stall frequently given the length of the gene, was also shown. These data are in agreement with a 
role for senataxin in resolving R-loop structures and that replication is necessary for the formation 
of these structures. 
 
Given that R-loops require the concomitant activities of both replication and transcription, the lack 
of R-loops in the nervous tissue may not be surprising since these are post-mitotic cells devoid of 
replication activity. In this Chapter, strong evidence has been provided for the lack of R-loop 
formation in TPT-treated of untreated Setx
-/-
 post-mitotic nervous tissues, which prompts the 
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question as to whether R-loop accumulation may actually be involved in the neuropathology of 
human AOA2 patients. Given the lack of nervous tissue sample availability for AOA2 patients and 
based on our findings, R-loops may not be the cause of the neurodegenerative phenotype observed 
in AOA2 patients. These findings point to the current limitations to decipher the neuropathology of 
AOA2 and indicate the necessity to develop a more relevant human neuronal model system. 
 
The absence of a neurodegenerative phenotype in Setx
-/- 
mice suggest that either (i) the mouse 
nervous system does not mimic the human nervous system due to significant evolutionary structural 
and functional differences, (ii) existing redundant pathways help resolve R-loop structures in the 
mouse nervous system, or (iii) that there is an alternative function for senataxin in the nervous 
tissue of these mice. There exists a plethora of R-loop resolving mechanisms that include the RNase 
H enzyme and other DNA/RNA helicases
284
,
285
. Senataxin has previously been shown to be 
involved in RNA metabolism and splice site selection
71
 therefore, it may be that abnormal splice 
site selection and/or transcriptional read-through of genes giving rise to abnormal transcripts is 
occurring instead, which would be reflected at the transcriptome level. Indeed, a recent study by 
Fogel et al. 2014 identified an AOA2-specific transcriptional signature
286
. Weighted gene co-
expression network analysis (WGCNA) identified two gene modules highly enriched for this 
transcriptional signature that were disease-specific and preserved in patient peripheral blood, patient 
fibroblasts and in the cerebellum of Setx
-/-
 mice, demonstrating conservation across species and cell 
types, including neurons. This study identified novel genes and cellular pathways related to 
senataxin function in normal and disease states, and implicate alterations in gene expression as 
underlying the phenotypic differences between AOA2 and ALS4, which is the autosomal dominant 
form of the disorder caused by mutant senataxin
286
.  
 
Further investigation of the role of senataxin in RNA metabolism and gene regulation in the 
nervous tissues of Setx
-/- 
mice
 
is currently under way as part of a collaboration with Dr Brent Fogel 
(UCLA, USA) through the in-depth analysis of the Setx
-/- 
transcriptome via RNA-seq on RNA 
isolated from nervous tissues, to study the nature of the transcripts and alternative splice variants. 
 
Altogether, these findings reveal a complex and coordinated network between transcription, DNA 
replication and repair pathways, thus supporting the emerging importance of RNA processing 
factors, such as senataxin, in the DNA damage response. Furthermore, they also highlight a more 
prominent role than previously suspected for RNA secondary structures such as R-loops in 
contributing to genomic instability and tissue degeneration. 
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CHAPTER 6: General Discussion & Future Directions 
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6.1 General discussion 
 
Autosomal recessive cerebellar ataxias (ARCA) are a class of neurodegenerative disorders that 
result from cerebellar atrophy and spinal cord dysfunction
1,4
. Ataxia oculomotor apraxia type II 
(AOA2) is one such ARCA and is characterized by cerebellar atrophy, oculomotor apraxia and 
axonal neuropathy with an onset during the 2
nd
 decade of life
67,69,190
. The gene mutated in AOA2 is 
SETX, which encodes for a 2,677 amino-acid protein called senataxin
60
. Senataxin is a putative 
DNA/RNA helicase that is involved in the protection against oxidative DNA damage and in 
transcription regulation such as mRNA splicing and DNA:RNA (R-loop) resolution
63,71,73
.  
 
This work reports the characterization of the first Setx
-/-
 mouse model which revealed male sterility 
due to a disruption of spermatogenesis. Setx
-/-
 mice unfortunately do not recapitulate the 
neuropathology seen in human AOA2 patients that include clinical hallmarks such as cerebellar 
atrophy, gait ataxia and loss of Purkinje cells in the cerebellum
61,69,184
. The absence of a 
neurological phenotype in ARCA mouse models is not uncommon, and it has been observed for 
several other models including those of Atm, Aptx, and Tdp1
20,59
. This raises the question as to 
whether the Mus musculus is an appropriate model to mimic neurodegenerative disorders in humans 
such as ARCAs. Rat models on the other hand, have been shown to mimic human disease more 
accurately, and these diseases include diabetes, cardiovascular disorders and neurological 
conditions such as Parkinson’s’287. It has also been reported that rat models are phylogenetically 
and physiologically more similar to humans, and have become the standardized toxicological model 
of choice, especially in the pharmaceutical industry
287,288
. 
 
Another parameter that is important to consider is that the onset of AOA2 is during the second 
decade of life. The difference in the life span of humans and mice may also affect the development 
of the progressive neurological phenotype. The progressive onset of neurodegeneration suggests 
that it results from a temporal accumulation of various lesions (e.g. DNA lesions) over time as in 
most cases the symptoms worsen as the patients’ age.  Indeed, evidence of accumulated DNA 
damage in the nervous system has been observed in human patients and may thus account for the 
neurological phenotype. However, an accumulation of DNA damage was not observed in both 
young and old-aged Setx
-/-
 mice, in agreement with the lack of neurological phenotype in these 
animals. 
 
Although, no neurodegenerative phenotype was observed in the Setx
-/-
 animals, this model has 
provided valuable mechanistic insights into the role of senataxin in DNA damage repair (DDR) and 
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transcription regulation. Indeed, many proteins involved in DDR have also been found to be 
essential for meiosis where sterility due to a disruption in various stages of meiosis is a fairly 
common phenotype observed in several other DDR mouse models such as the Atm
-/-
, Brca1
Δ11/Δ11
 
and the Mlh1
-/-
 mice
20,204,242,289
. We have shown that senataxin is essential for male germ cell 
maturation during spermatogenesis, acting during meiosis prophase I to ensure efficient meiotic 
recombination and meiotic sex chromosome inactivation (MSCI). The absence of senataxin results 
in an increase of unrepaired DNA breaks at pachytene stage which in turn prevents meiotic 
recombination and the exchange of genetic material between sister chromatids. Senataxin also 
localizes to the XY chromosomes during the pachytene stage, suggesting a potential role for 
senataxin during MSCI. Comparative analysis of the MSCI process between Setx
+/+
 and Setx
-/-
 
implicate senataxin as a novel, indispensable player in the silencing of XY chromosomes through 
the Atr signaling pathway. Atr and its downstream phosphorylation target, Chk1 are activated 
during DNA replication stress which can lead to the formation of ssDNA regions. These ssDNA are 
promptly coated by Rpa which then recruits Atr through Atrip. The formation of this complex, in 
addition to the SUMOylation of Atrip, subsequently drives the activation or phosphorylation of 
Chk1 and other downstream signalling partners that are crucial for coordinating cellular responses 
to DNA damage
221,290
. The lack of diffusion of these key DDR proteins to the XY chromatin 
domain and a defect in the Atr/Chk1 signaling pathway were observed in Setx
-/-
 mice, which may 
have contributed to aberrant X- and Y-linked gene expression. 
 
The abnormal chromatin topology observed in Setx
-/-
 spermatocytes could be due to the lack of an 
interaction with Chd4, a member of the nucleosome remodeling histone deacetylase (NuRD) 
complex, in the absence of senataxin. An interaction between senataxin and Chd4 via co-
immunoprecipitation in somatic cells was recently reported
233
. Indeed, senataxin was found to 
interact in vivo with Chd4 via PLA over the XY chromosomes in Setx
+/+
 spermatocytes and 
appeared to be necessary for its recruitment to the XY chromosomes, supporting a role for senataxin 
in heterochromatin formation. In addition, given that Atr has been reported to interact with Chd4, it 
could be that the compounding effects from the defect in Atr signaling as well as the lack of 
interaction between Chd4 and senataxin led to the defect in MSCI observed in the Setx
-/-
 mouse. 
Interestingly, Chd4 conditional knockout in rodents was reported to cause defects in the 
synaptogenesis of granule neuron parallel fiber/Purkinje cells and neurotransmission in the 
cerebellar cortex of these animals due to the NuRD-dependent promoter decommissioning
291
. These 
findings implicate the NuRD-dependent developmentally regulated mechanism in post-mitotic 
neurons as a driver of synaptic connectivity. While an in vivo interaction between senataxin and 
Chd4 has been reported here in the context of male meiosis, it remains unclear whether a functional 
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interaction is also taking place in the human nervous system that may account for the 
neurodegenerative cerebellar atrophy and Purkinje cell loss observed in AOA2 patients. To date, 
most studies on AOA2 have relied on proliferating patient-derived cells lines such as B-
lymphoblastoid cells (LCLs) or fibroblasts
63,71
. In order to investigate the functional significance of 
the senataxin-Chd4 interaction in developmental gene expression regulation in the pathophysiology 
of AOA2, an appropriate human neural human system must be developed.  Two such models could 
include patient-derived induced pluripotent stem cell (iPSC) models or patient-derived olfactory 
neural stem cell (ONSC) models, as reported for the ARCA, ataxia-telangiectasia (A-T)
292,293
. Both 
iPSC and ONSC have the capacity to differentiate into functional neurons which can then provide 
ideal models to delineate the neurological defect in AOA2 patients
292,293
. 
 
Despite the fact that the Setx
-/-
 mouse model did not recapitulate the AOA2 neurodegenerative 
phenotype, they provided evidence for genome-wide differential gene regulation in Setx
-/-
 and for a 
conserved AOA2-disease transcriptional signature
286
. There is increasing evidence linking the 
epigenetic machinery and chromatin modifications with neurologic dysfunction
294
. Indeed, 
chromatin-modifying drugs have emerged as potential therapeutic tools for neurodegeneration 
caused by a CAG-repeat expansion in ATXN7, a gene encoding ataxin-7, an essential component of 
the SPT3-TAF9-ADA-GCN5 (STAGA) acetyltransferase chromatin remodelling complex
295
. 
Recently, Duncan et al. 2013 have reported that histone deacetylase 3 (HDAC3) physically interacts 
with and stabilizes ataxin-7, in turn increasing modification of the protein
296
. Robust HDAC3 
expression in neurons and glia of the cerebellum and an increase in the levels of HDAC3 were 
observed in SCA7 mice
296
. Altered lysine acetylation levels and deacetylase activity in the brains of 
SCA7 transgenic mice indicate that SCA7 that may be treated by HDAC inhibitors. Additional 
evidence for the importance of histone acetylation in neurological disorders comes from the 
dysregulation of histone 4 lysine 16 (H4K16) acetylation in the mouse brain which has been linked 
to aging phenotypes and DDR deficiency
297,298
. One, two, or three- methyl groups can be added to 
or removed from lysine residues and differences in these processes can affect chromatin structure 
and gene expression
299
. Down-regulation of genes due to alterations in epigenetics lead to cognitive 
deficiencies associated with a range of neurological disorders such as Alzheimer’s disease, 
Huntington’s disease, Rett’s syndrome and other psychiatric disorders294. Thus it is possible that in 
AOA2, the absence of senataxin, which normally interacts with Chd4, may affect the NuRD 
complex distribution and/or activity, in turn leading to genome-wide alteration of chromatin 
modification. Given the high levels of transcription that occurs in neurons, this can consequently 
result in aberrant gene expression and subsequent neuronal cell death.  
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The Setx
-/-
 mouse model also provided the first in vivo evidence of R-loop accumulation in germ 
cells in the absence of senataxin. Although R-loop formation occurs naturally during transcription 
through the interaction of nascent RNA and the DNA strand from which is was transcribed from, its 
accumulation can cause the stalling of transcription, abnormal gene expression, aberrant 
splicing/termination of transcription, genomic instability and the subsequent collapse of the 
cell
74,150,159,164
. Our preliminary findings suggest that R-loops provide a novel level of DNA-RNA 
interactome complexity, playing key roles in gene expression controls, mutagenesis, recombination, 
chromosomal rearrangement, alternative splicing, DNA-editing and epigenetic modifications. An 
accumulation of R-loops was observed to be a common feature in several ARCA (Atm
-/-
, Aptx
-/-
, 
Setx
-/-
, Tdp1
-/-
) mouse models, although only Atm
-/-
 and Setx
-/-
 mice are sterile. While there are other 
elements contributing to the sterility observed in Atm
-/-
 and Setx
-/-
 mice such as defective DDR and 
meiotic recombination, the extent of R-loop accumulation in the seminiferous tubules in these 
mouse models is also likely to contribute to the difference between fertility and sterility observed in 
these models. These data also suggest that there may also be a threshold of R-loop accumulation in 
germ cells which when reached leads to apoptosis induction, loss of germ cells and consequently 
sterility. Indeed, the accumulation of R-loops can trigger genomic instability and altered gene 
expression and changes in chromatin condensation
74,150,164
, which are all very tightly regulated 
during spermatogenesis. Any adverse changes in these processes may then present a threat to the 
proper development and maturation of germ cells.  
 
The formation and accumulation of R-loops depend on several parameters, these include (i) the 
primary DNA sequence which can affect their location within the genome, (ii) the levels of 
transcription in the loci where R-loops can form, (iii) their frequency of occurrence within the 
genome with their effect on gene expression and (iv) transcription termination. In germ cells for 
instance, accumulation of R-loops may affect regions where Spo11-programmed DNA DSBs occur 
as well as at meiotic recombination hot spots, thus potentially impairing the meiotic recombination 
process and in turn the formation of crossing overs. The defect in meiotic recombination observed 
in Setx
-/-
 mice supports this argument and evidence in this Report has shown an accumulation of R-
loops in the recombination hotspot 44.2 on chromosome 19.  Additionally, R-loops may also affect 
regions containing genes important for spermatogenesis or contribute to the induction of DNA 
breaks. Using in silico R-loop formation site (RLFS) prediction programs and candidate gene 
approaches in combination with DNA/RNA immunoprecipitation (DRIP) assays, the presence of R-
loops has indeed been demonstrated on the autosomes at common fragile sites of long genes, 
recombination hotspots and in XY genes of Setx
-/- 
spermatocytes. 
 
 123 
 
In order investigate whether a neurological phenotype in these ARCA models can be induced by an 
increased accumulation of DNA damage, cross breeding of several models (Atm x Setx, Setx x Tdp1, 
Setx x Aptx) to generate double knockouts were carried out. Preliminary data showed that Atm
 
and 
Setx double knockouts were very rare events, occurring only at a very low frequency of ~1/250 live 
births, these mice die quickly as well. Only a couple of Atm
-/-
 Setx
-/-
 mice have been obtained and 
these have not shown any signs of neurodegeneration or abnormal neurological behavior either.  
The very low frequency of these double knockout mice suggests that many may die in utero.  From 
the few Atm
 
and Setx double knockout mice that survived, infertility due to defects in 
spermatogenesis was observed as well. For Tdp1 Setx double knockouts, similar observations were 
made. These double knockouts also occurred at a very low frequency of ~1/150 and no signs of 
neurodegeneration or abnormal neurological behavior were observed.  Similarly, histological 
analyses of testes sections from these mice revealed male sterility, indicating that the Setx
-/-
 
phenotype exerts dominance over the Tdp1
-/-
 phenotype. 
 
Camptothecin and its water-soluble analogue topotecan hydrochloride, are DNA Topoisomerase I 
inhibitors that are potent DNA damaging and transcription-blocking agents. These chemicals are 
also capable of inducing the formation of R-loops in cellular models
269,300
. Given R-loop 
accumulation was detected in the testes of ARCA mouse models, topotecan hydrochloride was 
administered to artificially increase R-loop formation in these models. It was observed that R-loop 
accumulation only occurred in proliferating tissues of the spleen, testes and intestines, and not in 
post-mitotic tissues of the nervous system such as the brain and cerebellum. These data are in 
agreement with previous reports of R-loop formation occurring preferentially under both the 
concomitant activities of replication and transcription
151,233,284
. The lack of R-loop accumulation in 
these post-mitotic tissues could also be due to a redundancy in R-loop resolution mechanisms that 
may exist in the nervous tissues of mice. Indeed, several pathways have evolved to resolve R-loops 
that include RNase H, DHX9 RNA helicase, NPH-II helicase, and splicing factor ASF-SF2
168,301
. 
Whether or not these are highly active in the nervous system of mice remains unclear. Furthermore, 
R-loops may not readily form in post-mitotic tissues due the lack of concomitant transcription and 
replication activities. Determining whether R-loops form and/or accumulate in the cerebellum of 
AOA2 patients and contribute to the loss of Purkinje cells will require the availability of human 
AOA2 cerebellar biopsies, which to date have not been available. 
 
In conclusion, the formation of R-loops in proliferative cells may result from the collision of the 
transcription apparatus with the replication machinery, with stalled replication forks and/or Holliday 
junctions that form during DNA damage repair. Once these accumulate due to the absence of 
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senataxin, they are likely to contribute to aberrant gene expression, mRNA splicing, abnormal 
transcriptional read-through, and formation of DNA breaks, thus leading to genomic instability and 
cell death. On the other hand, in non-replicative, post-mitotic highly-transcribed cells such as those 
from the nervous tissues of the brain and cerebellum, the absence of senataxin may affect splice site 
selection, transcriptional read-through and/or gene expression through chromatin modification and 
the binding of the transcription machinery. These may then contribute to the neuronal degeneration 
observed in AOA2/ALS4 patients. A model summarizing the findings of this work and the 
proposed role for senataxin in the neuropathology of AOA2 is shown in Figure 6.1. 
 
 
Fig 6.1: Senataxin in proliferating and post-mitotic cells. A. In proliferating cells, the absence of 
senataxin can cause R-loop formation through the collision of the transcription machinery with 
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replication, stalled replication forks and Holliday junctions, leading to aberrant gene expression and 
mRNA splicing, transcriptional read-through and DNA damage, resulting in genomic instability and 
cellular collapse. B. In non-proliferating, post-mitotic cells, it is hypothesized that the absence of 
senataxin may cause defects in transcription termination and splice site selection, leading to 
aberrant gene expression and subsequent genomic instability and cell death. Image taken from Lavin 
et al 2013. 
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6.2 Future directions 
 
Given that several roles for senataxin in transcription regulation have been described here, future 
work should aim to further dissect the mechanistic role of senataxin in germ cell development and 
chromatin remodeling. Future experiments will include: 
 
1) The investigation of senataxin as a DNA/RNA helicase. 
 
Senataxin is a putative DNA/RNA helicase that has a predicted C-terminal domain 
belonging to the superfamily I of helicases
68
. These helicases are motor proteins that are 
driven by ATP hydrolysis, translocating along and unwinding both DNA and RNA strands. 
The formation of single-stranded intermediates from the unwinding of these nucleic acids is 
essential for several aspects of cellular metabolism such as replication, repair and 
recombination
68,185
. To date, no direct evidence for senataxin’s helicase activity has yet been 
reported. Given that senataxin was recently shown to be required for the resolution of R-
loops
73,233,302
, it may be worthwhile investigating whether its helicase domain is responsible 
for the unwinding of these R-loops. This can be performed by a classical helicase assay that 
entails the addition of purified senataxin protein to radiolabeled RNA oligonucleotide 
annealed to a ssDNA template
303
. 
 
2) Gene expression profiling of Setx+/+ and Setx-/- testes. 
 
Recent gene expression profiling via RNA-Seq and microarray performed on senataxin-
defective (both AOA2 and ALS4) fibroblasts as well as on brain and cerebellar tissue from 
Setx
+/+
 and Setx
-/-
 mice revealed the altered expression of several genes implicated in 
neurogenesis
286
. Using the weighted gene co-expression network analysis (WGCNA), the 
associations of several networks with the clinical symptoms of AOA2 and ALS4 patients 
were also revealed
286
. These findings are essential in gaining a better understanding of the 
mechanism behind the neurodegeneration observed in AOA2/ALS4 patients. Using similar 
approaches, initial gene expression profiling is currently being performed on the testes of 
Setx
+/+
 and Setx
-/-
 mice to further identify the genes involved in meiotic recombination and 
XY silencing that are affected in the absence of senataxin. 
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3) The functional characterization of the Setx-Chd4 interaction. 
 
Chd4 is a component of the nucleosome remodeling and deacetylation (NuRD) complex that 
is associated with heterochromatin formation and gene silencing. Given its in situ interaction 
with senataxin over the XY chromosomes as shown in this Report, it would be worthwhile 
to examine the histone acetylation status of the XY chromosomes. Several other markers 
associated with histone acetylation include H3K9 and H4K12, and this can be investigated 
using antibodies against these histone marks on spermatocytes spreads made from Setx
+/+
 
and Setx
-/-
 mice. In addition, given the observation of the SUMOylation of senataxin in 
addition to the recent report of the SUMOylation of Chd4
259
, it would be interesting to map 
these interaction sites and determine whether this interaction is dependent on SUMO 
modification. 
 
4) The investigation of the association between Nek1 and Atrip in Atr/Chk1 signaling 
 
A relationship between Nek1 and Atrip was recently reported by Liu et al. 2013. They 
showed that Nek1 was essential for the stabilization of Atrip and that the association 
between these two proteins was required for the amplification of Atr/Chk1 signaling 
following DNA damage
229
. In this Report, significantly reduced levels of Atrip protein was 
observed in Setx
-/-
 spermatocytes. This was coupled with reduced levels and mis-localization 
of Nek1, suggesting that senataxin may be important for the expression, stability as well as 
recruitment of Nek1. A deregulation in the association of Nek1 and Atrip in the absence of 
senataxin may be responsible for the defect in Atr/Chk1 signaling that was observed in Setx
-
/-
 spermatocytes. Further examination is needed to investigate this phenomenon. 
 
5) Genome-wide mapping of R-loop forming sites and histone modifications 
 
Identifying sites of R-loop formation within a genome can potentially lead to the uncovering 
of novel target sites for drug therapy. It was recently reported by Skourti-Stathaki et al. 2014 
that the formation of R-loops could induce marks of chromatin repression, more specifically 
H3K9me2, at sites of protein-coding gene termination regions
304
. They proposed that the 
formation of these R-loop structures was required for the stalling of RNA Polymerase II, 
thereby allowing for the efficient termination of transcription
304
. Interestingly, preliminary 
data from immunostaining using an antibody against H3K9me2 in Setx spermatocytes 
revealed higher levels of this histone modification in Setx
-/-
 as compared to Setx
+/+
, in 
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agreement with the report by Skourti-Stathaki et al. 2014. Given the increased accumulation 
of R-loops coupled with abnormal heterochromatin formation observed in the spermatocytes 
of Setx
-/-
 mice, the extending and refining of these sites to recombination hot spots, fragile 
sites, and/or genes involved in meiosis and DNA damage repair will be performed using 
chromatin immunoprecipitation (ChIP) assays against H3K4me1 or H3K9me2 and S9.6 (R-
loop antibody) DNA:RNA immunoprecipitation assays (DRIP) from testes of Setx
-/-
 mice 
followed by next generation sequencing (DNA-Seq).  
 
While the Setx
-/-
 mouse model has provided us with valuable insight into the role of senataxin in 
DNA repair and transcription regulation, it does not recapitulate the neurological phenotype that is 
observed in human AOA2 patients. Hence, a more appropriate human neurological model is 
required to better understand the mechanism of neurodegeneration that occurs due to mutant 
senataxin in both in AOA2 and ALS4 patients. AOA2 patient-derived induced pluripotent stem 
cells (iPSC) have been generated and are currently under phenotypic characterization (unpublished 
data).  
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Abstract
Senataxin, mutated in the human genetic disorder ataxia with oculomotor apraxia type 2 (AOA2), plays an important role in
maintaining genome integrity by coordination of transcription, DNA replication, and the DNA damage response. We
demonstrate that senataxin is essential for spermatogenesis and that it functions at two stages in meiosis during crossing-
over in homologous recombination and in meiotic sex chromosome inactivation (MSCI). Disruption of the Setx gene caused
persistence of DNA double-strand breaks, a defect in disassembly of Rad51 filaments, accumulation of DNA:RNA hybrids (R-
loops), and ultimately a failure of crossing-over. Senataxin localised to the XY body in a Brca1-dependent manner, and in its
absence there was incomplete localisation of DNA damage response proteins to the XY chromosomes and ATR was retained
on the axial elements of these chromosomes, failing to diffuse out into chromatin. Furthermore persistence of RNA
polymerase II activity, altered ubH2A distribution, and abnormal XY-linked gene expression in Setx2/2 revealed an essential
role for senataxin in MSCI. These data support key roles for senataxin in coordinating meiotic crossing-over with
transcription and in gene silencing to protect the integrity of the genome.
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Introduction
Ataxia oculomotor apraxia type 2 (AOA2), a severe form of
autosomal recessive cerebellar ataxia (ARCA) is characterised by
progressive cerebellar atrophy and peripheral neuropathy, oculo-
motor apraxia and elevated a-fetoprotein [1,2]. The gene
defective in AOA2, SETX, is also associated with amyotrophic
lateral sclerosis 4 (ALS4), an autosomal dominant juvenile-onset
form of ALS [3]. Senataxin shares extensive homology in its
putative helicase domain with the yeast, Saccharomyces cerevisiae
splicing endonuclease 1 protein (Sen1p) which possesses helicase
activity and is involved in RNA processing, transcription and
transcription-coupled DNA repair [4]. A role for senataxin in
DNA repair is supported by the observation that AOA2 patient
cells display sensitivity to DNA damaging agents such as H2O2,
camptothecin and mitomycin C and have elevated levels of
oxidative DNA damage [5].
Senataxin also plays a role in transcription regulation by its
ability to modulate RNA Polymerase II (Pol II) binding to
chromatin and through its interaction with proteins involved in
transcription [6]. mRNA splicing efficiency, splice site selection,
and transcription termination were all defective in senataxin-
deficient cells [6]. A recent study has described an additional role
for senataxin in transcription elongation and termination [7]. Cells
deficient in senataxin displayed an increase in RNA read-through
and Pol II density downstream of the Poly(A) site and also
exhibited increased levels of R-loops (RNA:DNA hybrids that
form over transcription pause sites) formation [8,9]. The yeast
ortholog of senataxin, Sen1p, has also been shown to protect its
heavily transcribed genome from R-loop-mediated DNA damage
[10]. More recently, a role for senataxin has been described at the
interface between transcription and the DNA damage response
[11]. They revealed that senataxin forms nuclear foci in S/G2
phase cells and these foci increased in response to DNA damage
and impaired DNA replication. These foci disappeared upon
resolution of R-loops or after inhibition of transcription. Evidence
has also been provided for the association of the yeast ortholog of
senataxin, Sen1, with DNA replication forks across RNA
polymerase II transcribed genes [12]. These data demonstrate a
co-ordinating role for Sen1 between replication and transcription.
We generated a Setx knockout mouse model to investigate
further the role of senataxin. Our data revealed that this protein is
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essential for male meiosis, acting at the interface of transcription
and meiotic recombination, and also in the process of meiotic sex
chromosome inactivation (MSCI).
Results
Disruption of the mouse Setx gene
Setx2/2 mice were produced using a Cre-LoxP system to delete
exon 4 as outlined in Figure 1A. Crosses between Setx heterozy-
gotes produced all 3 genotypes (Wild type, heterozygotes and
homozygote knockouts) as expected (Figure 1B) and a Mendelian
inheritance pattern was observed (Wild type 25%; heterozygote
54%; knockout 21%; n= 87). Inactivation of the Setx gene was
confirmed by RT-PCR and the absence of Setx mRNA in the
knockout mouse as compared to the wild type (Figure 1C).
Immunoprecipitation (IP) with anti-senataxin antibodies from
testes extracts confirmed the presence of the protein in Setx+/+ mice
but senataxin was not immunoprecipitated from Setx2/2 extracts
(Figure 1D). While progressive cerebellar degeneration is charac-
teristic of senataxin-defective AOA2 patients [1,2] we failed to
detect either structural alterations, general cerebellar degenera-
tion, or specific loss of Purkinje cells in Setx2/2 mice (data not
shown). Using a simple phenotypic scoring system that has been
employed to evaluate mouse models of cerebellar ataxia [13], we
failed to reveal any significant neurological/behavioural difference
and ataxia between Setx+/+ and Setx2/2 animals (Figure S1).
Senataxin is essential for germ cell development and
fertility
Multiple attempts to breed Setx2/2 mice with each other or with
wild type mice were unsuccessful. Male mutant mice had normal
development of secondary sexual characteristics, and were capable
of the mechanics of mating, but were infertile. Histological
examination of Setx2/2 female ovaries at various ages (from 35
days to 8 months of age) revealed no overt phenotypic difference
from their wild type littermates, with normal structure and
presence of follicles at all stages and an ability to ovulate (Figure
S2). However, the yield of viable embryos at 0.5 dpc was very low
suggesting that Setx2/2 females are less fertile than their wild type
littermates. The fertility of an individual female is a reflection of
the number of eggs ovulated and their competence. To investigate
the fertility of Setx2/2 female mice, we carried out superovulation
and time mating to harvest one-cell stage (0.5 dpc, fertilised egg)
embryos in order to compare their viability. A greater than 3.5-
fold reduction in the yield of 0.5 dpc for Setx2/2 was observed
compared to wildtype animals (10–20 0.5 dpc embryos for Setx2/2
compared to 50–70 for wild types). In addition, only 23% of viable
embryos were obtained at 0.5 dpc for Setx2/2 and most of the
viable ones did not survive in culture, indicating that Setx2/2
females have a reduced fertility.
Since oligospermia and testicular abnormalities are a frequent
finding of ARCA patients and the corresponding mouse models
[14,15], we compared the development of testes and seminiferous
tubules from Setx2/2 with those from wild type mice. Setx2/2
testes were smaller in size (50–60% reduction in size) than wild-
type littermates (Figure 2A) and histological examination of testes
from 35 day-old Setx2/2 males revealed a severe disruption of the
seminiferous tubules and the absence of germ cells compared to
Setx+/+ males (Figure 2B–2G). Morphologically, spermatocytes in
Setx2/2 mice appear to have halted development at pachytene
stage of meiotic prophase (Figure 2E), suggesting that meiotic
arrest in Setx2/2 mice occurs during prophase I. Overall the
seminiferous epithelium from an 8-month Setx+/2 mouse testis
appears normal but there is evidence of some disruption in places,
with few round or elongated spermatids and debris in the lumen
(Figure S3). Histological examination of the epididymis from
Setx2/2 mice revealed the total absence of mature sperm
(Figure 2F–2G) thus confirming the infertility of Setx2/2 males
mice. Elevated levels of apoptosis were detected in some tubules of
Setx2/2 mice following TUNEL staining (Figure 2H–2I), suggest-
ing that arrested cells are eliminated via this pathway.
To monitor the development of spermatocytes we counted the
number of spermatocytes in all stages of meiotic prophase I
(Figure 2J). Synaptogenesis appeared to be grossly normal in
Setx2/2 mice as determined by staining for synaptonemal complex
protein 3 (SCP3) [16] but while the earlier stages of meiosis were
represented we failed to detect diplotene stage spermatocytes for
Setx2/2, indicating a block at the pachytene-diplotene transition
(Figure 2J). Further analysis of the first meiotic division of
prophase I revealed a significant reduction of pachytene
spermatocytes from day 16 to day 22 in Setx2/2 (Figure 2K) in
line with the lack of diplotene spermatocytes in Setx2/2.
Fragmentation of the synaptomemal complex (SC) at pachytene
stage in Setx2/2 was also observed. To investigate the cause of the
meiotic defect in more detail, we also determined the expression of
spermatogenesis stage-specific markers (Figure S4A) [17,18].
Expression levels of spermatogonial and early spermatocyte
markers Dmc1, Calmegin, and A-myb were similar in both Setx2/2
and Setx+/+. Pgk2, a marker expressed from the beginning (pre-
leptotene) and throughout meiosis (leptotene, zygotene, pachytene,
diplotene) up to the round spermatid stage showed only a small
reduction in expression in Setx2/2 as compared to Setx+/+. Markers
for haploid mature germ cells Prm1, Prm2 and Tnp1 showed
markedly reduced expression in Setx2/2 compared to Setx+/+
(Figure S4B). Together, these data indicate that male germ cells
proceed normally from spermatogonia up to the meiotic
pachytene stage in Setx2/2 but fail to enter into spermiogenesis
and form mature spermatids. Thus, both gene expression of
meiosis stage-specific markers and spermatocyte spread analysis
confirmed the blockage of meiosis in Setx2/2 male germ cells and
indicate that senataxin plays an essential role in the development
and maturation of germ cells.
Author Summary
Ataxia with oculomotor apraxia type 2 (AOA2) caused by a
defect in the gene Setx (coding for senataxin) is part of a
subgroup of autosomal recessive ataxias characterized by
defects in genes responsible for the recognition and/or
repair of damage in DNA. Cells from these patients are
characterized by oxidative stress and are defective in RNA
processing and termination of transcription. Recent data
suggest that senataxin is involved in coordinating events
between DNA replication forks and ongoing transcription.
To further understand the role of senataxin, we disrupted
the Setx gene in mice and demonstrated its essential role
in spermatogenesis during meiotic recombination and in
meiotic sex chromosome inactivation (MSCI). In the
absence of senataxin, DNA double-strand breaks persist,
RNA:DNA hybrids (R-loops) accumulate, and homologous
recombination is disrupted. Senataxin localised to the XY
chromosomes during pachytene. This was dependent on
Brca1, which functions early in MSCI to recruit DNA
damage response proteins to the XY body. In the absence
of senataxin, there was incomplete accumulation of DNA
damage response proteins on the XY chromosomes and
no MDC1-dependent diffusion of ATR to the broader XY
chromatin. The end result was a defect in MSCI, apoptosis,
and a failure to complete meiosis.
Senataxin Is Essential for Spermatogenesis
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DNA DSB persist and meiotic crossing-over is defective in
Setx2/2
Meiotic recombination is initiated by the formation of DNA
double strand breaks (DSB) catalysed by a type II topoisomerase-
like protein Spo11 [19]. These breaks trigger phosphorylation of
histone H2AX at ser139 (cH2AX) on large domains of chromatin
in the vicinity of the break [20]. As meiosis proceeds to the
pachytene stage, cH2AX disappears from synapsed chromosomes
and is restricted to the largely unsynapsed sex chromosomes in the
sex body [21,22]. Successful generation of DNA DSB and
initiation of repair was observed in Setx2/2 (Figure 3A). At
pachytene stage, DSBs disappeared from the autosomes in Setx+/+
mice and only the sex chromosomes stained positive for cH2AX as
expected [23,24]. On the other hand, cH2AX foci remained on
apparently synapsed autosomes at pachytene stage in Setx2/2,
indicating the persistence of unrepaired DSBs. Both Setx2/2 and
Setx+/+ displayed cH2AX staining at the sex chromosomes at
pachytene stage (Figure 3A). Staining of Setx2/2 testes sections for
cH2AX confirmed the greater intensity of labelling (Figure S5).
The repair of meiotic DNA DSB occurs via homologous
recombination (HR) and involves the participation of various
DNA repair factors including RPA, Dmc1 and Rad51 [16]. Both
Rad51 and Dmc1 play key roles in the initial steps of HR by
mediating strand invasion and homologous pairing. These
proteins are normally observed as multiple foci decorating the
chromosomes, first appearing at leptotene and sharply decreasing
at pachytene [25]. This was the case for Rad51 in Setx+/+ with few
foci labelling pachytene chromosomes (Figure 3B). In contrast,
multiple Rad51 foci persisted at pachytene stage in Setx2/2
(Figure 3B, Figure S6A), pointing to a defect in Rad51 filament
disassembly as a consequence of unrepaired DNA DSB and likely
to interfere with HR progression in Setx2/2. Indeed, quantitation
of the number of Rad51 foci at pachytene stage revealed a 6-fold
increase of these foci in Setx2/2 compared to Setx+/+ (Figure 3C).
This was not due to an over expression of Rad51 since comparable
mRNA levels are observed in both types of mice (Figure S7A). In
contrast, immunoblotting of testes protein extracts revealed
reduced levels of Rad51 protein in Setx2/2 testes as compared
to Setx+/+ indicating that the absence of senataxin is affecting the
translation or stability of Rad51 protein (Figure S7B). A similar
abnormal pattern of retention at pachytene stage was found for
Dmc1 with a 10-fold increase in Setx2/2 compared to Setx+/+
Figure 1. Targeted disruption of the mouse Setx gene. A. Diagram of the Setx wild type allele (WT), targeting vector, and mutant alleles (neo+
and KO). Primers used for PCR genotyping (In3F, In3R, LoxPR) and the length of the PCR fragments obtained for WT (In3F and In3R yielding a 600 bp
product) and KO (In3F and LoxpR yielding a 339 bp product) are indicated. E, exon; I, intron. NeoR represents the neomycin cassette, and triangles
the loxP sites. B. Representative image of PCR genotyping using In3F, In3R and LoxPR primers. Wild type (+/+), heterozygotes (+/2) and knockout (2/
2) alleles generate PCR products of 600 bp, 600 bp and 339 bp, and 339 bp, respectively. A negative control for the PCR reaction (2ve) is also
shown. M, 100 bp marker. C. RT-PCR of 35 day-old mice testes samples using primers specific to Setx cDNA indicates the absence of Setx expression in
KO testes. GAPDH was used as an internal standard. D. Immunoprecipitation of senataxin using anti-human senataxin antibodies (Ab-1/Ab-3) from 35
day-old mouse testes extracts confirmed the absence of the protein in the Setx2/2. Immunoprecipitation of senataxin from human lymphoblastoid
cell extracts from normal (C3ABR) and an AOA2 patient (SETX2RM) confirmed the similar size of senataxin in both species. A species-matched non-
specific serum (NSIg) was used as a negative control in for the IP experiments. As expected, no senataxin protein was brought down from Setx+/+
testes following the IP with the non-specific serum (NSIg).
doi:10.1371/journal.pgen.1003435.g001
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Figure 2. Spermatogenesis is disrupted in Setx2/2mice. A. Testes from 35-day-old Setx+/+ and Setx2/2mice. B–C. Hematoxylin and eosin (H&E)-
stained sections of testes from adults. Scale bar, 100 mm. D–E. Enlarged images of regions in (B) and (C). Asterisks in (C) and (E) show vacuolated
seminiferous tubules in which both spermatozoa and spermatids are absent. Scale bar, 100 mm. F–G. H&E sections of epididymis from Setx+/+ and
Setx2/2 adult mice. While there are numerous spermatozoids (Spm) in Setx+/+epididymis, no sperm is present in Setx2/2. Scale bar, 100 mm. H. TUNEL-
stained sections of testes from adult Setx+/+ and Setx2/2 mice. Many TUNEL-positive cells are observed in Setx2/2 testes. Scale bar, 50 mm. (1) and (2)
are magnifications of a seminiferous tubule. I. Increased number of apoptotic tubules in Setx2/2 (Tubules with $8 TUNEL-positive cells per tubule).
Data is plotted as the mean6standard deviation, n = 1330. J. Block of meiosis at pachytene stage in Setx2/2 mice. Meiotic stage distribution
(leptotene, zygotene, pachytene, diplotene) in Setx+/+ and Setx2/2. While a similar number of leptotene, zygotene and pachytene stage
spermatocytes were found in both testes, no diplotene stage spermatocytes were found in Setx2/2 testes indicating a block at pachytene in KO
animals. Data plotted as the mean6standard deviation obtained from 3 mice, 2000 spermatocytes were counted in total for both Setx+/+ and Setx2/2.
K. Severe reduction in the number of pachytene spermatocytes in Setx2/2 compared to Setx+/+ during the first meiotic division. No significant change
in the percentage of pachytene cells was observed in Setx+/+ from day 16 to 22. However, a significant reduction in the percentage of pachytene
spermatocytes was observed at day 22 in Setx2/2 compared to Setx+/+ (Student’s t-test, p,0.01). Data plotted as the mean6standard error, n = 6000.
* indicates p,0.01.
doi:10.1371/journal.pgen.1003435.g002
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Figure 3. Defective meiotic recombination and crossover formation in infertile Setx2/2 males. A. Initiation and repair of programmed
DNA DSB as shown by cH2AX staining of spermatocytes spreads of Setx+/+ and Setx2/2 adult mice. At pachytene, cH2AX staining is restricted to the
XY chromosomes (circle) in Setx+/+ spermatocytes, whereas some cH2AX foci remained on asynapsed autosomes indicating persistence of unrepaired
DSB in Setx2/2. Normal cH2AX staining of the XY chromosomes (circle) was observed in both Setx+/+ and Setx2/2 pachytene stage spermatocytes.
Scale bar, 20 mm. XY, sex chromosomes. B. Persistence of Rad51 foci at pachytene stage in Setx2/2 spermatocytes indicating the presence of
unrepaired DSBs (compare 1 and 2). Scale bar, 20 mm. C. Quantitation of Rad51 foci revealed a 6-fold increase in the number of Rad51 foci at
pachytene stage in Setx2/2 as compared to Setx+/+ (Student’s t-test, n = 50), * indicates p,0.05. D. Formation of chiasmata at pachytene stage in
Setx+/+ spermatocytes as marked by Mlh1 staining. No Mlh1 foci were detected in Setx2/2 pachytene cells indicating that crossovers do not occur in
Senataxin Is Essential for Spermatogenesis
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(Figure S6B–S6C). Similar to Rad51, comparable levels of Dmc1
mRNA levels were observed in both mice (Figure S7C). However,
we were not able to determine the levels of Dmc1 protein in testes.
To assess whether meiotic recombination is completed in
Setx2/2, we examined the distribution of the mismatch repair
protein Mlh1, which normally forms foci and marks the location of
chiasmata [26,27]. We observed an average of 22 Mlh1 foci per
pachytene-stage spermatocyte in Setx+/+ (Figure 3D), where up to
78% of spermatocytes SC contain one Mlh1 focus, 19.2% contain
2 foci, 0.5% contain 3 foci and 2.5% had no foci at all, in
agreement with previous report [28]. In contrast, no foci were
observed in Setx2/2 pachytene-stage spermatocytes (Figure 3D),
indicating the absence of crossovers. The lack of Mlh1 foci in
Setx2/2 spermatocytes was not due to a defective expression of
Mlh1 gene, as similar levels of the Mlh1 mRNAs were detected in
both Setx+/+ and Setx2/2 testes (Figure S7D). In contrast to Rad51,
similar levels of Mlh1 protein in both Setx+/+ and Setx2/2 were
shown by Mlh1 immunoblotting of testes protein extracts (Figure
S7E). These results confirmed an essential role for senataxin in
meiosis.
Lack of senataxin leads to germ cell accumulation of R-
loops and apoptosis
Sen1p, the yeast homolog of senataxin was recently found to
restrict the occurrence of RNA:DNA hybrids, also known as R-
loop structures, that form naturally during transcription, and can
trigger genomic instability if left unresolved [10]. Furthermore the
same group showed that senataxin resolves R-loop structures to
facilitate transcriptional termination in mammalian cells [7]. We
reasoned that the defective meiosis in Setx2/2 testes and the
consequent apoptosis at pachytene stage might be due to R-loop
accumulation as a consequence of transcriptional abnormalities in
the absence of senataxin. As shown in Figure 3E, a collection of
pachytene-stage spermatocytes from Setx2/2 mice showed a
marked accumulation of R-loops compared to Setx+/+. There
was some variation in the R-loop-specific (S9.6) antibody [29,30]
staining intensity between individual pachytene-stage spermato-
cytes of Setx2/2, indicating heterogeneity in R-loop accumulation
(Figure 3E–3F). The fluorescence intensity of individual pachy-
tene-stage spermatocytes detected by the R-loop-specific antibody
was classified into three categories: faint-none, medium and strong
as indicated in Figure 3E. No pachytene spermatocytes with strong
R-loop staining intensity were observed in Setx+/+ (Figure 3E). This
was confirmed with Setx2/2 testes sections which again showed
very intense R-loop staining which was variable in different
spermatocytes (Figure 4A). Pre-treatment of testes sections with
RNAse H prior to immunostaining reduced dramatically the
staining intensity in Setx2/2 confirming that these were indeed R-
loops (Figure 4B). Co-staining with TUNEL revealed that most
cells with accumulated R-loops also undergo apoptosis (Figure 4A,
4E). Although occasionally present in Setx+/+, R-loop accumula-
tion was dramatically increased in Setx2/2 seminiferous tubules as
shown by an increase in the number of R-loop positive cells per
tubules (Figure 4C–4D). Co-staining with TUNEL revealed that
most cells undergoing apoptosis in Setx2/2 had accumulation of R-
loops (Figure 4E). These data suggest that failure to resolve R-
loops is responsible for the accumulation of DNA DSB and
disruption of meiosis in Setx2/2.
Senataxin localises with DNA damage response proteins
to the sex chromosomes
To investigate in more detail the role of senataxin in meiosis, we
studied its localization by performing immunostaining on Setx+/+
spermatocyte spreads. As shown in Figure 5A–5B, senataxin
localised mostly to the sex chromosomes at pachytene stage. Some
background staining was also observed over the autosomes
(Figure 5A) in line with its effect on meiotic recombination and
R-loop resolution. As expected there was no senataxin labelling in
Setx2/2 spreads (Figure 5A). Partial co-localisation between
senataxin and Brca1 was observed albeit there was a more diffuse
distribution of senataxin in the XY body (Figure 5C). Brca1 labels
the axis of unsynapsed sex chromosomes at pachytene stage to
where it is recruited to initiate (MSCI) meiotic sex chromosome
inactivation [22]. While Brca1 localised to the axis of the sex
chromosomes in Setx2/2 this was incomplete since it was excluded
from part of the chromosome (Figure 5D). It appears that this
corresponds to the Y chromosome based on the structural
morphology [31]. We also determined whether there was a
dependence on Brca1 for localisation of senataxin to the sex
chromosomes using a Brca1D11/D11 p53+/2 mutant mouse. The
results in Figure 5E show that while senataxin localises to XY
chromosomes in wild-type mice it fails to do so in Brca1 mutant
mice. The Brca1D11/D11 mutant protein still localises to the sex
chromosome but is unable to recruit senataxin (Figure 5F). We
next determined whether senataxin and Brca1 interacted using
Brca1 and senataxin co-immunoprecipitations from testes extracts.
We failed to co-immunoprecipitate endogenous senataxin and
Brca1 from mouse testes extracts (data not shown). In addition,
Proximity Ligation Assay (PLA) which allows for the in situ
detection of endogenous protein-protein interactions failed to
reveal a direct interaction between these two proteins (Figure 5G).
In contrast, we confirmed the previously reported endogenous
Brca1 and ataxia-telangiectasia and Rad3 related (ATR) interac-
tion [22] using PLA in situ over the XY body (Figure 5H). A
specific PLA signal for the Brca1/ATR interaction is observed on/
around the axis of the unsynapsed XY chromosomes in Setx+/+
pachytene spermatocytes in agreement with the Brca1 and ATR
distribution patterns over the sex chromosomes.
At pachytene stage, ATR kinase, another marker of XY
chromosomes, is recruited to the unsynapsed axis of the XY
chromosomes through an interaction with Brca1 and then diffuses
to XY chromatin where it phosphorylates serine 139 of histone
H2AX to trigger chromosomal condensation and transcriptional
silencing [22,32]. The results in Figure 6A show a diffuse staining
pattern for ATR in Setx+/+ on the XY body. On the other hand,
ATR decorates only part of the XY chromosome in Setx2/2 and
does not diffuse out into chromatin (Figure 6A and Figure S8). The
mediator of DNA damage 1 (MDC1) protein also plays a key role
at this stage in MSCI [33]. Recognition of unsynapsed axis of the
XY chromosomes by Brca1, ATR and TopBP1 is independent of
MDC1 but the chromosome wide spreading of these proteins is
dependent on MDC1. We observed that MDC1 labelled the X
chromosome but as with Brca1 and ATR failed to decorate the
complete XY chromosome (Figure 6B). However, cH2AX
labelling was localised to XY chromatin (Figure 6C). As
spermatocytes progress from early to mid pachytene the X
chromosome appears elongated and sickle shaped prior to loop
Setx2/2. 1 and 2 represent magnification of autosomes. Scale bar, 20 mm. SCP3 or SCP1 were used to identify the meiotic stages. E. Defect in
senataxin leads to R-loop structures accumulation in germ cells. Staining with S9.6 antibody (R-loops) on adult spermatocytes revealed an increased
formation of R-loops in Setx2/2 germ cells. Scale bar, 20 mm. F. Number of pachytene spermatocytes showing none-faint, medium, and strong R-loop
staining intensities for Setx+/+ and Setx2/2.
doi:10.1371/journal.pgen.1003435.g003
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‘‘curled bundle’’ formation in late pachytene [31]. These looped
XY structures were observed in Setx+/+ but sickle shaped
chromosomes appeared mostly in Setx2/2 indicative of arrest in
mid pachytene (Figure 6D). Distinguishable ‘‘curled bundle’’ sex
chromosomes in Setx2/2 pachytene spermatocytes were seen only
in half the percentage of wildtype (Figure 6E). Thus, the absence of
senataxin also affects XY body formation/structure and reveals a
defect in the recognition and distribution of DNA damage
response proteins on the sex chromosomes and thus results in
MSCI failure.
Defective meiotic sex chromosome inactivation (MSCI) in
Setx2/2 spermatocytes
In mammalian spermatogenesis, the sex chromosomes are
transcriptionally-silenced during the pachytene stage of meiotic
prophase I, forming a condensed chromatin domain termed the
sex body [31,34]. In the majority of Brca1 mutant pachytene cells
sex bodies do not form and transcription is maintained,
demonstrating a failure in MSCI [22]. To determine whether
the absence of senataxin had a similar effect on MSCI, we
analysed the expression of sex-linked genes in Setx2/2 mice using
RT-PCR as previously described [35,36]. As shown in Figure 7A,
an increase in the expression of the X-linked Usp26 (2.44 fold),
Fthl17 (1.4 fold), Tktl1 (1.36 fold) and Ube1x (1.65 fold) genes was
observed for Setx2/2 mice compared to Setx+/+ mice. This was also
true for several Y-linked genes that include Ube1y (2 fold) and Rbmy
(2.14 fold) indicating that MSCI is defective in Setx2/2. Normal
expression for autosomal genes Actinb, Dazl, and Gapdh was also
observed, confirming the specific nature of MSCI (Figure 7A). In
order to confirm that MSCI was induced, staining for the activated
form (Phospho-S2) of RNA polymerase II (Pol II), which is
engaged in transcriptional elongation, revealed a lack of staining at
the XY body in Setx+/+, confirming transcriptional silencing
(Figure 7B). In contrast, Pol II staining was visible over XY
chromosomes in Setx2/2 (Figure 7B). Ubiquitination of histone
H2A has been shown to be associated with transcriptional
silencing of large unravelled chromatin regions of the XY
chromosomes [37]. Because of the continued presence of RNA
Pol II on the sex chromosomes in Setx2/2 we predicted that
ubiquitination of H2A would be defective in Setx2/2. The results
in Figure 7C revealed marked localisation of ubi-H2A to the XY
body in Setx+/+ spermatocytes. On the other hand the extent of
ubi-H2A on the XY body of Setx2/2 was much reduced but ubi-
H2A was also distributed across the autosomes. These data suggest
that senataxin plays a key role in the initial Brca1-dependent stage
in MSCI.
Discussion
This study provides compelling evidence for an essential role for
senataxin in spermatogenesis. We showed that senataxin removes
R-loops to maintain the integrity of the genome during meiotic
recombination and it is also required for effectiveMSCI. In Setx2/2
mutant mice, spermatogenesis was arrested in pachytene stage
where R-loop accumulation in cells coincided with apoptosis,
resulting in male infertility. Testicular atrophy, depletion of germ
cells and sterility are common features of animal models with
defects in meiotic proteins such as Spo11 [38], strand exchange
protein Dmc1 [39], Brca1 [40] and mismatch repair proteins
Msh4, Msh5, Mlh3 and Mlh1 [41–43]. The phenotype in Setx2/2
male mice overlaps with but is distinct from that described for these
mutant mice. Unlike that for Setx+/+, where breaks were confined to
the XY body in pachytene, breaks were still present in the
autosomes as well as the XY body in Setx2/2 mice indicating a
defect in repair of DNA DSB and consequently a defect in meiotic
recombination. This was confirmed by persistence of Rad51 and
Dmc1 on autosomes and a failure to detect chiasmata at late
meiotic nodules in Setx2/2 pachytene cells. Failure to remove
Rad51, as seen in Setx2/2, prevents the completion of meiotic DSB
repair. The meiotic phenotype of Setx2/2 mice resembles that seen
in Brca1D11/D11p53+/2 mice [44]. In that model, chromosome
synapsis occurred normally and cells progressed through to
pachytene, however no chiasmata were observed [44]. Further-
more, DSBs were not repaired in the correct temporal framework,
as demonstrated by persistent cH2AX foci. While the failure to
complete meiosis due to persistence of unrepaired DSB and lack of
cross-overs is common to the Setx2/2 and Brca1 mutants, one
obvious difference is diminished numbers of Rad51 foci and normal
localisation of Dmc1 in the Brca1 mutant [44] This could be
accounted for by the interaction of Rad51 with Brca1 which would
be disrupted in the Brca1 mutant.
Sen1, the yeast homolog of senataxin, restricts co-transcription-
ally formed R-loops which accumulate in sen1-1 mutant in a
transcription-dependent manner [10]. Furthermore, Mischo et al
[10] observed a genetic interaction between sen1 and various
factors involved in HR such as rad50, mre11, sgs1 and rad52 and
concluded that sen1 plays a pivotal role in preventing genomic
instability by transcription-mediated recombination [10]. More
recently, Skourti-Stathaki et al [7] provided evidence that
senataxin, like sen1, resolves R-loop structures formed at
transcriptional pause sites to ensure effective transcription
termination. In vivo accumulation of R-loops was evident in
Setx2/2 seminiferous tubules and in pachytene stage spermato-
cytes, supporting a role for senataxin in resolving such structures.
Furthermore, partial co-localisation between R-loops and TUNEL
staining in Setx2/2 germ cells indicates that this accumulation may
contribute to cell death (Figure 4A–4E). Transcriptional R-loop
formation in eukaryotes is highly correlated with DNA recombi-
nation and/or impairment of genome stability, indicating an
inherent impact of R-looping on the integrity of the genome
[9,45]. R-loop formation is capable of inducing hyper-recombi-
nation and/or hypermutation phenotypes in eukaryotes [8,4].
Recently, THO mutants from S. cerevisiae and C. elegans showed
defective meiosis and an impairment of premeiotic replication as
well as DNA-damage accumulation [46]. Gan et al. [47] have
shown that R-loop formation impairs DNA replication which is
responsible for the deleterious effects of those structures on
genome stability. More recently, Alzu et al. [12] provided evidence
Figure 4. Accumulation of R-loops correlates with apoptosis. A. R-loop and TUNEL co-staining of histological cross-sections of adult Setx2/2
mice revealed apoptosis in germ cells containing R-loops. Hoechst 33342 was used to stain for DNA. Scale bar, 50 mm. B. Pre-treatment of consecutive
testes sections from the same animal with RNAse H dramatically reduced R-loop signal intensity in Setx2/2. Similar results were obtained for
consecutive sections from different Setx2/2 animals (data not shown). C. Quantitation of R-loop positive tubules in Setx+/+ and Setx2/2. The Y-axis
represents the % of tubules containing at least one R-loop positive cell within the tubule. D. Higher number of R-loops positive germ cells per tubule
(1–5 R-loop-positive cells/tubule, 6–10 R-loop-positive cells/tubule, and more than 11 R-loop-positive cells/tubules) in Setx2/2 compared Setx+/+
confirming the role of senataxin in resolving R-loops in vivo. E. Correlation of apoptosis (TUNEL) with R-loop accumulation in Setx2/2 seminiferous
tubules uncovers an essential role for senataxin to resolve R-loops and prevent germ cell apoptosis. Graphic representation of the number of tubules
that contain TUNEL-only positive germ cells (white) and TUNEL and R-loop co-stained germ cells (black).
doi:10.1371/journal.pgen.1003435.g004
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Figure 5. Senataxin localises to the sex chromosomes during meiosis. A. Staining of spermatocytes spreads with an anti-senataxin antibody
(Ab-1) revealed that senataxin localised in majority to the XY chromosomes (1) at pachytene stage in Setx+/+. Some background staining was also
observed on the autosomes. No senataxin was detected in Setx2/2 spermatocytes confirming the specificity of our senataxin antibody. (1) and (2) are
magnification of the XY chromosomes. B. Double staining of Setx+/+ pachytene spermatocytes with senataxin (Ab-1) and SCP3 revealed a diffuse
localisation of senataxin to the XY body. Scale bar, 20 mm. C. Partial co-localisation of senataxin with the XY chromosome marker Brca1. While Brca1
stains exclusively the unsynapsed axis of the XY chromosomes, senataxin staining is more diffuse. D. Brca1 staining of the XY chromosomes in Setx+/+
and Setx2/2 pachytene spermatocytes (day 20). In Setx+/+, the unsynapsed axis of the XY chromosomes is entirely stained with Brca1 while an
incomplete covering (white arrow) of the XY chromosomes is observed in Setx2/2. Scale bar, 5 mm. E. Lack of senataxin recruitment to XY
chromosomes in Brca1D11/D11 p53+/2 as compared to Brca1+/+ p53+/2. F. Brca1 localised to only part of the unsynapsed axis of the XY chromosomes in
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that when transcription and replication collide Sen1 displaces
R-loops to counter recombinogenic events. Thus, R-loop
formation may be an intrinsic threat to genome integrity
throughout evolution and species have evolved a variety of co-
transcriptional processes to prevent the formation of these
structures [46]. Senataxin represents a novel factor that
minimizes the impact of R-loops that arise as part of normal
transcription processes [7,11] and/or DNA-damage-induced
transcription stalling [48]. In the case of Setx2/2 spermatocytes,
accumulation of R-loops occurs throughout leptotene and
zygotene at a time when DNA DSB are being repaired by
crossing over and other mechanisms. Consequently it is likely
that R-loops collide with Holiday junctions and interfere with
resolution of DNA DSB and thus meiotic recombination.
Furthermore, the accumulation of R-loops throughout the
chromatin would also affect the repair of DNA DSB that are
repaired through non crossover mechanisms.
Senataxin specifically localises to the XY body in pachytene
stage partially co-localising with Brca1, MDC1 and ATR
suggesting that it might have a role in MSCI. While Brca1 lines
the unsynapsed axes of the XY chromosomes, senataxin is
associated with these chromosomes but also has a more diffused
distribution on chromatin. Prior to MSCI initiation, Brca1 is
targeted to the unsynapsed axial elements of the X and Y
chromosomes where it remains [22]. It subsequently recruits ATR
to the axial elements where it phosphorylates H2AX. In
agreement with these findings we provided additional evidence
for a direct endogenous interaction between Brca1 and ATR in situ
over the XY body (Figure 5H). It seems likely that recruitment of
senataxin is Brca1-dependent since senataxin did not localize to
the XY chromosome in Brca1D11/D11 p53+/2 mutant mice even
though the smaller protein mutant Brca1 (lacking exon 11) lined
the axes of these chromosomes. We did not detect a direct
endogenous interaction between senataxin and Brca1, suggesting
Brca1D11/D11 p53+/2 while Brca1 coated the entire unsynapsed axis of the XY chromosomes in Brca1+/+ p53+/2. G. Lack of evidence for an in situ direct
endogenous interaction between senataxin and Brca1 on the XY chromosomes as revealed by negative Proximity Ligation Assay (PLA) results on
pachytene spermatocyte spreads. Immunostaining of Setx+/+ pachytene spermatocytes with Brca1 and Setx individually with SCP3 is also shown. H.
Endogenous interaction between ATR and Brca1 was confirmed by PLA. Here, we reveal for the first time a direct endogenous interaction between
Brca1 and ATR in situ over the XY chromosomes.
doi:10.1371/journal.pgen.1003435.g005
Figure 6. Defective localisation and diffusion of DNA damage response proteins in Setx2/2. A. Absence of ATR diffusion over the XY
chromatin domain in Setx2/2 compared to Setx+/+. Scale bar, 5 mm. B. Incomplete diffusion of MDC1 over the XY chromatin domain in Setx2/2, as
indicated by the white arrow. Scale bar, 5 mm. C. Reduced intensity and diffusion of cH2AX staining on the XY chromosomes in Setx2/2 compared to
Setx+/+. D. Altered XY chromosomes structure and formation in Setx2/2 as shown by SCP3 staining. Scale bar 5 mm. E. Percentage of Setx+/+ and Setx2/2
pachytene spermatocytes at days 16, 20 and 22 with clearly distinguishable XY chromosomes. At every time point, a significant higher percentage of
distinguishable XY chromosomes was observed in Setx+/+ (p,0.01 according to Student’s t-test, n = 3600). *,**,*** indicates p,0.01.
doi:10.1371/journal.pgen.1003435.g006
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that the Brca1-dependent localisation of senataxin to the XY
chromosome may be indirect and mediated by other DNA
damage response proteins involved in MSCI. On the other hand,
Brca1 still localised to the sex chromosomes in Setx2/2 mutant
mice. However, this was incomplete since it was excluded from
part of the XY structure in pachytene. This is consistent with a
recent report that the X and Y chromosomes have different
patterns of incorporation and release of recombination/repair and
MSCI-related factors during different stages of meiosis [31]. In
that study, they provided evidence that some MSCI steps are
triggered much later on the Y chromosome than the X
chromosome. Comparison with these results suggests that Brca1
has not localised to the Y chromosome in Setx2/2 spermatocytes
due to a block earlier in pachytene.
Once Brca1 localises to the axial elements of the sex chromosomes
it recruits ATR which phosphorylates H2AX and it subsequently
diffuses out into XY chromatin to trigger MSCI [22]. In Brca1
mutant cells, these proteins do not localise to the surrounding
chromatin [44]. Loss of senataxin did not change the overall
distribution of Brca1 on the XY chromosomes but ATR is no longer
diffusely distributed and is instead retained on the axial elements of
the XY chromosomes, similar to Brca1. The pattern of ATR staining
in Setx2/2 suggests that meiosis only proceeds from early to mid
pachytene in these mice and that ATR re-localisation is dependent
on senataxin (Figure 7D). Recent data show that in the absence of
MDC1, the diffusion of ATR, cH2AX and TopBP1 into XY
chromatin is defective [33]. In the absence of senataxin the failure of
ATR to diffuse from the axial elements to XY chromatin might be
explained by defective MDC1 function. Our observation that
MDC1 fails to localize fully to the XY body is consistent with this.
During leptotene and zygotene, the sex chromosomes are
transcriptionally active [49]. However, at pachytene stage when
meiotic synapsis is complete, the sex chromosomes are rapidly
silenced and compartmentalized into a peripheral nuclear
subdomain, the sex body [50]. MSCI then persists throughout
the rest of pachytene and diplotene [49]. The second wave of
phosphorylation only occurs on the chromatin of the sex
chromosomes and is absolutely essential for MSCI [24,50]. This
second wave of H2AX phosphorylation occurs in Setx2/2 but
breaks were still evident in the autosomes. This, together with
failure to form chiasmata points to regions of asynapsis in Setx2/2
autosomes. Extensive asynapsis has been shown to result in MSCI
failure and pachytene stage IV apoptosis [51,52]. Expression
analysis of X- and Y-linked genes revealed defective MSCI in
Setx2/2. Furthermore, in contrast to that for Setx+/+ mice RNA Pol
II staining was still visible on sex chromosomes in Setx2/2,
consistent with continuing transcription. A reduction in ubi-H2A
on the XY body of Setx2/2 is also consistent with a failure of
MSCI. While no ubi-H2A was observed associated with
autosomes in Setx+/+, in keeping with transcriptional reactivation
at pachytene stage, significant staining is seen on Setx2/2
autosomes pointing to widespread abnormalities in transcriptional
activity in these cells. This is in agreement with the increased R-
loop staining observed at pachytene stage in Setx2/2 cells. Recent
results show that Brca1 preferentially mono-ubiquitinates H2A at
satellite DNA regions and Brca1 deficiency impairs the integrity of
constitutive heterochromatin causing disruption of gene silencing
very likely through loss of ubi-H2A [53].
The evidence presented here suggests that R-loops accumulate
in Setx deficient, actively transcribing cells in the presence of
unrepaired DNA DSB. This supports a role for senataxin in
resolving R-loops (Figure 7D). However, we previously showed
that senataxin has a broader role in RNA processing since splicing
efficiency, alternate splicing and transcription termination are
abnormal in AOA2 cells [6]. It is unlikely that the extent of R-
loops accumulation in actively transcribing/replicating spermato-
cytes will be duplicated in post-mitotic cells, such as Purkinje Cells.
Neither DNA replication nor recombination is taking place in
neuronal cells thus avoiding collisions with the transcriptional
apparatus. Indeed, we were not able to detect R-loops in the
cerebellum and brain of Setx2/2 mice (unpublished data). These
data suggest that the major clinical neurodegenerative phenotype
seen in AOA2 patients is more likely to be due to a more general
defect in RNA processing leading to reduced transcription fidelity
rather than a failure to resolve R-loops. Altogether, these findings
reveal a complex and coordinated network between transcription,
RNA processing, and DNA repair pathways (Figure 7D), and
support the emerging importance of RNA processing factors such
as senataxin in the DNA damage response.
Materials and Methods
Ethics statement
All animal work and experiments have been approved by The
Queensland Institute of Medical Research Animal Ethics Com-
mittee
Targeted inactivation of mouse Setx gene
To disrupt the Setx gene a highly-effective recombineering
approach was employed [54]. Briefly, two cassettes, a loxP-F3-
Figure 7. Aberrant meiotic sex chromosome inactivation in Setx2/2mice. A. Relative levels of transcript of XY-linked germ cell specific genes
from Setx+/+ and Setx2/2 testes was determined by RT-PCR to assess MSCI as previously described [35]. Levels of Actb and Gapdh mRNA were used as
positive controls for ubiquitous gene expression. Levels of Dazl transcripts were determined as a positive control for previously documented
autosomal meiotic expression [35]. Levels of Ube1x and Ube1y transcripts were included as positive controls for previously documented X- and Y-
linked gene expression during spermatogenesis, respectively [35]. X-linked Usp26, Fthl17 and Tktl1, and Y-linked Rbmy genes have previously shown
evidence of MSCI [35]. RT-PCR control without template is also shown. B. Immunostaining for the transcriptionally-active form of RNA Pol II (phospho-
S2) revealed active transcription of the XY chromosomes in Setx2/2 spermatocytes (circle). In contrast, no signal for active Pol II was visible over the
XY chromosomes in Setx+/+ spermatocytes (circle) confirming the silencing of the XY chromosomes. Scale bar, 20 mm. C. Immunostaining for
ubiquitinated histone H2A (ubi-H2A) in Setx+/+ and Setx2/2 spermatocytes reveals a specific staining on the XY chromosomes (circle) in Setx+/+. In
contrast, while ubi-H2A staining was still present on the XY chromosomes in Setx2/2 (circle), it was also distributed on the autosomes. Scale bar,
20 mm. D. Model depicting the consequences of senataxin disruption on spermatogenesis. In wild type spermatocytes, senataxin resolves R-loops
structures that may form during pachytene following the resumption of transcriptional activity, thus allowing effective meiotic recombination to
proceed and spermatogenesis to be completed. Senataxin also localizes to the XY chromosomes in a Brca1-dependant manner thus enabling the
localization of DNA damage response proteins MDC1, ATR and TopBP1 to the entire XY chromatin domain. This ensures that MSCI takes place and
germ cells develop and mature properly. On the other hand, in Setx2/2 spermatocytes, R-loops accumulates at pachytene stage interfering with
meiotic recombination and the repair of DNA DSB. This leads to the absence of crossing-over, the arrest of meisois at pachytene stage and the
elimination of Setx2/2 spermatocytes by apoptosis. The absence of senataxin also results in impaired XY body formation, defective localization of
DNA damage response proteins on XY chromatin and failure to undergo MSCI. The combined defects of aborted meiotic recombination and MSCI
failure are responsible for the infertility observed in Setx2/2 males.
doi:10.1371/journal.pgen.1003435.g007
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PGK-EM7-Neo-F3 (Neo) cassette was inserted into a BAC clone
(RP23-389D11), Children’s Hospital Oakland Research Institute
corresponding to mouse chromosome 2 and covering the Setx
genomic sequence. The Neo cassette which provides positive
selection in ES cells was flanked by a 59 homology arm of 6.8 kb
and a 39homology arm of 3 kb. ES cells were then transfected with
the linearized targeting vector and selected with 150 mg/ml of
G418. Successful recombinant ES clones were determined by
Southern blotting with a specific probe and PCR genotyping, and
targeted cells (+neo) were subsequently micro-injected into
C57BL6/129Sv mice blastocysts to generate chimeras. Excision
of the Neo cassette was obtained by crossing the chimeras with a
Cre deleter stain to generate Setx2/2 mice containing only a LoxP
site.
Animal husbandry and genotyping
The mice were weaned at 21 days post-partum and ear clipped
for identification. Genotyping was carried out by PCR on genomic
DNA isolated from tail tips. Tail tips were lysed in directPCR Lysis
eagent (Qiagen, USA) as recommended by the manufacturer. The
primers used were In3F: 59-TTTAAGGAACAGTGCTGC-39,
In3R: 59-ATGAAGCAGGTAGGATT-39 and LoxPR: 59-
CGAAGTTATATTAAGGGT-39. PCR Cycling conditions were
as follows: 35 cycles, denaturation at 95uC for 30 sec, annealing at
49uC for 30 sec, extension at 72uC for 1 min, with a final cycle
and extension of 7 min at 72uC. Two PCR products were
generated, a wild-type PCR product of 600 bp, and the targeted
PCR product of 339 bp. PCR products were electrophoresed at
100 V for 30 min on 2% TAE Agarose (Boehringer Mannheim,
Amresco, Lewes, UK) stained with Ethidium bromide and
visualised with UV transillumination using a GelDoc XR (Biorad
Laboratories Inc, UK).
Histological analysis of Setx mice testes and ovaries
Testes from adult (35-day-old), 4 months, 8 months and 12
month-old mice were collected and fixed in PBS buffered 10%
formalin, embedded in paraffin block and sectioned at 4 mm.
Sections were stained with Hematoxylin and Eosin (H&E) and
Toluidine blue. Slides were examined under light microscope and
then scanned using Scanscope CS system (Aperio Technologies,
Vista, USA). Images corresponding to610 and620 magnification
were captured and assembled into Adobe Photoshop 7 (Adobe
Systems Inc, USA).
RT–PCR reactions and gene expression analysis
Total RNA was isolated from 35-day-old wild type and
knockout mice testes using the RNeasy mini kit (Qiagen, USA)
according to the manufacturer’s protocol. RNA concentrations
were determined by UV spectrophotometry using a Nanodrop
ND-1000 (Thermo scientific, USA). cDNA was made from 5 mg of
purified RNA. Briefly, RNA was mixed with 1 ml of random
hexamer primers (Bio-Rad Laboratories Inc. USA), 1 ml of
10 mM dNTP mix and DEPC-treated water up to a 14 ml
volume. The mixture was heat-denatured at 65uC for 5 min. 4 ml
of First Strand buffer (Invitrogen, USA), 1 ml of 1 mM DTT, 1 ml
of RNAaseIN (Promega, USA), and 1 ml of SuperScriptIII reverse
transcriptase enzyme (Invitrogen, USA) was added to the mixture,
and incubated for 10 min at 25uC, then 60 min at 50uC, 15 min
at 70uC, and chilled on ice. 1 ml of RNAse H was subsequently
added to each tube and incubated for 20 min at 37uC, followed by
heat inactivation for 20 min at 65uC. The resulting cDNA were
stored at 220uC prior to use. Gene expression analysis was
performed by PCR in a 2720 Thermal Cycler (Applied Biosystem,
USA). Reactions (25 ml) contained 14.5 ml of sterile water, 50 ng of
cDNA template, 16PCR Buffer II (Roche, Switzerland), 2.5 mM
MgCl2 (Roche, Switzerland), 20 mM dNTPs, 1 mM of each
primer, and 5 ml of AmpliTaq Gold DNA Polymerase (Roche,
Switzerland). The primer pairs used for gene expression analysis
are described in Table S1. Amplification was for 30 cycles and
cycling conditions were as follows: denaturation for 5 min at 95uC
for 30 sec, annealing at 55uC for 30 sec, elongation for 1 min at
72uC followed by a final extension step of 7 min at 72uC. PCR
reactions were separated on 2% TAE agarose gels and visualised
as above.
Cell extracts and senataxin immunoprecipitation
Testes from 35 day-old mice were collected and ground with a
pestle to disrupt their structure and lysed for 1 h at 4uC on a
rotating wheel with lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM
b-glycerophosphate, 150 mM NaCl, 10% glycerol, 1% Tween 20,
1 mM PMSF, 5 mM DTT and 16 EDTA-free Complete
Protease inhibitor (Roche, Switzerland). Cellular debris were
pelleted by centrifugation at 16,1006g at 4uC for 10 min, and
protein concentration was determined using Lowry Assay (Bio-
Rad Laboratories, Inc, USA). 2 mg of total cell extract were pre-
cleared with 50 ml of a mixture of 1:30 protein G+A beads
(Millipore, Germany) for 3 hours at 4uC on a rotating wheel.
Extract were centrifuged for 5 min at 20006g, beads were
removed, and 20 mg of anti-human senataxin antibody (Ab1/Ab-
3) was added to the extract. Extracts and antibody were incubated
overnight at 4uC on a rotating wheel to allow binding of the
antibody to mouse senataxin. The next day, 50 ml of protein G+A
beads were added to the extract and incubated for 1 h at 4uC on a
rotating wheel. The immunoprecipitate was subsequently washed
3 times with lysis buffer and the beads were resuspended in gel
loading buffer and separated on 5% SDS-PAGE at constant
current (20 mA per gel) for 1.5 h. Once separated, proteins were
transferred onto a nitrocellulose membrane (Hybond C, Amer-
sham) for 1 h at 4uC with constant voltage (100 Volts).
Immunoblotting with anti-senataxin (Ab-1) antibody was per-
formed using standard procedure as previously described [5].
Spermatocytes spreads, immunostaining, and imaging
All spreads were made from testes collected from adult 35-
day-old mice or at day 16, 20 and 22 post partum. Briefly, testes
were decapsulated, finely chopped and rinsed in GIBCO DME
medium (Invitrogen, USA). Large clumps were removed by
centrifugation at 67806g for 5 min at room temperature. The
remaining supernatant was centrifuged to pellet the cell
suspension and mixed with 0.1M sucrose and spread onto glass
slides pre-wetted with 1% paraformaldehyde and 0.1% Triton
X-100 in PBS. Cells were fixed on the glass slides for 2 h at
room temperature. The slides were subsequently washed with
PBS and air-dried in the presence of a wetting agent, 1:250
Kodak Photo-Flo 200 (Kodak professional, USA). Once dried,
spreads were stored at 280uC. For immunostaining, slides, were
rehydrated in dH20, and blocked in blocking buffer (0.2% BSA,
0.2% gelatine in PBS) for 30 min at room temperature. Spreads
were incubated with primary antibodies overnight at 4uC in a
humidified chamber. Primary antibodies used included anti-
SCP3 (1:100, NB300-230, Novus Biologicals), anti-SCP1-Dye-
Light conjugated (1:100, NB300-2201R, Novus Biologicals),
anti-cH2AX (1:100, Y-P1016, Millipore), anti-Rad51 (1:100,
SC-33626, Santa Cruz Biotechnology), anti-Dmc1 (1:50, 2H12/
4, Sapphire Bioscience), anti-Mlh1 (1:10, G168-15, Sapphire
Bioscience), anti-ATR (1:100, SC-1887, Santa Cruz Biotech-
nology), anti-senataxin (1:100, Ab-1, [5]), anti-R-loop (1:100,
S9.6), anti-RNA Pol II (phospho S2) (1:100, H5, ab24758,
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Abcam), anti-mouse Brca1 (1:300, David Livingston), anti-ubi-
H2A (1:100, Clone E6C5, Millipore). Slides were subsequently
washes 4 times for 3 min each in PBS on a rocker, and probed
with the appropriate Alexa-Dye488 or Alexa-Dye594-conjugat-
ed secondary antibodies (1:250, Invitrogen, Molecular Probes,
USA). Slides were washed again 4 times for 3 min each in PBS.
DNA was stained with Hoechst 33342 (1:10,000) for 10 min at
room temperature, and slides were mounted in Celvol 603
medium. Images were captured at room temperature using a
digital camera (AxioCam Mrm, Carl Zeiss Microimaging Inc.,
Germany) attached to a fluorescent microscope (Axioskop 2 mot
plus, Carl Zeiss Microimaging Inc., Germany) and the
AxioVision 4.8 software (Carl Zeiss, Microimaging Inc.
Germany). The objective employed was a 636 Zeiss Plan
Apochromat 1,4 Oil DIC (Carl Zeiss, Germany). Images were
subsequently assembled in Adobe Photoshop 7 (Adobe Systems
Inc, USA), and contrast and brightness were adjusted on the
whole image panel at the same time.
TUNEL assay for apoptosis
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) is a method for detecting DNA fragmentation by
labeling the terminal end of nucleic acids. TUNEL is a common
method for detecting DNA fragmentation that results from
apoptotic signaling cascades. The assay relies on the presence of
nicks in the DNA which can be identified by terminal
deoxynucleotidyl transferase (TdT), an enzyme that will catalyze
the addition of Fluorescein-labeled dUTP. Paraffin sections were
dewaxed and rehydrated with Shandon Varistain Gemini ES
(Thermo Scientific, USA). TUNEL assay was performed using the
Fluorescence in situ Cell Death Detection Kit (Roche, Switzerland)
following the manufacturer’s instructions. Slides were visualised
under a fluorescent microscope and images were captured as
previously described. The objective employed was a Zeiss Plan
Neofluar 610/0.30 (610 magnification). For double staining,
TUNEL was carried out first followed by immunostaining as
described below.
R-loop and DNA damage immunostaining on tissue
sections
Slides with tissue sections were dewaxed and enzymatic antigen
retrieval was performed by incubating the sections with 1:10
Trypsin dilution in PBS for 20 min at 37uC. Slides were washed 3
times for 5 min with PBS at room temperature for 5 min each.
Tissues sections were blocked in (20% FCS, 2% BSA, 0.2% Triton
X-100) for 1 h at room temperature. Slides were incubated with
anti-R-loop (1:100, S9.6) [29] or anti-cH2AX (1:100, Y-P1016,
Millipore) antibody overnight at 4uC in a humidified chamber.
Slides were washed 5 times with 16PBS containing 0.5% Triton
X-100 for 5 min each at room temperature. Alexa-Dye488 or
Alexa-Dye594-conjugated secondary antibody was added for 1 h
at 37uC in a humidified chamber. Subsequently, slides were
washed 3 times as before and Hoechst 33342 was added for
10 min to staining nuclei. Slides were finally washed twice and
glass coverslips were mounted for imaging. Imaging was
performed as described above. Confirmation of R-loop specific
staining was obtained by pre-treating Setx2/2 testes sections with
RNAse H (New England Biolads, USA).
Proximity Ligation Assay and endogenous in situ
interaction
To investigate a possible interaction between Brca1, ATR and
senataxin we employed in situ Proximity Ligation Assay (PLA)
(Duolink, Olink Bioscience, Uppsala, Sweden) on wild type (Setx+/+)
spermatocytes spreads. PLA allows the monitoring of protein
interactions and modifications with high specificity and sensitivity.
Protein targets can be readily detected and localized with single
molecule resolution and objectively quantified in unmodified cells
and tissues. Utilizing only a few cells, sub-cellular events, such as
transient or weak interactions are revealed in situ. Two primary
antibodies raised in different species recognize the target antigens of
interest. Species-specific secondary antibodies, called PLA probes,
each with a unique short DNA strand attached to it, bind to the
primary antibodies. When the PLA probes are in close proximity,
the DNA strands can interact through a subsequent addition of two
other circle-forming DNA oligonucleotides. After joining of the two
added oligonucleotides by enzymatic ligation, they are amplified via
rolling circle amplification using a polymerase. After the amplifi-
cation reaction, several-hundredfold replication of the DNA circle
has occurred, labeled complementary oligonucleotide probes
highlight the product. The resulting high concentration of
fluorescence in each single-molecule amplification product is visible
as a distinct bright spot when viewed with a fluorescence
microscope. The assay was performed according to the manufac-
turer’s protocol using rabbit anti-mouse Brca1 (1:200, David
Livingston), sheep anti-senataxin (1:200, Ab-1) and goat anti-ATR
antibody (1:100, SC-1887, Santa Cruz Biotechnology) antibodies
and the corresponding anti-goat PLA Probe MINUS and anti-
rabbit PLA probe PLUS. Identification of pachytene stage
spermatocytes was determined by counterstaining with SCP3
antibody. PLA was also carried out on Setx2/2 spermatocytes
spreads as a negative control. Slide mounting and imaging was
performed as described above.
Supporting Information
Figure S1 Absence of neurological phenotype and ataxia in
Setx2/2 mice. Neurological phenotype and ataxia were examined
according to the phenotypic scoring system developed by Guyenet
et al. 2010 [13]. No gross abnormal behaviour and ataxic
phenotype progression was observed over a period of 3 to 17
months. Briefly, this scoring system combines phenotypic assess-
ments that have been previously employed to assess various models
of neurological disease including spinocerebellar ataxia, Hunting-
ton’s disease and spinobulbar muscular atrophy [55–57]. Mea-
sures include hindlimb clasping, ledge test, gait and kyphosis. Each
measure was recorded on a scale of 0–3 (0 representing the
absence of the relevant phenotype and 3 the most severe
manifestation) with a combined total of 0–12 for all four measures.
Ledge test is a direct measure of coordination, the most directly
comparable to human signs of cerebellar ataxia, which is impaired
in cerebellar ataxias and many other neurodegenerative disorders.
Hindlimb clasping is a marker of disease progression in many
mouse models of neurodegeneration and certain ataxias [55]. Gait
is a measure of coordination and muscle function and kyphosis is a
characteristic dorsal curvature of the spine that is commonly
observed in mouse models of neurodegenerative diseases [56,57].
Mice were assessed on a 0–3 scale each for ledge test, clasping, gait
and kyphosis. Average composite score for Setx+/+ and Setx2/2 at
each age was calculated.
(TIF)
Figure S2 Normal ovary structure in Setx2/2 mice. We
examined the histology of Setx2/2 ovaries at 8 months of age to
determine whether they exhibited similar signs as in the human
patients [1,2]. A–D: Haematoxylin and eosin-stained 4 mm
sections of four 8-month old Setx2/2 mouse ovaries. Pre-antral
and antral follicles (F) are present in all sections and many follicles
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contain oocytes (asterisks). All sections also contain corpora lutea
(CL), suggesting ovulation has occurred and the hypothalamic-
pituitary-gonadal endocrine axis is intact in these mice. (Arrow-
heads denote the position of the bursal membrane enclosing the
mouse ovary.) Scale bar, 200 mm.
(TIF)
Figure S3 Testis histology of Setx-deficient mice. A. Testis of a
35-day old Setx+/+ mouse showing normal testis histology. Scale
bar, 200 mm. B. Testis of a 35-day-old Setx+/+ mouse. Scale bar,
100 mm. Interstitial (Leydig) cells lie between the seminiferous
tubules (LD). C. Seminiferous tubule from a Setx+/+ mouse at
higher magnification. The tubule contains primary spermatocytes
undergoing mitosis (short arrow), and elongated spermatids
(asterisks) towards the lumen of the tubule, in which few sperm
tails (T) can be seen. LD cells lie between the tubules. Sertoli cell
nuclei (SCN) are present on the basement membrane of the
tubule. D. Testis of a 35-day-old Setx2/2 mouse showing
seminiferous tubules with smaller diameter and disrupted
spermatogenesis. Scale bar, 200 mm. E. Testis of a 35-day-old
Setx2/2 mouse, showing tubules at different stages of the
seminiferous epithelial cycle. In some stages, spermatocytes
(asterisks) are abundant. In other stages of the seminiferous cycle
spermatogonia and some spermatocytes (Sp) line an almost empty
tubule. Scale bar, 100 mm F. Seminiferous tubule of a 35-day-old
Setx2/2 mouse testis, showing spermatogonia (Spn) and Sertoli cell
nuclei (SCN) lining the basement membrane of the tubule. The
lumen appears to contain remnants of Sertoli cell cytoplasm.
Elongated spermatids and spermatozoa are completely absent. G–
J. Male Setx+/2 mice exhibit signs of reduced fertility at 8 months
of age. G. Seminiferous tubules contain few mature spermatozoa
and large inclusions (arrowheads), suggesting increased apoptosis
of spermatogenic cells. The seminiferous epithelium contains post-
meiotic round and elongating spermatids. Scale bar, 200 mm. H.
Seminiferous tubule from an 8-month Setx+/2 mouse testis; Scale
bar, 100 mm. The seminiferous epithelium contains all stages of
spermatogenesis, including round (R) and elongating spermatids
(asterisks) and there are sperm tails (T) in the lumen. I.
Seminiferous tubule from an 8-month Setx+/2 mouse testis. Scale
bar, 100 mm. The seminiferous epithelium appears disrupted in places
(arrow), with few round or elongated spermatids and debris in the
lumen. J. In this seminiferous tubule from 8-month Setx+/2mouse testis
there are few round (R) or elongated spermatids (asterisks) present and
the lumen contains cell debris (arrow). Scale bar, 100 mm.
(TIF)
Figure S4 Abortion of meiosis following a block at pachytene stage
in Setx2/2 mice. A. Schematic representation of the various stages of
spermatogenesis and the temporal expression of stage-specific makers
as previously reported [58]. B. Semi-quantitative RT-PCR analysis of
spermatogenesis stage-specific markers in Setx+/+ and Setx2/2 testes.
Similar levels of expression for mitosis and meiosis-specific markers
(Dmc1, Calmegin, A-myb) were observed in both Setx+/+ and Setx2/2
testes. A reduction of Pgk2 is noticable in Setx2/2. A marked
reduction in expression for post-meiotic germ cells (Prm1, Prm2 and
Tnp1) is observed in Setx2/2 testes in agreement the absence of these
cells in Setx2/2 seminiferous tubules as shown in Figure 2. These data
suggest that Setx2/2 spermatocytes do not proceed past meiosis.
Gapdh was used as an internal standard. Cal, Calmegin.
(TIF)
Figure S5 Elevated levels of DSBs in adult Setx2/2 testes
sections. cH2AX staining of adult testes histological sections
highlight the extensive amount of DNA DSB breaks in Setx2/2
seminiferous tubules.
(TIF)
Figure S6 Persistance of Rad51 and Dmc1 foci at pachytene
stage in Setx2/2 and Brca1D11/D11p53+/2 spermatocytes. A. Persistence
of DSB repair intermediates in pachytene cells of Setx2/2 mice.
Normal Rad51 foci formation occurred at leptotene and zygotene
stage in Setx+/+ and Setx2/2 mice, there was persistence of Rad51
foci at pachytene stage in Setx2/2 spermatocytes indicating the
presence of unrepaired DSBs. Scale bar, 20 mm. B. Persistence of
DSB repair intermediates in pachytene cells of Setx2/2 mice.
Normal Dmc1 foci formation occurred at leptotene and zygotene
stage in Setx+/+ and Setx2/2 mice, there was persistence of Dmc1
foci at pachytene stage in Setx2/2 spermatocytes indicating the
presence of unrepaired DSBs (compare 1 and 2). Scale bar, 20 mm.
C. Quantitation of Dmc1 foci at pachytene stage in Setx+/+ and
Setx2/2 mice. A 10-fold increase of Dmc1 foci was observed in
Setx2/2. (Student’s t-test, n= 50) * indicates p,0.05. D. Rad51 foci
in Brca1+/+p53+/2 and Brca1D11/D11p53+/2. Normal Rad51 foci
formation occurred at leptotene and zygotene stage in Setx+/+ and
Setx2/2mice, there was persistence of Rad51 foci at pachytene stage
in Brca1D11/D11p53+/2 spermatocytes indicating the presence of
unrepaired DSBs. Scale bar, 20 mm. E. Quantitation Rad51 foci at
pachytene stage in Brca1+/+p53+/2 and Brca1D11/D11p53+/2 sper-
matocytes. A 2.5-fold increase in the numbers of Rad51 foci was
observed in Brca1D11/D11p53+/2 (Student’s t-test, n = 50). * indicates
p,0.05.
(TIF)
Figure S7 Expression levels of recombination factors. A. RT-PCR
analysis of Rad51 expression revealed that the increased number of
Rad51 foci in Setx2/2 is not due to an increased expression of Rad51
gene since similar levels of Rad511 mRNA levels were detected in
Setx+/+ and Setx2/2 testes. B. Immunoblotting of Setx+/+ and Setx2/2
testes protein extracts with anti-Rad51 antibody shows reduced levels
of Rad51 protein in Setx2/2. Anti-GAPDH was used as a loading
control. C. RT-PCR analysis of Dmc1 expression revealed that the
increased number of Dmc1 foci in Setx2/2 is not due to an increased
expression of Dmc1 gene since similar levels of Dmc1 mRNA levels
were detected in Setx+/+ and Setx2/2 testes. D. RT-PCR analysis of
Mlh1 expression revealed that the absence of Mlh1 foci in Setx2/2 is
not due to a lack of expression of Mlh1 gene since similar levels of
Mlh1 mRNA levels were detected in Setx+/+ and Setx2/2 testes. E.
Immunoblotting of Setx+/+ and Setx2/2 testes protein extracts with
anti-Mlh1 antibody shows similar levels of Mlh1 protein. Anti-
GAPDH was used as a loading control.
(TIF)
Figure S8 Abnormal localisation of ATR in Setx2/2 pachytene
spermatocytes. ATR foci formation occurred at leptotene and
zygotene stages in Setx+/+ and Setx2/2 spermatocytes, however,
ATR failed to spread to XY chromatin domain in Setx2/2 at
pachytene stage. Scale bar, 20 mm.
(TIF)
Table S1 Sequences of primers used for the gene expression
analysis. Sequences of the primers used for the spermatogenesis
stage specific markers and X- and Y-linked gene expression analysis.
(PDF)
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APPENDIX II 
WORLD OF REPRODUCTIVE BIOLOGY 
 
Senataxin Saves Sperm 
 
A multitasking protein controls chromosomal activities during spermatogenesis in mice, 
according to a new report. The evolutionarily conserved protein, senataxin, is required for 
proper homologous recombination during meiosis and helps mediate the silencing of the XY 
body, which is restricted in a process called meiotic sex chromosome inactivation.  
 
Studies in proliferating mammalian cells and yeast have suggested that senataxin may help 
co-ordinate replication, transcription, and DNA repair through multiple mechanisms. For 
instance, the yeast ortholog of senataxin is associated with DNA replication forks, and the 
mammalian protein binds to proteins involved in transcription. Moreover, senataxin seems to 
protect the genome from DNA damage by helping to eliminate R loops, RNA:DNA hybrids 
that form over transcription pause sites. 
 
To further investigate the role of senataxin, Olivier Becherel et al. created mice deficient for 
this protein. The female mice had reduced fertility and the male mice were completely 
infertile. The researchers focused their studies on understanding the impairment in males.  
 
The researchers found that in senataxin-deficient spermatocytes, R loops accumulated during 
meiotic recombination. Perhaps as a consequence of this defective R-loop elimination, DNA 
double-stranded breaks also accumulated, ultimately resulting in a failure of the essential step 
in meiosis, crossing over.  
 
Proper formation of the XY body was also impaired. The XY body was transcriptionally 
active in senataxin-deficient mice, and proteins involved in XY silencing did not localize 
properly to the XY chromosomes. Senataxin was found to be associated with the XY body, a 
process that requires DNA repair protein BRCA1. As a result of these meiotic defects, 
spermatogenesis was arrested in the pachytene stage, resulting in apoptosis and male 
infertility.  
 
The findings show how DNA-regulating proteins can be deployed for multiple tasks. Other 
examples include proteins involved in the response to DNA damage that also play essential 
roles in meiosis, such as BRCA1, MDC1, and H2AX.  
  
—Charlotte Schubert 
 
Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera AM, Woods R, Fleming J, 
Carrie D, McKinney K, Xu X, Deng C, et al. Senataxin plays an essential role with 
DNA damage response proteins in meiotic recombination and gene silencing. PLoS 
Genet 2013; 9(4):e1003435.  
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Ataxia oculomotor apraxia type 2 (AOA2) is a rare autosomal reces-
sive disorder characterized by cerebellar 
atrophy, peripheral neuropathy, loss of 
Purkinje cells and elevated α-fetoprotein. 
AOA2 is caused by mutations in the 
SETX gene that codes for the high molec-
ular weight protein senataxin. Mutations 
in this gene also cause dominant neuro-
degenerative disorders. Similar to that 
observed for other autosomal recessive 
ataxias, this protein protects the integ-
rity of the genome against oxidative and 
other forms of DNA damage to reduce 
the risk of neurodegeneration. Senataxin 
functions in transcription termination 
and RNA splicing and it has been shown 
to resolve RNA/DNA hybrids (R-loops) 
that arise at transcription pause sites or 
when transcription is blocked. Recent 
data suggest that this protein functions at 
the interface between transcription and 
DNA replication to minimise the risk of 
collision and maintain genome stability. 
Our recent data using SETX gene-dis-
rupted mice revealed that male mice were 
defective in spermatogenesis and were 
infertile. DNA double strand-breaks per-
sisted throughout meiosis and crossing-
over failed in SETX mutant mice. These 
changes can be explained by the accumu-
lation of R-loops, which interfere with 
Holiday junctions and crossing-over. We 
also showed that senataxin was localized 
to the XY body in pachytene cells and 
was involved in transcriptional silencing 
of these chromosomes. While the defect 
in meiotic recombination was striking in 
these animals, there was no evidence of 
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neurodegeneration as observed in AOA2 
patients. We discuss here potentially dif-
ferent roles for senataxin in proliferating 
and post-mitotic cells.
Autosomal recessive cerebellar ataxias 
are a class of progressive neurodegenera-
tive disorders that result from cerebellar 
atrophy and spinal tract dysfunction.1 
One of these, ataxia oculomotor apraxia 
type 2 (AOA2) is characterized by pro-
gressive cerebellar atrophy and periph-
eral neuropathy, oculomotor apraxia and 
elevated α-fetoprotein serum levels, with 
an onset between 10–20 y of age.2-4 Brain 
MRI reveals diffuse cerebellar atrophy 
and electroneuromyography confirms the 
peripheral neuropathy.4 The major clinical 
features of this disorder are shown in Table 
1. In a post-mortem AOA2 case, Criscuolo 
et al.5 observed reduced brain size and cer-
ebellar atrophy which was most evident at 
the level of the vermis and anterior lobe; 
the cerebellar cortex had marked loss of 
Purkinje cells and brainstem and spinal 
cord were slightly reduced. Thus, as with 
other autosomal recessive ataxias, pathol-
ogy in the cerebellum features strongly. 
However, unlike that for the related disor-
der ataxia telangiectasia (A-T), there is no 
evidence of increased cancer susceptibility 
in AOA2.
The gene mutated in AOA2 was ini-
tially mapped to chromosome 9q34 and 
subsequently identified as SETX.6 SETX 
is predicted to code for a 2,667 amino 
acid protein (senataxin) that contains a 
highly conserved C-terminal seven-motif 
domain found in the superfamily 1 of 
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and the cells had elevated levels of oxida-
tive DNA damage.8 In support of a role for 
senataxin in the DNA damage response, it 
has also been demonstrated that telomere 
length is constitutively reduced in AOA2 
lymphocytes and the rate of telomere 
shortening by DNA damage is increased 
in these cells.14 Interaction of Sen1p with 
Rnt1p (an endoribonuclease required for 
RNA maturation) suggested that Sen1p 
is also involved in RNA processing and 
transcription.13 We provided evidence for 
a similar role in human cells by identi-
fying novel senataxin-interacting pro-
teins, the majority of which are involved 
in transcription and RNA processing, 
including RNA polymerase II.15 Binding 
of RNA polymerase II to candidate genes 
was significantly reduced in senataxin 
deficient cells and this was accompanied 
by decreased transcription of these genes, 
suggesting a role for senataxin in the 
regulation/modulation of transcription. 
RNA polymerase II-dependent transcrip-
tion termination was defective in cells 
depleted of senataxin in keeping with the 
observed interaction of senataxin with 
poly(A) binding proteins 1 and 2. Splicing 
mutation, causing a cerebellar phenotype 
termed tremor-ataxia syndrome, has been 
described for a mother and daughter. 
These patients showed cerebellar atrophy, 
oculomotor defects and tremor but no evi-
dence of peripheral neuropathy or pyrami-
dal signs.11 In short, mutations in SETX 
can give rise to both dominant and reces-
sive disorders with some overlap in fea-
tures. A greater insight into the function 
of senataxin and the proteins it interacts 
with will help to resolve the quandary of 
several distinct disorders from mutations 
in a single gene.
Senataxin shares extensive homology 
with the yeast Saccharomyces cerevisiae 
splicing endonuclease 1 protein (Sen1p), 
which possesses helicase activity, and is 
involved in the processing of tRNA, rRNA, 
small nuclear and small nucleolar RNA.12 
Sen1p also interacts with Rad2, which is 
required for DNA repair, suggesting that 
the protein may be involved in protecting 
the genome.13 We demonstrated that this 
might also be the case for senataxin by 
showing that AOA2 patient cells display 
sensitivity to DNA damaging agents such 
as H
2
O
2
, camptothecin and mitomycin C 
DNA/RNA helicases and an N-terminal 
domain important for protein-protein 
interaction.7,8 Generally speaking, muta-
tions in a single gene, such as SETX, gives 
rise to one syndrome, which, of course, 
may show heterogeneity depending on 
the nature and localization of the muta-
tions. In the case of SETX, up to 4 dif-
ferent syndromes are associated with 
mutations in this gene (Table 2). Juvenile 
amyotrophic lateral sclerosis (ALS4) is 
a form of juvenile ALS characterized by 
distal muscle weakness and atrophy, nor-
mal sensation and pyramidal tract signs. 
The ALS4 locus maps to chromosome 
9q34. Chen et al.9 detected missense 
mutations in a single allele in the SETX 
gene (which maps to this locus) which 
segregated with the disease. Subsequent 
studies have detected SETX mutations in 
additional ALS4 patients. Heterozygous 
SETX gene mutations were also detected 
in patients with autosomal dominant 
proximal spinal muscular atrophy.10 These 
patients showed proximal and distal mus-
cular atrophy and pareses. While there 
was overlap with ALS4, this appeared to 
be a discrete entity. A dominant SETX 
Table 1. Ataxia Oculomotor Apraxia type 2 
(AOA2): clinical Features
Onset second decade
diffuse cerebellar atrophy (mri)
Peripheral neuropathy
early loss of reflexes
loss of Purkinje cells
Oculomotor apraxia
extra-neurological features of A-t missing but 
α-fetoprotein elevated
Autosomal recessive cerebellar ataxia
Table 2. mutations in SETX give rise to different neurodegenerative disorders
Disorder Age of onset (yr) Major Clinical Phenotype Gene/Protein Inheritance References
Ataxia oculomotor apraxia type 2 (AOA2) 10–20 cerebellar ataxia with peripheral 
neuropathy
Setx/senataxin recessive 1–5
tremor ataxia syndrome (tAS) 3, 13* cerebellar ataxia without peripheral 
neuropathy
Setx/senataxin dominant 11
Juvenile Amyotrophic lateral sclerosis 
(AlS4)
14** limb weakness and severe muscle 
wasting
Setx/senataxin dominant 9
Autosomal dominant proximal spinal mus-
cular atrophy (AdSmA)
10–20 muscular atrophy and weakness Setx/senataxin dominant 10
*Age of onset for daughter and mother. **Average age of onset.
Figure 1. r-loop structure. r-loops form at sites when the rnA polymerase complex encoun-
ters G-rich sequences such as those found at transcription pause sites, cpG islands in promoter 
regions, repeat sequences and telomeric regions.31,32 Pairing of the nascent rnA remains with the 
ssdnA region behind the elongating rnA polymerase complex leads to r-loop (dnA/rnA hybrid) 
formation.
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AOA2 patients is progressive neurodegen-
eration in post-mitotic tissue. Under those 
conditions, ongoing transcription will not 
encounter DNA replication forks. What 
then is the role of senataxin in the brain? 
Vantaggiato et al.23 provided evidence that 
senataxin plays a role in neuritogenesis 
and cytoprotection during neuronal dif-
ferentiation which is mediated by fibro-
blast growth factor 8. However, since this 
is a progressive disease, it is unlikely that 
the role of senataxin is restricted to devel-
opment. To address this further, we dis-
rupted the SETX gene in a mouse model 
for AOA2, which was the subject matter 
of our recent publication.24 Unfortunately, 
we did not observe a neurodegenerative 
phenotype in the Setx−/− mice and there 
was no evidence of more subtle behav-
ioral differences in these mice, which lim-
ited investigation into the nature of the 
defect in the brains of these mice. This 
was not altogether surprising since knock-
out of several of the genes causing auto-
somal recessive ataxias in humans fails 
to re-capitulate the phenotype in mouse 
transient R-loop accumulation, giving rise 
to transcription-associated recombination 
and genome instability. More insight into 
this was provided recently by Alzu et al.21 
who showed that Sen1p associates with 
DNA replication forks to protect their 
integrity across RNA Pol II – transcribed 
genes. Thus, Sen1p plays an important 
role in coordinating replication with tran-
scription to protect the genome. Support 
for a similar role for the human ortholog, 
senataxin, was provided recently by Yuce-
Petronczki and West22 who showed that 
senataxin localized to distinct nuclear foci 
in S/G2 phase cells and that the num-
ber of these foci increased in response to 
impaired replication. These data suggest 
that senataxin localizes to collision sites 
between the transcription apparatus and 
components of the replisome.
All of the investigations above have 
described a role for senataxin in prevent-
ing collision between DNA replication 
forks and ongoing transcription to pre-
serve genome integrity in proliferating 
cells. However, the major phenotype in 
efficiency of specific mRNAs and alter-
nate splice-site selection of both endog-
enous genes and artificial minigenes were 
altered in senataxin-depleted cells.15 A role 
for senataxin in transcription elongation 
and termination is further supported by 
a report showing that cells with senataxin 
knockdown displayed an increase in RNA 
read-through and Pol II density down-
stream of the Poly (A) site and also exhib-
ited increased levels of R-loop formation.16 
R-loops are RNA/DNA hybrids that form 
over transcription pause sites by interac-
tion with a ssDNA template behind an 
elongating Pol II complex (Fig. 1). These 
structures are potentially harmful and 
can cause genomic instability if left unre-
solved.16-18 The yeast ortholog of senataxin 
Sen1p, has also been shown to protect its 
heavily transcribed genome from R-loop-
mediated DNA damage.19 More recently, 
Hazelbaker et al.20 showed that kinetic 
competition between elongating RNA pol 
II and Sen1p helicase likely explains the 
temporal and spatial window for early Pol 
II termination. Loss of Sen1p results in 
Figure 2. Accumulation of r-loops in Setx−/− germ cells. (A) immunostaining of testes cross-sections from wildtype (+/+) and Setx knockout (−/−) mice 
with the S9.6 dnA/rnA (r-loop) antibody. nuclei were stained with Hoechst 33342. Scale bar, 100 μm. regions 1 and 2 show magnifications. (B) im-
munostaining of pachytene spermatocytes from wildtype (+/+) and Setx knockout (−/−) with S9.6 antibody shows a dramatic accumulation of r-loops 
in senataxin deficient germ cells. ScP3 was used to stain for the synaptonemal complex and identify pachytene stage cells. Scale bar, 20 μm.
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subsequently showed that senataxin had 
an essential role in spermatogenesis in 
mice and in its absence these cells failed to 
progress past the pachytene stage of pro-
phase 1 of meiosis.24 The DNA double-
strand breaks (DSB) introduced by Spo11 
in readiness for meiotic recombination 
were inefficiently repaired on autosomes, 
resulting in a failure to complete crossing-
over. During the process of crossing-over, 
autosomes remain transcriptionally active, 
so it was possible that in the absence of 
senataxin, R-loops would accumulate 
in the vicinity of unrepaired DNA DSB 
leading to collapse of Holiday junctions 
and inhibition of the crossing-over step. 
Indeed this was the case since we detected 
elevated levels of R-loops in both sper-
matocyte spreads and testes sections (Fig. 
2). Wild-type mice showed a very much 
reduced level of signal. So in the case of 
spermatocyte differentiation, the R-loops 
that accumulate in the absence of senataxin 
appear to collide with Holiday junctions 
rather than with advancing replication 
forks. We also screened for the presence 
of R-loops in the brains of Setx mutant 
mice but failed to detect these structures 
by immunofluorescence (unpublished 
data). This was not altogether surprising 
since neither DNA replication nor DNA 
recombination is taking place in this tis-
sue. It is possible that persistence of DNA 
damage in post-mitotic cells might lead 
to the accumulation of these structures, 
which in turn could contribute to the neu-
rodegenerative changes in AOA2 patients. 
However, we and others have provided 
evidence for a broader role for senataxin in 
transcription and other cellular processes. 
Senataxin plays an important role in tran-
scription termination to prevent RNA 
readthrough, which may or may not be 
related to R-loop resolution.15,16 The pres-
ence of significant readthrough of mRNA 
may lead to inefficient or aberrant protein 
synthesis and consequently cell toxicity. 
Senataxin has also been shown to play a 
role in the regulation of splicing15 and defi-
ciency of the SR splicing factor ASF/SF2 
leads to R-loop accumulation and genome 
instability.18 This in turn may interfere 
with the fidelity of the transcriptome in 
AOA2 cerebellum.
AOA2 is just one of several neuro-
degenerative disorders characterized by 
Figure 3. Protection of the genome by senataxin in proliferating vs. post-mitotic cells. (A) in 
proliferating cells, collision of the transcription apparatus (rnA Pol) with replication forks (dnA 
Pol), stalled replication forks following dnA damage exposure, or Holiday junctions during 
homologous recombination, lead to the formation and accumulation of r-loop structures. in the 
presence of senataxin, r-loops are effectively resolved by its putative dnA/rnA helicase activity, 
thus leading to normal cellular metabolism and cell survival. in the absence of senataxin, r-loops 
accumulate and impact on rnA metabolism through the alteration of mrnA splicing, the inhibi-
tion of transcription termination, the promotion of readthrough, the alteration of gene expression 
and the formation of dnA breaks. the accumulation of these defects drives genomic instability 
and ultimately cell death. (B) in contrast, in post-mitotic cells, such as neurons, the absence of 
dnA replication and homologous recombination, and the lack of r-loops accumulation suggest 
senataxin’s role in protecting the genome may be directly due to its effect on mrnA splicing, 
transcription termination and the modulation of gene expression through its interaction with 
rnA binding proteins.
patients who entered menopause in early 
adulthood which was also observed in a 
separate study.5 Ovarian failure has also 
been observed in a patient with AOA226 
and another patient had a diagnosis 
of polycystic ovarian syndrome.27 We 
models.25 However, we observed that 
Setx−/− male mice were infertile and fertil-
ity was reduced in females. While there is 
no information on male fertility in AOA2, 
there are a few reports of hypogonadism 
in females. Criscuolo et al.4 reported two 
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and DNA replication in proliferating cells. 
Resolution of R-loops is prominent in that 
role but it is evident that senataxin has a 
broader involvement in RNA process-
ing (Fig. 3). Its role in post-mitotic cells 
is not clear, but it is likely that this will 
be on some aspect of RNA metabolism 
to protect the integrity of the genome/
transcriptome. What remains intriguing 
is how mutations in a single gene SETX, 
often in close proximity to one another, 
can cause both autosomal dominant and 
recessive disorders. However, while muta-
tions in SETX give rise to what appears 
to be 4 different syndromes, it is also 
evident that there is some overlap across 
these disorders. To date, several senataxin-
interacting proteins have been identified, 
all of which are involved in some aspect of 
RNA processing.15 Mutations in some of 
these also give rise to other neurodegener-
ative disorders.28 It seems likely that these 
defects in RNA metabolism that impact 
either gene transcription, pre-mRNA 
splicing, ribonucleoprotein complex for-
mation, mRNA transport, RNA transla-
tion or RNA degradation.28 One form of 
the motor neuron disease, amyotrophic 
lateral sclerosis (ALS) is caused by defects 
in TDP-43 and FUS/TLS, both of which 
contain RNA-binding motifs29 and spi-
nal muscular atrophy (SMA) is caused by 
deletion or mutation in survival of motor 
neuron 1 (SMN1). Profound loss of splic-
esome integrity is a critical mechanism 
common to ALS and SMA.30 It is also of 
interest that we previously identified SMN 
as one of the proteins that interact with 
senataxin, pointing to an overlapping role 
in RNA processing.15
In summary, much progress has been 
made recently on the function of senataxin 
and its yeast ortholog Sen1p in resolving 
potential conflict between transcription 
17. Aguilera A, Gómez-González B. Genome instability: 
a mechanistic view of its causes and consequences. 
Nat Rev Genet 2008; 9:204-17; PMID:18227811; 
http://dx.doi.org/10.1038/nrg2268
18. Li X, Manley JL. Inactivation of the SR protein splic-
ing factor ASF/SF2 results in genomic instability. 
Cell 2005; 122:365-78; PMID:16096057; http://
dx.doi.org/10.1016/j.cell.2005.06.008.
19. Mischo HE, Gómez-González B, Grzechnik P, 
Rondón AG, Wei W, Steinmetz L, et al. Yeast Sen1 
helicase protects the genome from transcription-
associated instability. Mol Cell 2011; 41:21-32; 
PMID:21211720; http://dx.doi.org/10.1016/j.mol-
cel.2010.12.007
20. Hazelbaker DZ, Marquardt S, Wlotzka W, Buratowski 
S. Kinetic competition between RNA Polymerase II 
and Sen1-dependent transcription termination. Mol 
Cell 2013; 49:55-66; PMID:23177741
21. Alzu A, Bermejo R, Begnis M, Lucca C, Piccini 
D, Carotenuto W, et al. Senataxin associates with 
replication forks to protect fork integrity across RNA-
polymerase-II-transcribed genes. Cell 2012; 151:835-
46; PMID:23141540; http://dx.doi.org/10.1016/j.
cell.2012.09.041
22. Yüce O, West SC. Senataxin, defective in the neuro-
degenerative disorder ataxia with oculomotor apraxia 
2, lies at the interface of transcription and the DNA 
damage response. Mol Cell Biol 2013; 33:406-
17; PMID:23149945; http://dx.doi.org/10.1128/
MCB.01195-12
23. Vantaggiato C, Bondioni S, Airoldi G, Bozzato A, 
Borsani G, Rugarli EI, et al. Senataxin modulates 
neurite growth through fibroblast growth factor 8 sig-
nalling. Brain 2011; 134:1808-28; PMID:21576111; 
http://dx.doi.org/10.1093/brain/awr084
24. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, 
Suraweera AM, et al. Senataxin plays an essential 
role with DNA damage response proteins in mei-
otic recombination and gene silencing. PLoS Genet 
2013; 9:e1003435; PMID:23593030; http://dx.doi.
org/10.1371/journal.pgen.1003435
25. Lavin MF. The appropriateness of the mouse model 
for ataxia-telangiectasia: Neurological defects but no 
neurodegeneration. DNA Repair (Amst) 2013; In 
press; PMID:23731731; http://dx.doi.org/10.1016/j.
dnarep.2013.04.014.
proteins function in complexes to control 
RNA metabolism and different mutations 
in the various subunits may impact differ-
ently on the function of the complex(es), 
giving rise to the heterogeneity of neu-
rodegenerative disorders observed. The 
challenge that lies ahead is to understand 
the relationships of these proteins to one 
another in the complexes and how they 
function to control processes in neurons 
and other cell types in the brain to mini-
mise the risk of neurodegeneration.
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